<SEC-DOCUMENT>0001493152-26-031067.txt : 20260629
<SEC-HEADER>0001493152-26-031067.hdr.sgml : 20260629
<ACCEPTANCE-DATETIME>20260629160518
ACCESSION NUMBER:		0001493152-26-031067
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20260629
FILED AS OF DATE:		20260629
DATE AS OF CHANGE:		20260629

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Beeline Holdings, Inc.
		CENTRAL INDEX KEY:			0001534708
		STANDARD INDUSTRIAL CLASSIFICATION:	MORTGAGE BANKERS & LOAN CORRESPONDENTS [6162]
		ORGANIZATION NAME:           	02 Finance
		EIN:				203937596
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38182
		FILM NUMBER:		261135722

	BUSINESS ADDRESS:	
		STREET 1:		188 VALLEY STREET,
		STREET 2:		SUITE 225
		CITY:			PROVIDENCE
		STATE:			RI
		ZIP:			02909
		BUSINESS PHONE:		971-888-4264

	MAIL ADDRESS:	
		STREET 1:		188 VALLEY STREET,
		STREET 2:		SUITE 225
		CITY:			PROVIDENCE
		STATE:			RI
		ZIP:			02909

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Eastside Distilling, Inc.
		DATE OF NAME CHANGE:	20141202

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Eurocan Holdings Ltd.
		DATE OF NAME CHANGE:	20111110
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>formdef14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:BLNE="http://makeabeeline.com/20251231">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02B_ECD%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_034_BLNE_makeabeeline.com_20251231 -->
<!-- Field: Set; Name: xdx; ID: xdx_04E_20250101_20251231 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05D_edei%2D%2DEntityCentralIndexKey_0001534708 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_065_Ratio_4_xbrli%2D%2Dpure -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2025-01-01to2025-12-31" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2025-01-01to2025-12-31" id="Fact000004" name="dei:EntityCentralIndexKey">0001534708</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2025-01-01to2025-12-31" id="xdx2ixbrl0011" name="dei:DocumentType">DEF 14A</ix:nonNumeric>
  <ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2023-01-012023-12-31_custom_NicholasRLiuzzaJrMember" id="xdx2ixbrl0033" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2023-01-012023-12-31_custom_NicholasRLiuzzaJrMember" id="xdx2ixbrl0034" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl0037" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2025-01-012025-12-31_custom_NicholasRLiuzzaJrMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember" id="xdx2ixbrl0060" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2025-01-012025-12-31_custom_NicholasRLiuzzaJrMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" id="xdx2ixbrl0061" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2025-01-012025-12-31_custom_NicholasRLiuzzaJrMember_custom_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember" id="xdx2ixbrl0062" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2025-01-012025-12-31_custom_NicholasRLiuzzaJrMember_custom_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember" id="xdx2ixbrl0063" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2025-01-012025-12-31_custom_GeoffreyGwinMember_custom_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember" id="xdx2ixbrl0067" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2025-01-012025-12-31_custom_GeoffreyGwinMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember" id="xdx2ixbrl0068" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2025-01-012025-12-31_custom_GeoffreyGwinMember_custom_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember" id="xdx2ixbrl0071" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2025-01-012025-12-31_ecd_NonPeoNeoMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember" id="xdx2ixbrl0076" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2025-01-012025-12-31_ecd_NonPeoNeoMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" id="xdx2ixbrl0077" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2025-01-012025-12-31_ecd_NonPeoNeoMember_custom_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember" id="xdx2ixbrl0078" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2025-01-012025-12-31_ecd_NonPeoNeoMember_custom_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember" id="xdx2ixbrl0079" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_custom_NicholasRLiuzzaJrMember_custom_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember" id="xdx2ixbrl0082" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_custom_NicholasRLiuzzaJrMember_custom_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember" id="xdx2ixbrl0083" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_custom_NicholasRLiuzzaJrMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember" id="xdx2ixbrl0084" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_custom_NicholasRLiuzzaJrMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" id="xdx2ixbrl0085" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_custom_NicholasRLiuzzaJrMember_custom_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember" id="xdx2ixbrl0086" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_custom_NicholasRLiuzzaJrMember_custom_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember" id="xdx2ixbrl0087" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_custom_GeoffreyGwinMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember" id="xdx2ixbrl0092" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_custom_GeoffreyGwinMember_custom_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember" id="xdx2ixbrl0094" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_custom_GeoffreyGwinMember_custom_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember" id="xdx2ixbrl0095" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember" id="xdx2ixbrl0098" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember" id="xdx2ixbrl0099" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember" id="xdx2ixbrl0100" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" id="xdx2ixbrl0101" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember" id="xdx2ixbrl0102" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember" id="xdx2ixbrl0103" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2023-01-012023-12-31_custom_NicholasRLiuzzaJrMember" id="xdx2ixbrl0105" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_custom_NicholasRLiuzzaJrMember_custom_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember" id="xdx2ixbrl0106" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_custom_NicholasRLiuzzaJrMember_custom_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember" id="xdx2ixbrl0107" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_custom_NicholasRLiuzzaJrMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember" id="xdx2ixbrl0108" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_custom_NicholasRLiuzzaJrMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" id="xdx2ixbrl0109" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_custom_NicholasRLiuzzaJrMember_custom_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember" id="xdx2ixbrl0110" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_custom_NicholasRLiuzzaJrMember_custom_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember" id="xdx2ixbrl0111" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2023-01-012023-12-31_custom_NicholasRLiuzzaJrMember" id="xdx2ixbrl0112" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_custom_GeoffreyGwinMember_custom_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember" id="xdx2ixbrl0114" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_custom_GeoffreyGwinMember_custom_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember" id="xdx2ixbrl0115" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_custom_GeoffreyGwinMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember" id="xdx2ixbrl0116" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_custom_GeoffreyGwinMember_custom_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember" id="xdx2ixbrl0118" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_custom_GeoffreyGwinMember_custom_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember" id="xdx2ixbrl0119" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember" id="xdx2ixbrl0121" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember" id="xdx2ixbrl0122" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember" id="xdx2ixbrl0123" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember" id="xdx2ixbrl0124" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember" id="xdx2ixbrl0126" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember" id="xdx2ixbrl0127" unitRef="USD" xs:nil="true"></ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="blne-20251231.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2025-01-01to2025-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_2025-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:typedMember dimension="ecd:RestatementDateAxis">
            <ecd:RestatementDateAxis.domain>2025-12-31</ecd:RestatementDateAxis.domain>
          </xbrldi:typedMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_NicholasRLiuzzaJrMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:NicholasRLiuzzaJrMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_GeoffreyGwinMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:GeoffreyGwinMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_NicholasRLiuzzaJrMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:NicholasRLiuzzaJrMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_GeoffreyGwinMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:GeoffreyGwinMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_NicholasRLiuzzaJrMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:NicholasRLiuzzaJrMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_GeoffreyGwinMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:GeoffreyGwinMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_NicholasRLiuzzaJrMember_custom_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:NicholasRLiuzzaJrMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_NicholasRLiuzzaJrMember_custom_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:NicholasRLiuzzaJrMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_NicholasRLiuzzaJrMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:NicholasRLiuzzaJrMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_NicholasRLiuzzaJrMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:NicholasRLiuzzaJrMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_NicholasRLiuzzaJrMember_custom_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:NicholasRLiuzzaJrMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_NicholasRLiuzzaJrMember_custom_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:NicholasRLiuzzaJrMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_GeoffreyGwinMember_custom_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:GeoffreyGwinMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_GeoffreyGwinMember_custom_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:GeoffreyGwinMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_GeoffreyGwinMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:GeoffreyGwinMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_GeoffreyGwinMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:GeoffreyGwinMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_GeoffreyGwinMember_custom_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:GeoffreyGwinMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_GeoffreyGwinMember_custom_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:GeoffreyGwinMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ecd_NonPeoNeoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ecd_NonPeoNeoMember_custom_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ecd_NonPeoNeoMember_custom_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ecd_NonPeoNeoMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ecd_NonPeoNeoMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ecd_NonPeoNeoMember_custom_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ecd_NonPeoNeoMember_custom_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_NicholasRLiuzzaJrMember_custom_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:NicholasRLiuzzaJrMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_NicholasRLiuzzaJrMember_custom_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:NicholasRLiuzzaJrMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_NicholasRLiuzzaJrMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:NicholasRLiuzzaJrMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_NicholasRLiuzzaJrMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:NicholasRLiuzzaJrMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_NicholasRLiuzzaJrMember_custom_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:NicholasRLiuzzaJrMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_NicholasRLiuzzaJrMember_custom_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:NicholasRLiuzzaJrMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_GeoffreyGwinMember_custom_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:GeoffreyGwinMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_GeoffreyGwinMember_custom_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:GeoffreyGwinMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_GeoffreyGwinMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:GeoffreyGwinMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_GeoffreyGwinMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:GeoffreyGwinMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_GeoffreyGwinMember_custom_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:GeoffreyGwinMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_GeoffreyGwinMember_custom_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:GeoffreyGwinMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_NicholasRLiuzzaJrMember_custom_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:NicholasRLiuzzaJrMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_NicholasRLiuzzaJrMember_custom_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:NicholasRLiuzzaJrMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_NicholasRLiuzzaJrMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:NicholasRLiuzzaJrMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_NicholasRLiuzzaJrMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:NicholasRLiuzzaJrMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_NicholasRLiuzzaJrMember_custom_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:NicholasRLiuzzaJrMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_NicholasRLiuzzaJrMember_custom_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:NicholasRLiuzzaJrMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_GeoffreyGwinMember_custom_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:GeoffreyGwinMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_GeoffreyGwinMember_custom_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:GeoffreyGwinMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_GeoffreyGwinMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:GeoffreyGwinMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_GeoffreyGwinMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:GeoffreyGwinMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_GeoffreyGwinMember_custom_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:GeoffreyGwinMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_GeoffreyGwinMember_custom_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:GeoffreyGwinMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Ratio">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  <ix:relationship fromRefs="Fact000017" toRefs="Footnote000041"/>
  <ix:relationship fromRefs="Fact000025" toRefs="Footnote000041"/>
  <ix:relationship fromRefs="xdx2ixbrl0033" toRefs="Footnote000041"/>
  <ix:relationship fromRefs="Fact000019" toRefs="Footnote000042"/>
  <ix:relationship fromRefs="Fact000027" toRefs="Footnote000042"/>
  <ix:relationship fromRefs="Fact000035" toRefs="Footnote000042"/>
  <ix:relationship fromRefs="Fact000018" toRefs="Footnote000043"/>
  <ix:relationship fromRefs="Fact000020" toRefs="Footnote000043"/>
  <ix:relationship fromRefs="Fact000022" toRefs="Footnote000043"/>
  <ix:relationship fromRefs="Fact000026" toRefs="Footnote000043"/>
  <ix:relationship fromRefs="Fact000028" toRefs="Footnote000043"/>
  <ix:relationship fromRefs="Fact000030" toRefs="Footnote000043"/>
  <ix:relationship fromRefs="xdx2ixbrl0034" toRefs="Footnote000043"/>
  <ix:relationship fromRefs="Fact000036" toRefs="Footnote000043"/>
  <ix:relationship fromRefs="Fact000038" toRefs="Footnote000043"/>
  <ix:relationship fromRefs="Fact000021" toRefs="Footnote000044"/>
  <ix:relationship fromRefs="Fact000029" toRefs="Footnote000044"/>
  <ix:relationship fromRefs="xdx2ixbrl0037" toRefs="Footnote000044"/>
  <ix:relationship fromRefs="Fact000023" toRefs="Footnote000045"/>
  <ix:relationship fromRefs="Fact000031" toRefs="Footnote000045"/>
  <ix:relationship fromRefs="Fact000039" toRefs="Footnote000045"/>
  <ix:relationship fromRefs="Fact000024" toRefs="Footnote000046"/>
  <ix:relationship fromRefs="Fact000032" toRefs="Footnote000046"/>
  <ix:relationship fromRefs="Fact000040" toRefs="Footnote000046"/>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; font-size: 1pt; border-bottom: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_90F_edei--DocumentType_dxL_c20250101__20251231_zcMrhdOxstjl" title="::XDX::DEF%2014A"><span style="-sec-ix-hidden: xdx2ixbrl0011">SCHEDULE
14A</span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proxy
Statement Pursuant to Section 14(a) of the Securities</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange
Act of 1934 (Amendment No. )</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 36%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed by Registrant</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 62%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed by Party other than Registrant</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check the appropriate box:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 36%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preliminary Proxy Statement</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 56%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Confidential, for Use of the Commission
    Only (as permitted by Rule 14a-6(e)(2))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive Proxy Statement</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive Additional Materials</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting Materials Pursuant to &#167;240.14a-12</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: (select); font-size: 18pt"><b><span id="xdx_905_edei--EntityRegistrantName_c20250101__20251231_z1o0JXpWTwba"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" id="Fact000012" name="dei:EntityRegistrantName">BEELINE
HOLDINGS, INC.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name
of Registrant as Specified In Its Charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name
of Person(s) Filing Proxy Statement, if other than the Registrant)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
of Filing Fee (Check the appropriate box):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No fee required.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee computed
    on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title of each class of
    securities to which transaction applies:</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate number of securities
    to which transaction applies:</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Per unit price or other
    underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated
    and state how it was determined):</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$_____ per share as determined
    under Rule 0-11 under the Exchange Act.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposed maximum aggregate
    value of transaction:</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total fee paid:</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee paid previously
    with preliminary materials.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check box if
    any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was
    paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount previously paid:</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form, Schedule or Registration
    Statement No.:</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filing Party:</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date Filed:</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt; border-bottom: Black 4pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Beeline
Holdings, Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>188
Valley Street, Suite 225,</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Providence,
RI, 02909</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>888-810-5760</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTICE
OF 2026 ANNUAL MEETING OF STOCKHOLDERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TO
BE HELD ON August 17, 2026</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the Stockholders of Beeline Holdings, Inc.:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are pleased to invite you to attend our 2026 Annual Meeting of Stockholders (the &#8220;Annual Meeting&#8221;), which will be held at
11:00 a.m., Eastern Time on August 17, 2026, virtually via audio conference call. No in-person meeting will be held.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Annual Meeting is being held to consider and vote on the following proposals:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<b>Election of Directors Proposal</b> &#8211; To elect five directors to the Board of Directors;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<b>Auditor Ratification Proposal</b> &#8211; To ratify the selection of Salberg &amp; Company, P.A. as the Company&#8217;s independent
registered public accounting firm for the fiscal year ending December 31, 2026;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<b>Equity Line of Credit Proposal</b> &#8212; To approve potential future amendments or modifications to the provisions of the Company&#8217;s
Equity Line of Credit, or ELOC, which the Company and the Purchaser may adopt, including amendments or modifications to the pricing per
share thereunder, other than the maximum total dollar amount of sales thereunder which shall remain $20 million; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<b>Adjournment Proposal</b> &#8211; To approve an adjournment of the Annual Meeting to a later date or time, if necessary, to permit
further solicitation and vote of proxies if there are not sufficient votes at the time of the Annual Meeting to approve any of the proposals
presented for a vote at the Annual Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note</b>:
Transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors has fixed the close of business on June 18, 2026 as the record date for a determination of the stockholders entitled
to notice of, and to vote at, the Annual Meeting or any adjournment or postponement thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with rules of the Securities and Exchange Commission, instead of mailing printed copies of our proxy materials to each stockholder
of record, we are furnishing the proxy materials for the Annual Meeting by providing access to these documents on the Internet. A notice
of Internet availability of proxy materials (the &#8220;Notice&#8221;) is being mailed to our stockholders on or about July 2, 2026.
The Notice contains instructions for accessing and reviewing our proxy materials and submitting a proxy over the Internet. Our proxy
materials were made available at www.BLNE.vote on the date that we first mailed or delivered the Notice. The Notice also contains instructions
on how to request our proxy materials in printed form or by e-mail, at no charge. The Notice contains a control number that you will
need to submit a proxy to vote your shares. We encourage stockholders to access our proxy materials electronically to reduce our impact
on the environment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Important
Notice Regarding the Availability of Proxy Materials for the Annual Meeting</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>to
Be Held on August 17, 2026</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Notice, Proxy Statement and 2025 Annual Report on Form 10-K are available at <span style="text-decoration: underline">www.BLNE.vote.</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
year, our Annual Meeting will be accessible exclusively via live audio conference call. No in-person meeting will be held. You can attend
our Annual Meeting by joining the audio conference call. The Annual Meeting will be conducted via an audio conference call and not in
person. To be admitted to the Annual Meeting, you must have the control number found on your proxy card or voting instruction form. We
have adopted an audio conference format for our Annual Meeting, which allows us to make participation accessible for stockholders from
any geographic location with phone connectivity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
BOARD UNANIMOUSLY RECOMMENDS THAT STOCKHOLDERS APPROVE EACH OF THE PROPOSALS LISTED ABOVE.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Whether
or not you expect to participate in the Annual Meeting, we urge you to vote your shares at your earliest convenience. This will ensure
the presence of a quorum at the meeting. Promptly voting your shares via the Internet, by phone or by signing, dating, and returning
the enclosed proxy card will save us the expenses and extra work of additional solicitation. Submitting your proxy now will not prevent
you from voting your shares at the meeting if you desire to do so, as your proxy is revocable at your option.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Your
vote is important, so please act today</b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By the Order of the Board of Directors:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/ Nicholas
    R. Liuzza, Jr.</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer; Chairman of the Board</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
2, 2026</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Table
of Contents</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 88%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#R_001">Questions and Answers Regarding the Annual Meeting</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#R_002">Proposal 1. Election of Directors</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#R_003">Executive Officers</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#R_004">Corporate Governance</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#R_005">Certain Relationships and Related Party Transactions</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#R_006">Security Ownership of Certain Beneficial Owners and Management</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#R_007">Executive Compensation</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#R_008">Director Compensation</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#R_009">Proposal 2. Auditor Ratification Proposal</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#R_010">Audit Committee Report</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#R_011">Proposal 3. Equity Line of Credit Proposal</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#R_012">Proposal 4. Adjournment Proposal</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Beeline
Holdings, Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>188
Valley Street, Suite 225,</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Providence,
RI, 02909</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>888-810-5760</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2026
ANNUAL MEETING OF STOCKHOLDERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROXY
STATEMENT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Proxy Statement is being made available to the holders of shares of the voting stock of Beeline Holdings, Inc., a Delaware corporation
(&#8220;Beeline&#8221; or the &#8220;Company&#8221;) in connection with the solicitation of proxies by our Board of Directors (the &#8220;Board&#8221;)
for use at the 2026 Annual Meeting of Stockholders of Beeline (the &#8220;Annual Meeting&#8221;) to be held at 11:00 a.m. Eastern Time
on August 17, 2026. The Annual Meeting will be a virtual meeting conducted via an audio conference call and no in-person meeting will
be held. To attend the Annual Meeting, vote your shares, and submit your questions during the Annual Meeting, dial 1-877-407-3088 and
present your unique 12-digit control number. The Notice of Internet availability of proxy materials is first being mailed to our stockholders
on or about July 2, 2026.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="R_001"></span>QUESTIONS
AND ANSWERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following are some questions you may have regarding the Proposals and the Annual Meeting. We urge you to read carefully this entire proxy
statement, including the other documents to which this Proxy Statement refers or which it incorporates by reference because the information
in this section may not provide all the information that is important to you.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Why
did I receive a notice in the mail regarding the internet availability of proxy materials instead of a full set of proxy materials?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the Securities and Exchange Commission (the &#8220;SEC&#8221;) rules, we may furnish proxy materials, including this
Proxy Statement and our Annual Report on Form 10-K (our &#8220;Annual Report&#8221;), to our stockholders by providing access to such
documents on the Internet instead of mailing printed copies. Accordingly, we are sending a Notice of Internet availability of proxy materials
to our stockholders of record and beneficial holders as of June 18, 2026, which is the record date for the Annual Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>How
can I access the proxy materials over the internet?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Notice of Internet availability of proxy materials, and proxy card or voting instruction card included with the proxy materials for the
Annual Meeting will contain instructions on how to view the proxy materials on the Internet. Electronic copies of this Proxy Statement
and the Annual Report are available at www.BLNE.vote.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Who
is entitled to vote?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Directors has set June 18, 2026 (the &#8220;Record Date&#8221;) as the record date for the Annual Meeting. If you were a holder
of record of any class of our voting stock at the close of business on the Record Date, you are entitled to receive notice of the meeting
and to vote your shares at the meeting and at any postponement or adjournment thereof. Holders of the Company&#8217;s Common Stock are
entitled to one vote per share. Holders of the Company&#8217;s Series B Preferred Stock are entitled to a total of 4,032 votes. Holders
of the Company&#8217;s Series F (the &#8220;Series F&#8221;) and Series F-1 (the &#8220;Series F-1&#8221;) Convertible Preferred Stock
are entitled to a total of 126,839 votes. Holders of the Company&#8217;s Series G Preferred Stock (the &#8220;Series G&#8221;) are entitled
to a total of 307,454 votes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
is the difference between holding shares as a record holder and as a beneficial owner?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
your shares are registered in your name with Transfer Online, our transfer agent, you are the &#8220;record holder&#8221; of those shares.
If you are a record holder, a notice of Internet availability of this Proxy Statement has been provided directly to you by Beeline.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
your shares are held in a stock brokerage account, a bank or other holder of record, you are considered the &#8220;beneficial owner&#8221;
of those shares held in &#8220;street name.&#8221; If your shares are held in street name, these materials have been forwarded to you
by that organization. As the beneficial owner, you have the right to instruct this organization on how to vote your shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Who
may attend the meeting and how do I attend?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Record
holders and beneficial owners may attend the Annual Meeting by joining the audio conference call. This year the Annual Meeting will be
held exclusively via audio conference call. No in-person meeting will be held.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Set
forth below is a summary of the information you need to attend the virtual Annual Meeting:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At the time of the virtual
    Annual Meeting, access the live audio conference call at 1-877-407-3088 and present your unique 12-digit control number;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Instructions on how to
    attend and participate in the virtual Annual Meeting, including how to demonstrate proof of stock ownership, are also available at
    <b>www.BLNE.vote</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholders
may vote and submit questions while attending the virtual audio conference call Annual Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>How
do I vote?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are a stockholder of record, you may vote:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">By internet</span>. The
    website address for Internet voting is www.BLNE.vote. The deadline for internet voting is August 16, 2026 at 11:59 p.m. ET.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">By email</span>. Mark,
    date, sign, and email the proxy card to proxy@equitystock.com, Attention: Shareholder Services.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">By mail</span>. Mark, date,
    sign and mail promptly the enclosed proxy card to Equity Stock Transfer, 237 W 37<sup>th</sup> Street, Suite 602, New York, New York
    10018, Attention: Shareholder Services.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">By fax.</span> Mark, date,
    sign, and fax the proxy card to 347-584-3644, Attention: Shareholder Services.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">By audio conference
    call during the Annual Meeting</span>: At the time of the meeting, access the live audio conference call at 1-877-407-3088 and present
    your unique 12-digit control number.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you vote by internet or email, please DO NOT mail your proxy card.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the shares you own are held in street name, your broker, bank, trust, or other nominee, as the record holder of your shares, is required
to vote your shares according to your instructions. Your broker, bank, trust, or other nominee is required to send you directions on
how to vote those shares. The shares that do not receive voting instructions will be treated as &#8220;broker non-votes.&#8221; Broker
non-votes are included in the calculation of the number of votes deemed present at the meeting for purposes of determining the presence
of a quorum.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholders
will not be able to attend the Annual Meeting in person. If you were a stockholder of record as of the Record Date, you may access the
virtual meeting by calling 1-877-407-3088 and presenting the unique 12-digit control number on the proxy card.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 7.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you were a beneficial owner as of the Record Date of shares held in &#8220;street name&#8221; through a broker, bank or other nominee
and you wish to attend the meeting and/or vote your shares during the meeting or submit questions during the meeting, you will need to
provide proof of your authority to vote (legal proxy), which you must obtain from your nominee reflecting your holdings. You may forward
an e-mail from your nominee or attach an image of your legal proxy and transmit it via e-mail to Equity Stock Transfer, LLC, at <span style="text-decoration: underline">proxy@equitystock.com</span>
- and you should label the e-mail &#8220;Legal Proxy&#8221; in the subject line. Requests for registration must be received no later
than 5:00 p.m., Eastern Time, on August 13, 2026. You will then receive confirmation of your registration, with a control number by e-mail
from Equity Stock Transfer, LLC. At the time of the meeting, access the live audio conference call at 1-877-407-3088 and present your
unique 12-digit control number.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 7.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Online
access to the Annual Meeting will open at 11:00 a.m. Eastern Time to allow time for stockholders to call-in prior to the start of the
Annual Meeting. You may vote or ask questions during the Annual Meeting by following the instructions available on the meeting website
during the meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 7.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Whether
or not stockholders plan to participate in the audio-only Annual Meeting, the Company urges stockholders to vote and submit their proxies
in advance of the meeting by one of the methods described in the proxy materials for the Annual Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
constitutes a quorum?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
carry on the business of the Annual Meeting, we must have a quorum. A quorum is present when one-third of the outstanding shares of stock
entitled to vote, as of the Record Date, are represented in person or by proxy. Shares owned by Beeline are not considered outstanding
or considered to be present at the Annual Meeting. Under Nevada law, broker non-votes and abstentions are counted as present for the
purpose of determining the existence of a quorum.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
happens if Beeline is unable to obtain a quorum?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a quorum is not present to transact business at the Annual Meeting or if we do not receive sufficient votes in favor of the proposals
by the date of the Annual Meeting, the persons named as proxies may propose one or more adjournments of the Annual Meeting to permit
solicitation of proxies. Our Bylaws allow the Chairman of any Annual or Special Meeting of the Stockholders to have the authority to
adjourn or postpone such meeting if a quorum is not present, or as otherwise authorized or instructed by the Board of Directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>How
Many Votes are Needed for Each Proposal to Pass?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proposals</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vote
    Required</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 47%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Election
    of Directors Proposal</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plurality</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Auditor
    Ratification Proposal</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Majority
    of the votes cast</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
    Line of Credit Proposal</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Majority
    of the votes cast</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjournment
    Proposal</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Majority
    of the votes cast</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Election
of Directors Proposal</span>. In order to be elected to the Board, each nominee must receive a plurality of the votes cast. This means that
the five director nominees who receive the highest number of votes &#8220;FOR&#8221; their election are elected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Auditor
Ratification Proposal</span>. Ratification of the Company&#8217;s independent registered public accounting firm for the fiscal year ending
December 31, 2026. The affirmative vote of a majority of the votes cast on the proposal is required.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Equity
Line of Credit Proposal. </span>Approval of the Equity Line of Credit Proposal requires the affirmative vote of a majority of the votes
cast.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Adjournment
Proposal</span>. Approval of the Adjournment Proposal requires the affirmative vote of a majority of the votes cast to approve adjournment
of the Annual Meeting to a later date or time, if necessary, to permit further solicitation and vote of proxies if there are not sufficient
votes at the time of the Annual Meeting to approve any of the proposals presented for a vote at the Annual Meeting. Notwithstanding the
results of this vote, the Chairman of the Annual Meeting has authority to adjourn the meeting if a quorum is not present or as otherwise
instructed by the Board of Directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
are the Voting Procedures?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
voting by proxy with regard to the election of directors, you may vote in favor of all nominees, withhold your votes as to all nominees,
or withhold your votes as to specific nominees. On Proposals 2, 3, and 4, you may vote in favor of or against the proposal, or you may
abstain from voting on the proposal. You should specify your respective choices on the proxy card or your voting instruction form.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>How
are abstentions treated?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abstentions
and broker non-votes are not considered votes cast and, except for the Equity Line of Credit Proposal, will have no effect on the foregoing
Proposals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
the Equity Line of Credit Proposal is a non-routine matter under applicable rules, your bank, broker or other nominee cannot vote without
instructions from you.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proposals</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Effect
    of Abstentions on the Proposal</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 47%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Election of Directors Proposal</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No effect</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Auditor Ratification Proposal</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No effect</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity Line of Credit Proposal</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No effect</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4..</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjournment Proposal</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No effect</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abstentions
will not have any effect on Proposals 1 through 4.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
if I am a record holder and sign and return my proxy without making any selections?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are the stockholder of record, and you sign and return a proxy card without giving specific voting instructions, then your shares
will be voted in accordance with the Board of Directors&#8217; recommendations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
if I am a beneficial owner and I do not give the nominee voting instructions?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
your shares are held in street name, you must instruct the organization that holds your shares how to vote. Such organization is bound
by the rules of the New York Stock Exchange, or NYSE, regarding whether or not it can exercise discretionary voting power for any particular
proposal in the absence of voting instructions from you. Although, brokers have the authority to vote shares for which their customers
do not provide voting instructions on certain &#8220;routine&#8221; matter, <b>Proposal 3 is a non-routine matter and your broker is
not permitted to vote on Proposal 3, unless you provide voting instructions on Proposal 3 for the Annual Meeting</b>. Please review the
voting information form used by your broker to see if you can submit your voting instructions by Internet. We expect that your broker,
bank or other nominee will be permitted to vote in favor of Proposals 1, 2, and 4 if you do not vote, but your broker is not obligated
to do so. You should check with the broker that holds your shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Broker
non-votes will not have any effect on Proposals 1 through 4. Broker non-votes are included in the calculation of the number of votes
deemed present at the Annual Meeting for purposes of determining the presence of a quorum.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Is
My Proxy Revocable?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes,
you may revoke your proxy and change your vote at any time before your proxy is voted at the Annual Meeting. If you are a stockholder
of record, you may revoke your proxy and change your vote by submitting a later-dated proxy by telephone, internet, or mail, by voting
in person at the meeting, or by delivering to our Corporate Secretary a written notice of revocation. Attending the meeting will not
revoke your proxy unless you specifically request to revoke it.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you hold your shares in street name, contact your broker, bank, trust, or other nominee regarding how to revoke your proxy and change
your vote</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Who
is Paying for the Expenses Involved in Preparing and Mailing Proxy Materials?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of the expenses involved in preparing, assembling and mailing applicable proxy materials in connection with the Annual Meeting and all
costs of soliciting proxies will be paid by Beeline. In addition to solicitation by mail, proxies may be solicited by our officers and
regular employees by telephone or in person. Such persons will receive no compensation for their services other than their regular salaries.
Arrangements will also be made with brokerage houses and other custodians, nominees and fiduciaries to forward solicitation materials
to the beneficial owners of the shares held of record by such persons, and we may reimburse such persons for reasonable out of pocket
expenses incurred by them in so doing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
Happens if Additional Matters are Presented at the Annual Meeting?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than the items of business described in this Proxy Statement, we are not aware of any other business to be acted upon at the Annual Meeting.
If you submit a signed proxy card, the persons named as proxy holders, Messrs. Nicholas R. Liuzza, Jr., our Chief Executive Officer,
and Christopher Moe, our Chief Financial Officer, will have the discretion to vote your shares on any additional matters properly presented
for a vote at the Annual Meeting. If for any reason any of our nominees is not available as a candidate for director, the persons named
as proxy holders will vote your shares &#8220;FOR&#8221; such other candidate or candidates as may be properly nominated by the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
is &#8220;householding&#8221; and how does it affect me?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Record
holders who have the same address and last name will receive only one copy of the applicable proxy materials, unless we are notified
that one or more of these record holders wishes to continue receiving individual copies. This procedure will reduce our printing costs
and postage fees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are eligible for householding, but you and other record holders with whom you share an address, receive multiple copies of the applicable
proxy materials, or if you hold Beeline stock in more than one account, and in either case you wish to receive only one copy of each
of these documents for your household, please contact our Corporate Secretary at: 188 Valley Street, Suite 225, Providence, RI, 02909,
Attention: Corporate Secretary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you participate in householding and wish to receive a separate copy of the applicable proxy materials, or if you do not wish to continue
to participate in householding and prefer to receive separate copies of these documents in the future, please contact our Corporate Secretary
as indicated above. Beneficial owners can request information about householding from their brokers, banks or other holders of record.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Do
I Have Dissenters&#8217; (Appraisal) Rights?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Appraisal
rights are not available to Beeline stockholders with respect to any of the proposals to be brought before the Annual Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Can
a Stockholder Present a Proposal to be Considered at the Next Annual Meeting?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you wish to submit a proposal to be considered at the 2027 annual meeting of stockholders (the &#8220;Next Annual Meeting&#8221;), the
following is required:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For a stockholder proposal
    to be considered for inclusion in Beeline&#8217;s Proxy Statement and proxy card for the Next Annual Meeting pursuant to Rule 14a-8
    under the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) our Corporate Secretary must receive the written proposal
    no later than March 4, 2027, which is 120 calendar days prior to the anniversary date Beeline&#8217;s Proxy Statement was released
    to the stockholders in connection with the Annual Meeting. Such proposals also must comply with the SEC regulations under Rule 14a-8
    regarding the inclusion of stockholder proposals in company sponsored materials.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Bylaws include advance
    notice provisions that require stockholders desiring to recommend or nominate individuals for election to the Board or who wish to
    present a proposal at the Next Annual Meeting to do so in accordance with the terms of the advance notice provisions. For a stockholder
    proposal or a nomination that is not intended to be included in Beeline&#8217;s Proxy Statement and proxy card under Rule 14a-8,
    our Corporate Secretary must receive the written proposal no later than 90 calendar days prior to the Next Annual Meeting; <span style="text-decoration: underline">provided</span>,
    <span style="text-decoration: underline">howeve</span>r, that in the event that less than 100 days&#8217; notice of public disclosure of the date of the meeting is given
    to stockholders, notice by the stockholder to be timely must be received no later than the close of business on the tenth day after
    public disclosure of the Next Annual Meeting is made. If a stockholder fails to meet these deadlines and fails to satisfy the requirements
    of Rule 14a-8 under the Exchange Act, we may exercise discretionary voting authority under proxies we solicit to vote on any such
    proposal as we determine appropriate. Your notice must contain the specific information set forth in our Bylaws.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
nomination or other proposal will be disregarded if it does not comply with the above procedures. All proposals and nominations should
be sent to our Corporate Secretary at 188 Valley Street, Suite 225, Providence, RI, 02909.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
reserve the right to amend our Bylaws and any change will apply to the Next Annual Meeting unless otherwise specified in the amendment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Interest
of Officers and Directors in Matters to be Acted Upon</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
in the Election of Directors Proposal (Proposal 1), none of the officers or directors have any interest in any of the matters to be acted
upon at the Annual Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Where
can I find voting results of the Annual Meeting?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will announce the results for the proposals voted upon at the Annual Meeting and publish voting results in a Current Report on Form 8-K
filed within four business days after the Annual Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Board of Directors Recommends that Stockholders Vote &#8220;<span style="text-decoration: underline">FOR</span>&#8221; Proposals 1, 2, 3, and 4.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="R_002"></span>PROPOSAL
1. ELECTION OF DIRECTORS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the authority granted to our Board of Directors (the &#8220;Board&#8221;) under our Bylaws, effective June 30, 2026, the Board has
fixed the number of directors constituting the entire Board at five. The Board currently consists of five directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the recommendation of the Corporate Governance and Nominating Committee of the Board, our Board has nominated the five individuals named
below currently serving as directors of the Company to be elected as directors at the Annual Meeting, each to hold office until the next
annual meeting of stockholders and until his or her successor is duly elected and qualified.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
BOARD RECOMMENDS A VOTE &#8220;<span style="text-decoration: underline">FOR</span>&#8221; THE ELECTION OF ALL OF THE DIRECTOR NOMINEES (PROPOSAL 1).</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOMINEES
FOR DIRECTOR</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information provided by the nominees. All of the nominees are currently serving as directors of Beeline. All
of the nominees have consented to serve if elected by our stockholders. There are no family relationships among our directors and executive
officers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 26%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of Nominee</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Position</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nicholas R. Liuzza, Jr.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer and Chairman of the Board</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joseph Caltabiano</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joseph Freedman</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">61</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Francis Knuettel, II</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stephen Romano</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Director
Nominees Biographies</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nicholas
R. Liuzza, Jr.</b> became the Chief Executive Officer of the Company on March 7, 2025. He is also the Chief Executive Officer of Beeline
Financial Holdings, Inc. (&#8220;Beeline Financial&#8221;), the Company&#8217;s principal subsidiary<i>.</i> Mr. Liuzza co-founded Beeline
Financial in 2019 and has served as its Chief Executive Officer since 2019. He has been a director of Red Cat Holdings, Inc. [Nasdaq:
RCAT] since June 1, 2019. Mr. Liuzza&#8217;s service on the Board of another Nasdaq company, as well as his control over the Company
qualifies him to serve as a director.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Joseph
Caltabiano</b> was appointed to our Board on October 7, 2024 in connection with the merger of Beeline Financial into a subsidiary of
the Company (the &#8220;Merger&#8221;)<i>.</i> Mr. Caltabiano&#8217;s career is currently focused on emerging medicine industries. As
co-founder and CEO of Healing Realty Trust, a real estate investment company founded in 2023, he is devoted to developing clinical infrastructure
necessary to support the administration of healthcare services and novel therapies in the behavioral health market. As founder of JSC
Fund, which was founded in 2020, Mr. Caltabiano helps uncover and advance opportunities in cannabis and other regulated sectors. Mr.
Caltabiano helped pioneer the cannabis industry by co-founding Cresco Labs in 2013, one of North America&#8217;s largest vertically integrated
cannabis operators, which he grew into a multi-state operator with annualized revenue of over $250 million. Before focusing on emerging
medicine industries, Mr. Caltabiano served as Senior Vice President of Mortgage Banking at Guaranteed Rate, one of the largest mortgage
providers in the U.S. We believe Mr. Caltabiano&#8217;s extensive experience in mortgage banking will contribute to our efforts in expanding
our presence in that industry, which qualifies him to be a director.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Joseph
Freedman</b> Joseph Freedman was appointed to the Board on October 7, 2024, in connection with the Merger. He previously joined the Board
of Beeline Financial in 2023. Effective April 1, 2026, Mr. Freedman became Chief Executive Officer of Dronazon Corporation. In connection
with that appointment, Mr. Freedman resigned as Lead Director, but not as a director, of Red Cat Holdings, Inc. (Nasdaq: RCAT), where
he has been a director since 2021 and previously chaired both the Compensation and Nominating &amp; Governance Committees. Mr. Freedman
also holds board roles at OneTap Maintenance (proptech), ResiCom Capital Partners (real estate investment), and Fluid Capital Network
(financial services). From 2006 to 2024, he served as co-founder and CEO of Event Works Rental, a full-service event rental company.
Earlier in his career, he founded and led companies in legal services, title insurance, software, and executive search. With a proven
track record as both an operator and board member, Mr. Freedman brings deep cross-sector experience spanning finance, technology, and
high-growth businesses. We believe that Mr. Freedman&#8217;s experience as a director of a Nasdaq company qualifies him to be a director.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Francis
Knuettel, II</b> was appointed to the Board of Directors on May 14, 2025. <span style="background-color: white">Mr. Knuettel has been
Chief Executive Officer of Channel Therapeutics Corporation [NYSE American: CHRO] since July 2023 and Channel&#8217;s Chief Financial
Officer since June 2022. He has also been a director of Channel since August 2024. Prior to that, from December 2020 to March 2022, he
served as Chief Executive Officer and director of Unrivaled Brands, Inc. [OTCQX: UNRV]. Mr. Knuettel has been a director of Splash Beverage
Group, Inc. since April 27, 2026. We believe serving as a Chief Executive Officer and a director of other public companies qualifies
him to serve as a director.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stephen
Romano</b> <span style="background-color: white">was appointed as a director of the Company on March 7, 2025. In July 2021, he founded
CredEvolv, a fintech software platform that connects consumer, lenders, and nonprofit credit counselors, where he continues to serve
as President. From December 13, 2021 to September 2024, Mr. Romano served as President of Grand River Mortgage Company, LLC (d/b/a GRMC
Lending), a digital mortgage company specializing in providing home loans to consumers. Mr. Romano&#8217;s experience in the mortgage
industry led to his appointment as a director.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="R_003"></span>EXECUTIVE
OFFICERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 26%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Position</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nicholas R. Liuzza, Jr.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Christopher R. Moe</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tiffany Milton</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Accounting Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
above for the biography of Nicholas R. Liuzza Jr.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Christopher
R. Moe</b> was appointed as our Chief Financial Officer on October 7, 2024. Since June 2023, Mr. Moe has served as the Chief Financial
Officer of Beeline Financial. Mr. Moe has been a director of Red Cat Holdings, Inc. [Nasdaq: RCAT] since February 16, 2022. From 2018
until 2023, he was the Chief Financial Officer and a director of Yates Electrospace Corporation, a heavy payload, contested logistics
drone provider.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tiffany
Milton </b>was appointed as the Company&#8217;s Chief Accounting Officer on April 25, 2025. Ms. Milton served as the Company&#8217;s
Controller since January 2021. Prior to joining the Company, Ms. Milton served as Director of Financial Reporting at Gemini Rosemont
Commercial Real Estate from January of 2015 to December of 2020. She has over 20 years of experience in many industries, primarily in
SEC reporting. She is a certified public accountant in the state of New Mexico.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="R_004"></span>CORPORATE
GOVERNANCE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
Committees and Charters</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board and its committees meet and act by written consent from time to time as appropriate. The Board has formed the following three standing
committees: (i) the Audit Committee, (ii) the Compensation Committee, and (iii) the Corporate Governance and Nominating Committee. These
committees regularly report on their activities and actions to the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of our Audit, Compensation, and Nominating and Corporate Governance Committees has a written charter. Each of these committee charters
is available through the &#8220;Investors&#8221; section on our website, which can be found at https://makeabeeline.com/investor-relations/.
The information on, or that can be accessed through, our website is not incorporated into this Proxy Statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table identifies the independent and non-independent current Board and Committee members.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Independent</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Audit</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nominating
    and Corporate Governance</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nicholas R. Liuzza, Jr.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joseph Caltabiano</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chair</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joseph Freedman</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chair</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Francis Knuettel, II</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chair</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stephen Romano</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of the directors, then serving as directors, attended over 75% of the applicable Board and Committee meetings held in 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
and Committee Meetings</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board held a total of 4 meetings during 2025. The Board took formal action by unanimous consent on approximately 47 occasions in 2025.
We have no formal policy regarding attendance by directors or officers at our stockholders&#8217; meetings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
2025, our Audit Committee held a total of 4 meetings, the Corporate Governance and Nominating Committee held 6 meetings, and the Compensation
Committee held 4 meetings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Independence</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board, exercising its reasonable business judgment, has determined that each of Beeline&#8217;s directors, except Mr. Liuzza, qualifies
as an independent director pursuant to Rule 5605(a)(2) of The Nasdaq Stock Market, LLC (&#8220;Nasdaq&#8221;) listing rules (the &#8220;Nasdaq
Rules&#8221;) and applicable SEC rules and regulations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Audit
Committee</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Audit Committee oversees the engagement of our independent public accountants, reviews our audited financial statements, meets with our
independent public accountants to review internal controls and reviews our financial plans. Our Audit Committee currently consists of
Francis Knuettel, II, who is the Chair of the Committee, Joseph Freedman and Stephen Romano. Each of Messrs. Knuettel, Freedman and Romano
has been determined by our Board to be independent in accordance with Nasdaq and SEC standards. Our Board has also designated Mr. Knuettel
as an &#8220;audit committee financial expert&#8221; as the term is defined under SEC regulations and has determined that Mr. Knuettel
possesses the requisite &#8220;financial sophistication&#8221; under applicable Nasdaq Rules. The Audit Committee operates under a written
charter which is available on our website at https://makeabeeline.com/investor-relations/. Our website is not part of this Proxy Statement.
Both our independent registered accounting firm and internal financial personnel regularly meet with our Audit Committee and have unrestricted
access to the Audit Committee. Each member of the Audit Committee is able to read and understand fundamental financial statements, including
our consolidated balance sheets, consolidated statements of operations and consolidated statements of cash flows. Further, no member
of the Audit Committee has participated in the preparation of our consolidated financial statements, or those of any of our current subsidiaries,
at any time during the past three years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation
Committee</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Compensation Committee reviews and recommends policies, practices, and procedures relating to compensation for our directors, officers
and other employees and advising and consulting with our officers regarding managerial personnel and development. Our Compensation Committee
currently consists of Joseph Freedman, who is the Chair of the Compensation Committee, and Stephen Romano. Each of Messrs. Freedman and
Romano has been determined by our Board to be independent in accordance with Nasdaq standards. Each member of our Compensation Committee
is also a non-employee director, as defined pursuant to Rule 16b-3 promulgated under the Exchange Act. The Compensation Committee operates
under a written charter. Under its charter, the functions of the Compensation Committee include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reviewing and approving
    annually the corporate goals and objectives applicable to the Chief Executive Officer;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reviewing and approving
    the compensation of all other executive officers;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reviewing and making recommendations
    to the Board regarding incentive compensation plans and equity-based plans;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reviewing and approving
    any employment agreements, severance agreements or plans or change-in-control arrangements with executive officers;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reviewing director compensation
    for service on the Board and committees at least once a year and to recommend any changes to the Board; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Developing and recommending
    to the Board for approval an officer succession plan to develop and evaluate potential candidates for executive positions.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee may delegate any of its responsibilities, along with the authority to take action in relation to such responsibilities,
to one or more subcommittees as the Compensation Committee may deem appropriate in its sole discretion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to its charter, the Compensation Committee has the authority, in its sole discretion, to select, retain and obtain the advice of a compensation
consultant, outside legal counsel, or other advisors as it deems necessary to fulfill its duties and responsibilities under its charter.
The Compensation Committee did not engage any consultants during the year ended December 31, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation
Committee Interlocks and Insider Participation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
member of the Compensation Committee has at any time been an officer or employee of Beeline or of any subsidiary or affiliate of Beeline.
None of the members was party to any transaction or had any related party relationship with Beeline or any of its subsidiaries or affiliates
during the year ended December 31, 2025, except as disclosed under &#8220;Certain Relationships and Related Party Transactions.&#8221;
In addition, Messrs. Freedman, Moe and Liuzza are members of the Board of Directors of Red Cat Holdings, Inc. [Nasdaq: RCAT].</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nominating
and Corporate Governance Committee</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Nominating and Corporate Governance Committee (the &#8220;Nominating Committee&#8221;) evaluates the composition, size and governance
of our Board and its committees, evaluates and recommends candidates for election to our Board, establishes a policy for considering
stockholder nominees and reviewing our corporate governance principles and provides recommendations to the Board. Our Nominating Committee
currently consists of Joseph Caltabiano, who is the Chair of the Nominating Committee, and Joseph Freedman, each of whom has been determined
by our Board to be independent in accordance with Nasdaq standards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Special
Committee</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board has formed a special committee (the &#8220;Special Committee&#8221;) for purposes of reviewing and approving potential transactions
with related party entities. The Special Committee is comprised of Francis Knuettel II, Joseph Caltabiano and Stephen Romano, each of
whom is an independent director. Mr. Knuettel is Chairman of the Special Committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Code
of Business Conduct and Ethics</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have adopted a Code of Business Conduct and Ethics that applies to all of our employees, officers, and directors. We will provide to
any person without charge, upon request, a copy of our Code of Business Conduct and Ethics. Requests may be directed to our principal
executive offices at 188 Valley Street, Suite 225, Providence, RI, 02909. Also, a copy of our Code of Business Conduct and Ethics is
available on our website. We will disclose, on our website, any amendment to, or a waiver from, a provision of our Code of Business Conduct
and Ethics that applies to our principal executive officer, principal financial officer, principal accounting officer or controller,
or persons performing similar functions and that relates to any element of the Code of Business Conduct and Ethics enumerated in applicable
rules of the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
Assessment of Risk</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board is actively involved in the oversight of risks that could affect Beeline. This oversight is conducted primarily through the Audit
Committee, but the full Board has retained responsibility for general oversight of risks. The Audit Committee considers and reviews with
management the adequacy of our internal controls, including the processes for identifying significant risks and exposures, and elicits
recommendations for the improvements of such procedures where desirable. In addition to the Audit Committee&#8217;s role, the full Board
is involved in oversight and administration of risk and risk management practices. Members of our senior management have day-to-day responsibility
for risk management and establishing risk management practices, and members of management are expected to report matters relating specifically
to the Audit Committee directly thereto, and to report all other matters directly to the Board as a whole. Members of our senior management
have an open line of communication to the Board and have the discretion to raise issues from time-to-time in any manner they deem appropriate,
and management&#8217;s reporting on issues relating to risk management typically occurs through direct communication with directors or
committee members as matters requiring attention arise. Members of our senior management regularly attend portions of the Board&#8217;s
meetings, and often discuss the risks related to our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board actively interfaces with management on seeking solutions to any perceived risk.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation
Policies and Practices as Related to Risk Management</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee and management do not believe that the Company maintains compensation policies or practices that are reasonably
likely to have a material adverse effect on the Company. Our employees&#8217; base salaries are fixed in amount and thus we do not believe
that they encourage excessive risk-taking. Our Compensation Committee has in the past granted and may in the future grant in its sole
discretion equity awards to employees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Insider
Trading Policy</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has implemented an <span id="xdx_901_eecd--InsiderTrdPoliciesProcAdoptedFlag_dbT_c20250101__20251231_zx7hJE4pa1Xf" class="xdx_phnt_RGlzY2xvc3VyZSAtIEluc2lkZXIgVHJhZGluZyBQb2xpY2llcyBhbmQgUHJvY2VkdXJlcwA_"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" format="ixt:booleantrue" id="Fact000013" name="ecd:InsiderTrdPoliciesProcAdoptedFlag">Insider Trading Policy</ix:nonNumeric></span> applicable to its officers and directors and employees with access to material nonpublic
information, as well as such persons&#8217; family members, which generally prohibits such persons from conducting transactions involving
the purchase or sale of the Company&#8217;s securities during a blackout period. For this purpose, the term &#8220;blackout period&#8221;
is defined in the Policy as a quarterly period beginning on the 10 calendar days prior to the end of each fiscal quarter and ending two
days following the date of public disclosure of the financial results for such fiscal quarter. In addition, under the Policy the Company
may adjust the duration of a particular blackout period, or impose &#8220;event specific&#8221; blackout periods, including when there
are nonpublic developments that would be considered material for insider trading law purposes. The Policy also strictly prohibits and
trading on material nonpublic information, regardless of whether such a transaction occurs during a blackout period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 16, 2025, the Board waived the Company&#8217;s blackout period and permitted the Company&#8217;s officers and directors to make
purchases of the Company&#8217;s Common Stock on the open market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
the granting of options and other equity awards to officers, directors and other employees is not expressly addressed in the Insider
Trading Policy described above, the Company follows the same principles set forth in such Policy when granting equity awards, including
options, to its officers, directors and other employees with access to material nonpublic information. Generally, the Board or Compensation
Committee does not approve grants of such awards during a blackout period and does not take material nonpublic information into account
when determining the timing and terms of such an award. Further, the Company does not have a policy or practice of timing the disclosure
of material nonpublic information for the purpose of affecting the value of executive compensation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Anti-Hedging
Policy</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Company&#8217;s Insider Trading Policy, all officers, directors and certain identified employees are prohibited from engaging in
hedging transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Clawback
Policy</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_987_eecd--ErrCompAnalysisTextBlock_c20250101__20251231__ecd--RestatementDateAxis__2025-12-31_zesGtFhvYLN3" class="xdx_phnt_RGlzY2xvc3VyZSAtIFJlY292ZXJ5IG9mIEVycm9uZW91c2x5IEF3YXJkZWQgQ29tcGVuc2F0aW9uAA__" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><ix:nonNumeric contextRef="From2025-01-012025-12-31_2025-12-31" escape="true" id="Fact000014" name="ecd:ErrCompAnalysisTextBlock"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has implemented <span style="background-color: white">a Clawback Policy in accordance with the Nasdaq Rules, to recoup &#8220;excess&#8221;
incentive compensation, if any, earned by current and former executive officers during a three year look back period in the event of
a financial restatement due to material noncompliance with any financial reporting requirement under the securities laws (with no fault
required)</span>. The Company also uses forms of agreements relating to equity grants which also include other drawbacks relating to
improper conduct.</span></ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stockholder
Communications</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we do not have a formal policy regarding communications with our Board, stockholders may communicate with the Board by writing to the
Corporate Secretary of Beeline Holdings, Inc. at 188 Valley Street, Suite 225, Providence, RI, 02909, or by email at: ir@makeabeeline.com.
Stockholders who would like their submission directed to a member of the Board may so specify, and the communication will be forwarded,
as appropriate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Delinquent
Section 16(a) Reports</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
16(a) of the Exchange Act requires our directors, executive officers, and persons who own more than 10% of our Common Stock to file initial
reports of ownership and changes in ownership of our Common Stock and other equity securities with the SEC. These individuals are required
by the regulations of the SEC to furnish us with copies of all Section 16(a) forms they file. Based solely on a review of the copies
of the forms furnished to us, we believe that all filing requirements applicable to our officers, directors and 10% beneficial owners
were complied with during 2025, except for two Form 4&#8217;s for Mr. Liuzza, reporting the purchase of shares of the Company&#8217;s
Common Stock and the purchase of shares of the Company&#8217;s Series G Convertible Preferred Stock and Warrants to purchase Common Stock,
not timely filed due in each case to an administrative error.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="R_005"></span>CERTAIN
RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than as disclosed below and the compensation arrangements including those described under &#8220;Executive Compensation,&#8221; there
have been no transactions since January 1, 2024, involving the Company, in which the amount exceeded $120,000, and in which any of our
directors, executive officers, beneficial owners of 5% or more of our Common Stock or certain other related persons had a direct or indirect
material interest.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequent
to March 31, 2026, Mr. Liuzza surrendered to the Company 70,454 shares of the Company&#8217;s Common Stock in lieu of repaying cash of
$0.1 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
April 2026, Mr. Liuzza entered into an additional SAFE with MagicBlocks, Inc. (&#8220;MagicBlocks&#8221;), an entity in which the Company
also has a 47.6% ownership interest, Mr. Liuzza is a member of the board of directors and in which Mr. Moe is the Treasurer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning
in June 2025, the Company has partnered with TYTL Holdings, Inc. (&#8220;TYTL&#8221;). Mr. Liuzza is Chief Executive Officer and a principal
stockholder of TYTL. In addition, Christopher Moe and Joseph Freedman are each TYTL stockholders. TYTL finances certain residential real
estate transactions funded through the sale of a cryptocurrency token which is backed by real property. In these transactions, TYTL purchases
equity from homeowners seeking liquidity, funding such purchases from the sale of the cryptocurrency tokens. The Company provides TYTL
with certain services in connection with these transactions, specifically through providing access to its platform, and providing title
and escrow services through Beeline Title Holdings, Inc., a subsidiary of the Company (&#8220;Beeline Title Holdings&#8221;) in exchange
for cash fees. Other than providing title and escrow services as noted above, the Company is not involved in any cryptocurrency or other
transactions of TYTL. During the year ended December 31, 2025, the Company recorded $22,009 of revenue related to this transaction, of
which $16,100 was included in accounts receivable, net &#8211; related party on the consolidated balance sheets as of December 31, 2025.
On December 19, 2025, the Company advanced TYTL $0.4 million, included in due from affiliate on its consolidated balance sheets as of
December 31, 2025. During the three months ended March 31, 2026, the Company further advanced $0.1 million to TYTL and had received payment
of $0.3 million. As of March 31, 2026, the Company was owed $0.2 million included in due from affiliate on its consolidated balance sheets.
Mr. Liuzza personally guaranteed these advances to TYTL. The Company receives a transaction fee of 3.5% of the amount of equity sold
by homeowners to TYTL for customer service, transaction processing and platform support. Revenue is recognized at a point in time when
the closing occurs between TYTL and the homeowner. On January 1, 2026, the Company entered into a one-year Master Services Agreement
with TYTL for $0.2 million whereby the Company provides certain agreed upon monthly consulting services. During the three months ended
March 31, 2026, the Company received $0.1 million related to this Agreement and recorded $50,000 of revenue, which is included in other
revenues in the consolidated statements of operations. The remaining $50,000 is included in accrued liabilities on the consolidated balance
sheets as of March 31, 2026.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February and March of 2025, Mr. Liuzza advanced the Company $0.1 million. In exchange for these advances, on April 25, 2025, the Board
of Directors approved the advances as loans, and the Company issued Mr. Liuzza a promissory note which bears interest at a rate of 8%
per annum and is payable on demand. On May 29, 2025, the Company amended the note to $0.4 million. As of December 31, 2025, the note
was fully repaid.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2025, Mr. Liuzza entered into a SAFE with MagicBlocks.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to its acquisition by the Company, Beeline Financial issued a note to a private company in which Joseph Freedman, a Board member of the
Company, has an ownership interest. This note was for $0.1 million, accrues interest at 7% per annum and is due on demand. This note
was subsequently repaid in January 2025. Additionally in January 2025, Mr. Freedman purchased 238,418 shares of Series G Preferred Stock
and five-year Warrants to purchase a total of 11,921 shares of Common Stock for total gross proceeds of $0.1 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
March 2025, Mr. Liuzza purchased 4,308,155 shares of Series G Preferred Stock and five-year Warrants to purchase a total of 215,409 shares
of Common Stock for total gross proceeds of $2.2 million<i>.</i> In addition, Mr. Liuzza converted his $0.7 million bridge loan from
December 31, 2024 into $0.7 million of units comprised of 1,372,549 shares of Series G Preferred Stock and five-year Warrants to purchase
a total of 68,628 shares. During December 2024, Mr. Liuzza purchased 1,960,784 shares of Series G Preferred Stock and five-year Warrants
to purchase a total of 98,040 shares of Common Stock for total gross proceeds of $1.0 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jessica
Kennedy, Beeline Financial&#8217;s Chief Operating Officer, owns a 5% interest in Tower Title, which is a vendor to certain subsidiaries
of the Company. During the three months ended March 31, 2026 and 2025, the Company had transactions of $9,870 and $2,759, respectively,
with Tower Title. During the years ended December 31, 2025 and 2024, the Company had transactions of $15,702 and $7,457, respectively,
with Tower Title.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beeline
Loans, Inc. (&#8220;Beeline Loans&#8221;) partnered with CredEvolv on February 26, 2025 to help declined borrowers improve their credit
and secure mortgage approval. Steve Romano is co-founder and President of CredEvolv. Beeline Financial engaged Mr. Romano to provide
certain consulting services pursuant to an agreement dated July 29, 2024 to continue until terminated by written notice. As of December
31, 2025, the Company paid Mr. Romano $0.1 million. In December 2025, the Company ended its consulting relationship with Mr. Romano.
Mr. Romano continues to serve on the Company&#8217;s Board of Directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 16, 2024, the Company entered into a Loan Agreement with the SPV, Aegis, Bigger, District 2 and LDI. Pursuant to the Loan Agreement,
Bigger, District 2 and LDI (the &#8220;Subscribers&#8221;) loaned the Company for $1,100,000 and received promissory notes in the aggregate
principal amount of $1,100,000 (the &#8220;2024 Secured Notes&#8221;). The 2024 Secured Notes could be satisfied by payment of 105% of
principal on or before July 31, 2024, by payment of 110% of principal on or before November 29, 2024, by payment of 130% of principal
on or before March 30, 2025 or by payment of 140% of principal on March 31, 2025. With each 2024 Secured Note, the Company issued a Warrant
to purchase a share of the Company&#8217;s Common Stock for $5.00 exercisable for five years after December 2, 2024 if on November 29,
2024 the 2024 Secured Note issued to the Warrant holder remains unsatisfied. LDI received a Warrant to purchase 59,802 shares and each
of Bigger and District 2 received a warrant to purchase 29,901 shares. The Company&#8217;s obligations under the 2024 Secured Notes were
secured by the Company&#8217;s pledge of its assets, subject to certain specified exceptions. In connection with the Loan Agreement,
the Company, Aegis, Bigger and District 2 amended and restated the Intercreditor Agreement they had executed on September 29, 2023. In
the Amended and Restated Intercreditor Agreement, Aegis, Bigger and District 2 subordinated their liens on any barrels of spirits owned
by the Company, and the parties agreed that the net proceeds of any sale of barrels would be paid to the Subscribers in satisfaction
of the 2024 Secured Notes. Commencing when all barrels have been sold, the lien of the Subscribers under the Secured 2024 Notes would
become pari passu with the senior lien on the remaining collateral. Subsequent to the closing, the 2024 Notes were included in the October
2024 debt exchange with the remaining collateral being contributed with the exchanged assets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 4, 2024, the Company and Craft entered into the Exchange Agreement with the SPV, Aegis, Bigger, District 2, LDI and three individual
creditors including Robert Grammen, a director. Subsequent to the execution of the Exchange Agreement, the assets of the SPV were distributed
to its members, i.e. Aegis, Bigger, District 2 and LDI. To reflect the effect of the distribution on the transactions contemplated by
the Exchange Agreement, the parties, on October 3, 2024, executed the First Amended and Restated Debt Exchange Agreement, and the transaction
closed on October 7, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 25, 2025, the Company entered into a Debt Satisfaction Agreement (the &#8220;DSA&#8221;) with Bridgetown Spirits Corp. (&#8220;Spirits&#8221;),
the Company&#8217;s 53%-owned subsidiary and three individuals (the &#8220;Buyers&#8221;) including Geoffrey Gwin, the President of Spirits,
pursuant to which the Company transferred to the Buyers all 530,000 shares of Spirits common stock held by the Company, representing
53% of the outstanding Spirits common stock, in exchange for the satisfaction of outstanding amounts payable by the Company to the Buyers
totaling $367,404 and released from Spirits and the Buyers relating thereto. The Company also released Spirits from certain obligations
and liabilities in connection with the transaction. As a result of the foregoing, Spirits is no longer a subsidiary of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the DSA, the Company loaned Spirits $75,000, in exchange for which Spirits executed and delivered to the Company a Senior
Secured Original Issue Discount Promissory Note and Security Agreement (the &#8220;Note&#8221;) in the principal amount of $100,000,
reflecting an original issue discount of $25,000. The Note is payable as follows: (i) $50,000 is payable on April 24, 2026, and the remaining
$50,000 is payable on July 25, 2026. The obligations of Spirits evidenced by the Note are secured by the assets of Spirits pursuant to
the Note.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jay
Stockwell (a Company co-founder and the MagicBlocks CEO) owns an equity interest in SpeedPPC Pty. Ltd., which provides marketing services
to the Company and certain of its subsidiaries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beeline
Loans, Inc., a Beeline subsidiary, is a member of The Mortgage Collaborative, which is an industry trade group founded by David Kittle.
Beeline Loans, Inc. pays membership fees to The Mortgage Collaborative. Mr. Kittle was a member of the Beeline Board until October 7,
2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2024, Mr. Freedman purchased a total of $121,593 of units comprised of a total of 238,418 shares of Series G and 119,209 G Warrants
on the same terms as all other investors in the Series G and G Warrant offering. Mr. Freedman&#8217;s subscription amount was used to
repay the $121,593 of indebtedness owed to Mr. Freeman by Beeline. Mr. Freedman made a $75,000 loan to Beeline on December 11, 2023 which
was due February 11, 2024. The sums due above the principal represented default interest, fees and penalties. Mr. Liuzza guaranteed payment
of the note issued to Mr. Freedman.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Related
Party Transactions Policy</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that the foregoing transactions were in the best interests of the Company and Beeline Financial, respectively. Consistent with
Section 78.140 of the Nevada Revised Statutes, it is our current policy that all transactions between us and our officers, directors
and their affiliates will be entered into only if such transactions are approved by a majority of the disinterested directors, are approved
by vote of the stockholders, or are fair to us as a corporation as of the time they are authorized, approved or ratified by the board.
We will conduct an appropriate review of all related party transactions on an ongoing basis, and, where appropriate, we will utilize
our Audit Committee for the review of potential conflicts of interest.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="R_006"></span>Security
Ownership of Certain Beneficial Owners and Management</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the number of shares of our Common Stock beneficially owned as of the Record Date by (i) those persons known
by us to be owners of more than 5% of our Common Stock, (ii) each director and director nominee, (iii) each of our named executive officers
and (iv) all current executive officers and directors of Beeline as a group. Unless otherwise specified in the notes to this table, the
address for each person is: c/o Beeline Holdings, Inc., 188 Valley Street, Suite 225, Providence, RI, 02909. The term &#8220;named executive
officer&#8221; means each of the Company&#8217;s principal executive officer, the two most highly paid executive officers with compensation
exceeding $100,000 during the fiscal years ended December 31, 2025 and 2024, and two additional individuals for whom the foregoing would
apply but for the fact that they were not executive officers of the Company as of December 31, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Beneficial Owner Name &amp;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Address</b></span></p></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount of Class of Stock Beneficially Owned (1)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Percent of Class of Stock Beneficially Owned (1)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Voting Power (1) (2)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Percent of Voting Power (2)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: center">Named Executive Officers and Directors</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; text-align: left">Nicholas Liuzza, Chief Executive Officer and Director (3)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">8,157,844</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">22.8</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">8,157,844</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">22.4</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Christopher R. Moe, Chief Financial Officer (4)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">209,167</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">209,167</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Tiffany Milton, Chief Accounting Officer (5)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">43,012</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">43,012</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Joseph Caltabiano, Director (6)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">168,984</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">168,984</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Joseph Freedman, Director (7)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">499,305</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.6</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">499,305</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.5</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Stephen Romano (8)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">86,463</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">86,463</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Francis Knuettel II (9)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">80,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">80,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Eric Finnsson, Former Director (10)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">90,926</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">90,926</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Geoffrey Gwin, former Chief Executive Officer (11)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">113,575</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">113,575</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">All directors and executive officers as a group (7 persons)(12)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,244,775</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25.5</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,294,775</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25.1</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Other 5% shareholders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Sansar Capital Master Fund LP (13)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,042,906</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9.5</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,042,906</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9.3</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Thomas Walsh (14)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,932,499</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,932,499</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.9</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*Less
than 1%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Applicable
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">percentages are based on 32,060,466 shares of Common
    Stock, 2,500,000 shares of Series B Convertible Preferred Stock, <span style="background-color: white">1,259,009 shares of Series
    F, 9,382 shares of Series F-1, and 691,571 shares of Series G, as applicable, issued and outstanding as of June 18, 2026, which is
    the Record Date for the Annual Meeting. Shares of Common Stock subject to options, warrants, convertible preferred stock and other
    derivative securities currently exercisable or convertible, or exercisable or convertible within 60 days are deemed outstanding for
    computing the percentage of the person holding such securities but are not deemed outstanding for computing the percentage of any
    other person. It does not include options held by our management, which are subject to performance standards. Unless otherwise indicated
    in the footnotes to this table, the Company believes that each of the stockholders named in the table has sole voting and investment
    power with respect to the shares indicated as beneficially owned by them. Does not give effect to potential future dilution pursuant
    to adjustment provisions under certain outstanding derivative securities.</span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Percentages of voting power
    are based on a total estimated voting power of 32,618,791 shares outstanding as of the Record Date, subject to certain beneficial
    ownership limitations with respect to outstanding shares of the Company&#8217;s preferred stock.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nicholas R. Liuzza,
    Jr</b>. Common Stock beneficially owned includes (i) 223,716 shares of Common Stock held by a trust of which Mr. Liuzza is the trustee,
    (ii) 33,093 shares of Common Stock owned by Mr. Liuzza&#8217;s family members which he is thereby deemed to beneficially own, (iii)
    3,762,880 shares of Common Stock issuable upon exercise of Warrants, as adjusted pursuant to price protection provisions therein,
    which are exercisable at $0.66 per share, and (iv) 25,000 stock options exercisable at $0.9216 per share which vested on May 28,
    2026. Does not include the remaining 25,000 stock options exercisable at $0.9216 per share which vest on May 28, 2027.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Christopher R. Moe</b>.
    Common Stock beneficially owned includes (i) 117,500 vested stock options exercisable at $0.9216 per share which vested on May 28,
    2026, and (ii) 41,667 stock options which have vested or will vest within 60 days having an exercise price of $2.21 per share. Does
    not include the remaining 117,500 stock options exercisable at $0.9216 per share which vest on May 28, 2027, or 33,333 stock options
    exercisable at $2.21 which vest monthly beginning September 30, 2026.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tiffany Milton</b>.
    Common Stock beneficially owned includes 17,500 stock options exercisable at $0.9216 per share which vested on May 28, 2026. Does
    not include the remaining 17,500 stock options exercisable at $0.9216 per share which vest on May 28, 2027. Common Stock beneficially
    owned also includes 10,003 shares held by Ms. Milton&#8217;s spouse for which Ms. Milton disclaims beneficial ownership.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Joseph Caltabiano</b>.
    Common Stock beneficially owned includes 30,000 restricted stock units which vest upon the earlier of (i) August 5, 2026 or (ii)
    the delivery of a final report and recommendation by the Special Committee of the Board of Directors.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Joseph Freedman</b>.
    Common Stock beneficially owned includes (i) 117,404 shares of Common Stock issuable upon exercise of Warrants, as adjusted pursuant
    to price protection provisions therein, which are exercisable at $0.66 per share and (ii) 30,000 restricted stock units which vest
    upon the earlier of (A) August 5, 2026 or (B) the delivery of a final report and recommendation by the Special Committee of the Board
    of Directors.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stephen Romano</b>.
    Common Stock beneficially owned does not include 30,000 restricted stock units which vest upon the earlier of (i) May 29, 2027 or
    (ii) the delivery of a final report and recommendation by the Special Committee of the Board of Directors.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Francis Knuettel II</b>.
    Common Stock beneficially owned includes does not 30,000 restricted stock units which vest upon the earlier of (i) December 16, 2026
    or (ii) the delivery of a final report and recommendation by the Special Committee of the Board of Directors.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Geoffrey Gwin</b>. Mr.
    Gwin served the Company&#8217;s Chief Executive Officer until March 7, 2025.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Eric Finnsson</b>. Mr.
    Finnsson resigned as a director effective June 30, 2026.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Officers and Directors
    as a Group</b>. This amount includes ownership by all directors and all current executive officers including named executive officers
    and those who are not named executive officers under the SEC&#8217;s disclosure rules. Does not include former officers and directors
    who are no longer in such roles.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sansar Capital Master
    Fund LP</b>. Based upon a Schedule 13G filed on May 4, 2026. Sansar Capital Master Fund LP is controlled by Sanjay Motwani, President.
    Address is 220 Riverside Blvd., Apt 20N New York, NY 10069.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Thomas Walsh</b>. Based
    upon a Schedule 13G filed on June 4, 2026. Represents shares beneficially owned by funds (the &#8220;Funds&#8221;) which Mr. Walsh
    controls or shares control, as described a Schedule 13G filed on June 4, 2026. Mr. Walsh disclaims beneficial ownership of any shares
    of Common Stock held by the Funds. Reference is made to the Schedule 13G for further details.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="R_007"></span>EXECUTIVE
COMPENSATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Summary
Compensation Table</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the compensation awarded to, earned by or paid to our Chief Executive Officer (principal executive officer)
and named executive officers, for services rendered during the fiscal years ended December 31, 2025 and 2024. The term &#8220;named executive
officer&#8221; means each of the Company&#8217;s principal executive officer, each individual who served as a principal executive officer
during 2025, the two most highly paid executive officers with compensation exceeding $100,000 during the fiscal year ended December 31,
2025 and up to two additional individuals who would qualify under the preceding category but for the fact that they did not serve as
an executive officer as of December 31, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Name and Position</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Salary ($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Bonus ($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Stock Awards ($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Option Awards ($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 41%; font-weight: bold; text-align: center">Nicholas R. Liuzza, Jr.</td><td style="width: 2%">&#160;</td>
    <td style="width: 6%; text-align: center">2025</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">30,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">46,080</td><td style="width: 1%; text-align: left">(2)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">76,080</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">Chief Executive Officer (1)</td><td>&#160;</td>
    <td style="text-align: center">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: center">Geoffrey Gwin</td><td>&#160;</td>
    <td style="text-align: center">2025</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">200,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,300</td><td style="text-align: left">(4)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">214,300</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">Former Chief Executive Officer and <br/> Chief Financial Officer; Current President of Bridgetown Spirits Corp. (3)</td><td>&#160;</td>
    <td style="text-align: center">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">350,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">190,000</td><td style="text-align: left">(5)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">232,000</td><td style="text-align: left">(6)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">772,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: center">Christopher R. Moe</td><td>&#160;</td>
    <td style="text-align: center">2025</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">180,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">216,576</td><td style="text-align: left">(8)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">396,576</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">Chief Financial Officer (7)</td><td>&#160;</td>
    <td style="text-align: center">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">150,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">140,672</td><td style="text-align: left">(9)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">290,672</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: center">Tiffany Milton</td><td>&#160;</td>
    <td style="text-align: center">2025</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">165,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">32,256</td><td style="text-align: left">(11)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">197,256</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">Chief Accounting Officer (10)</td><td>&#160;</td>
    <td style="text-align: center">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Liuzza was appointed
    as the Chief Executive Officer of the Company on March 7, 2025.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents an award of
    50,000 stock options under the Amended and Restated 2025 Equity Incentive Plan (the &#8220;2025 Plan&#8221;) exercisable at $0.9216
    per share, vesting annually in equal amounts over two years from May 28, 2025, subject to continued service on the applicable vesting
    date.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Gwin served as the
    Company&#8217;s Chief Executive Officer until his resignation from such role on March 7, 2025. He also previously served as Chief
    Financial Officer until his resignation from such role on October 7, 2024, and as President of Bridgetown Spirits until the sale
    of that entity on July 25, 2025.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with Mr.
    Gwin&#8217;s resignation as Chief Executive Officer of the Company and appointment as President of Bridgetown Spirits, in April 2025
    the Board approved and the Company issued Mr. Gwin 10,000 shares of Common Stock at $1.43 per share.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents 3,279 shares
    of Common Stock issued at $30.50 per share in lieu of a $100,000 bonus payment, and 18,000 shares of Common Stock at $5.00 per share
    which the Company issued to Mr. Gwin in lieu of a $90,000 bonus payment for special services performed in 2024, as elected by Mr.
    Gwin. See &#8220;Employment Agreements-Geoffrey Gwin&#8221; below for more information.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents 40,000 shares
    of restricted Common Stock issued at $5.80 per share which the Company issued to Mr. Gwin pursuant to his Employment Agreement, as
    amended. See &#8220;Employment Agreements-Geoffrey Gwin&#8221; below for more information.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Moe was appointed as
    the Chief Financial Officer of the Company on October 7, 2024.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents an award of
    235,000 stock options under the 2025 Plan exercisable at $0.9216 per share, vesting annually in equal amounts over two years from
    May 28, 2025, subject to continued service on the applicable vesting date.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reflects a cash bonus earned
    by Mr. Moe in connection with a recapitalization transaction in June 2024, of which $20,096 was paid in 2024 and the balance was
    paid in 2025.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms. Milton was appointed
    as the Chief Accounting Officer of the Company on April 25, 2025. Does not include a total of $170,000 of compensation Ms. Milton
    received in 2024 prior to being appointed Chief Accounting Officer.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents an award of
    35,000 stock options under the 2025 Plan exercisable at $0.9216 per share, vesting annually in equal amounts over two years from
    May 28, 2025, subject to continued service on the applicable vesting date.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 20; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding
Equity Awards at 2025 Fiscal Year-End</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Listed
below is information with respect to unvested stock awards for each named executive officer outstanding as of December 31, 2025:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Name</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of<br/> securities<br/> underlying<br/> unexercised<br/> options<br/> (#) exercisable</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of<br/> securities<br/> underlying<br/> unexercised<br/> options<br/> (#) unexercisable (1)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Equity incentive<br/> plan awards:
    Number of securities<br/> underlying unexercised unearned options (#)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Option</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Exercise<br/> Price<br/> ($)</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Option Expiration Date</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 20%; text-align: justify">Nicholas R. Liuzza, Jr.</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">50,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">0.9216</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 12%; text-align: right">May 28, 2035</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Christopher R. Moe</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">235,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.9216</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right">May 28, 2035</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Tiffany Milton</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.9216</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right">May 28, 2035</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents stock options
    that were granted under the 2025 Plan, vesting annually in equal amounts over two years from May 28, 2025, subject to continued service
    on the applicable vesting date.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Employment
Agreements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nicholas
R. Liuzza, Jr.</b> Mr. Liuzza was appointed the Chief Executive Officer of the Company on March 7, 2025 and receives compensation of
$30,000 annually.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Christopher
R. Moe</b>. Mr. Moe was appointed as the Chief Financial Officer of the Company on October 7, 2024 and receives a monthly salary of $15,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tiffany
Milton</b>. Ms. Milton was appointed as the Chief Accounting Officer of the Company on April 25, 2025 and receives a monthly salary of
$13,750.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="R_008"></span>Director
Compensation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the compensation awarded to, earned by or paid to the non-employee members of our Board for services rendered
as a director during the fiscal year ended December 31, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Name</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fees Earned<br/> ($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Stock<br/> Awards ($)(1)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">All Other<br/> Compensation<br/> ($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total ($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; text-align: left">Joseph Caltabiano</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">57,500</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">486,273</td><td style="width: 1%; text-align: left">(2)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">543,773</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Eric Finnsson*</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">62,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">335,198</td><td style="text-align: left">(3)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">397,698</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Joseph Freedman</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">60,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">708,651</td><td style="text-align: left">(4)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">768,651</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Francis Knuettel II</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">263,900</td><td style="text-align: left">(5)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">313,900</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stephen Romano</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">288,265</td><td style="text-align: left">(6)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">105,000</td><td style="text-align: left">(7)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">443,265</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*Mr.
Finnsson resigned as a director effective June 30, 2026.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All amounts reflect the
    aggregate grant date fair value calculated based on the closing price of the Company&#8217;s Common Stock on October 1, 2025 of $3.77
    per share. These amounts do not reflect the actual economic value realized by the director.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents (i) 49,818 shares
    of vested Common Stock in lieu of cash for prior services, (ii) 30,000 shares of Common Stock vesting one-third annually over three
    years from May 28, 2025, (iii) 19,166 shares of Common Stock vesting on May 28, 2026 and (iv) 30,000 restricted stock units vesting
    on the earlier of one year from the grant date or delivery of a final report by a special committee of the Board.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents (i) 48,913 shares
    of vested Common Stock in lieu of cash for prior services, (ii) 30,000 shares of Common Stock vesting one-third annually over three
    years from May 28, 2025 and (iii) 10,000 shares of Common Stock vesting on May 28, 2026.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents (i) 99,638 shares
    of vested Common Stock in lieu of cash for prior services, (ii) 30,000 shares of Common Stock vesting one-third annually over three
    years from May 28, 2025, (iii) 28,333 shares of Common Stock vesting on May 28, 2026, and (iv) 30,000 restricted stock units vesting
    on the earlier of one year from the grant date or delivery of a final report by a special committee of the Board.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents (i) 30,000 shares
    of Common Stock vesting one-third annually over three years from May 28, 2025, (ii) 10,000 shares of Common Stock vesting on May
    28, 2026, and (iii) 30,000 restricted stock units vesting on the earlier of one year from the grant date or delivery of a final report
    by a special committee of the Board.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents (i) 30,797 shares
    of vested Common Stock, (ii) 30,000 shares of Common Stock vesting one-third annually over three years from May 28, 2025, and (iii)
    15,666 shares of Common Stock vesting on May 28, 2026.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents fees paid to
    the director for consulting services unrelated to his service as a director pursuant to a consulting agreement which was terminated
    in December 2025. See &#8220;Certain Relationships and Related Party Transactions.&#8221;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 21; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity
Compensation Plan Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table provides information concerning compensation plans under which our equity securities are authorized for issuance as of
December 31, 2025:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Plan Category</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of shares to be issued upon exercise of outstanding options, SARs and Warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted Average Exercise Price of Outstanding Options</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of Options Remaining for Future Issuance Under Equity Compensation Plan</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Equity compensation plans approved by security holders (1)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">1,742,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">0.95</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">2,324,470</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Equity compensation plans not approved by security holders</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1, 742,000</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.95</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,324,470</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 1, 2025, the
    Company&#8217;s Board of Directors adopted the 2025 Plan and it was approved by stockholders on October 2, 2025. The 2025 Plan initially
    authorized 4,588,802 shares of Common Stock, which was equal to 15% of the outstanding shares of Common Stock on a fully-diluted
    basis available for award under the 2025 Plan. The 2025 Plan provides for an annual increase to such available number of shares by
    5% of the shares of Common Stock outstanding on a fully-diluted basis each year for a period of seven years, with the first such
    increase to occur on January 1, 2026. The 2025 Plan provides for the issuance of incentive stock options, non-statutory stock options,
    share appreciation rights, restricted shares, restricted share units, and other share-based awards.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pay
Versus Performance</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pay
versus Performance Table</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
required by Item 402(v) of Regulation S-K, we are providing the following information about the relationship between executive compensation
actually paid and the Company&#8217;s financial performance. The amounts in the table below are calculated in accordance with SEC rules
and do not represent amounts actually earned or realized by our named executive officers (&#8220;NEOs&#8221;), which for purposes of
the below table are divided into individuals who serve or have served as principal executive officer in 2025 (&#8220;PEOs&#8221;) and
other NEOs who are not and have not served as principal executive officer in 2025 (&#8220;non-PEOs&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact000016" name="ecd:PvpTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_880_eecd--PvpTableTextBlock_zBvx4atBvnR1" summary="xdx: Disclosure - Pay vs Performance Disclosure" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: center">Year <br/> (a)</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_481_eecd--PeoTotalCompAmt_hecd--IndividualAxis__custom--NicholasRLiuzzaJrMember_zCHKJsOPM1Fg" style="border-bottom: Black 1pt solid; text-align: center">Summary
    Compensation Table Total for PEO (Nicholas R. Liuzza, Jr.)<br/> (b)<span id="xdx_F5C_zhf3gNDGe9X9">(1)</span>($)</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_48E_eecd--PeoActuallyPaidCompAmt_hecd--IndividualAxis__custom--NicholasRLiuzzaJrMember_z0yEM0AQE258" style="border-bottom: Black 1pt solid; text-align: center">Compensation
    Actually Paid to PEO (Nicholas R. Liuzza, Jr.)<br/> (c)<span id="xdx_F5B_zorajZrQbL68">(3)</span>($)</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_481_eecd--PeoTotalCompAmt_hecd--IndividualAxis__custom--GeoffreyGwinMember_zbwmuCs8nAN" style="border-bottom: Black 1pt solid; text-align: center">Summary
    Compensation Table Total for PEO (Geoffrey Gwin) <br/> (b)<span id="xdx_F5E_zpegBq8nz6l9">(2)</span>($)</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_480_eecd--PeoActuallyPaidCompAmt_hecd--IndividualAxis__custom--GeoffreyGwinMember_zZCrIUs84tzk" style="border-bottom: Black 1pt solid; text-align: center">Compensation
    Actually Paid to PEO (Geoffrey Gwin)<br/> (c)<span id="xdx_F5E_z7srRy3clvDh">(3)</span>($)</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_483_eecd--NonPeoNeoAvgTotalCompAmt_zcJWEJlMHFBh" style="border-bottom: Black 1pt solid; text-align: center">Average
    Summary Compensation Table Total for non-PEO Named Executive Officers<br/> (d)<span id="xdx_F5A_ztJ7RKaQUkmb">(4)</span>($)</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_48A_eecd--NonPeoNeoAvgCompActuallyPaidAmt_zWTTYBUuKkH" style="border-bottom: Black 1pt solid; text-align: center">Average
    Compensation Actually Paid to non-PEO Named Executive Officers<br/> (e)<span id="xdx_F50_zFbOUeqwaxr5">(3)</span>($)</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_480_eecd--TotalShareholderRtnAmt_pp2d_z01T7iiuPHL1" style="border-bottom: Black 1pt solid; text-align: center">Value
    of Initial Fixed $100 Investment Based On Total Shareholder Return<br/> (f)<span id="xdx_F5A_z5Zmcbgw8VRg">(5)</span>($)</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_48B_eus-gaap--NetIncomeLoss_zUsHkNlheIK" style="border-bottom: Black 1pt solid; text-align: center">Net Income/
    (Loss)<br/> (g)<span id="xdx_F55_zox12ceEF5r3">(6)</span>($)</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_416_20250101__20251231_zUUH9HU1GC38" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 9%; text-align: center">2025</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%; text-align: right"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2025-01-012025-12-31_custom_NicholasRLiuzzaJrMember" id="Fact000017" format="ixt:numdotdecimal" decimals="0" unitRef="USD">76,080</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%; text-align: right"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2025-01-012025-12-31_custom_NicholasRLiuzzaJrMember" id="Fact000018" format="ixt:numdotdecimal" decimals="0" unitRef="USD">107,700</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2025-01-012025-12-31_custom_GeoffreyGwinMember" id="Fact000019" format="ixt:numdotdecimal" decimals="0" unitRef="USD">214,300</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2025-01-012025-12-31_custom_GeoffreyGwinMember" id="Fact000020" format="ixt:numdotdecimal" decimals="0" unitRef="USD">55,900</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2025-01-01to2025-12-31" id="Fact000021" format="ixt:numdotdecimal" decimals="0" unitRef="USD">296,916</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2025-01-01to2025-12-31" id="Fact000022" format="ixt:numdotdecimal" decimals="0" unitRef="USD">382,290</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><ix:nonFraction name="ecd:TotalShareholderRtnAmt" contextRef="From2025-01-01to2025-12-31" id="Fact000023" format="ixt:numdotdecimal" decimals="2" unitRef="USD">28.18</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2025-01-01to2025-12-31" id="Fact000024" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">23,381,000</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_413_20240101__20241231_z0Wn5UiTQEZ7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2024-01-012024-12-31_custom_NicholasRLiuzzaJrMember" id="Fact000025" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2024-01-012024-12-31_custom_NicholasRLiuzzaJrMember" id="Fact000026" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2024-01-012024-12-31_custom_GeoffreyGwinMember" id="Fact000027" format="ixt:numdotdecimal" decimals="0" unitRef="USD">772,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2024-01-012024-12-31_custom_GeoffreyGwinMember" id="Fact000028" format="ixt:numdotdecimal" decimals="0" unitRef="USD">925,160</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2024-01-012024-12-31" id="Fact000029" format="ixt:numdotdecimal" decimals="0" unitRef="USD">290,672</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2024-01-012024-12-31" id="Fact000030" format="ixt:numdotdecimal" decimals="0" unitRef="USD">290,672</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ecd:TotalShareholderRtnAmt" contextRef="From2024-01-012024-12-31" id="Fact000031" format="ixt:numdotdecimal" decimals="2" unitRef="USD">21.03</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-012024-12-31" id="Fact000032" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">13,076,000</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_41C_20230101__20231231_z3zkBHj7DGL" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0033">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0034">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2023-01-012023-12-31_custom_GeoffreyGwinMember" id="Fact000035" format="ixt:numdotdecimal" decimals="0" unitRef="USD">250,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2023-01-012023-12-31_custom_GeoffreyGwinMember" id="Fact000036" format="ixt:numdotdecimal" decimals="0" unitRef="USD">256,878</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0037">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2023-01-012023-12-31" id="Fact000038" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,452</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ecd:TotalShareholderRtnAmt" contextRef="From2023-01-012023-12-31" id="Fact000039" format="ixt:numdotdecimal" decimals="2" unitRef="USD">3.76</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31" id="Fact000040" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,535,000</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="display: none; vertical-align: top">
  <td style="text-align: left; width: 0.25in"><span id="xdx_F08_zV4MImJFb9W3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
  <td style="text-align: justify"><span id="xdx_F1F_zLBI9uznkzB7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000041" xml:lang="en-US">Represents the amounts reported for Mr. Liuzza, the Company&#8217;s
current Chief Executive Officer, in the &#8220;Total&#8221; column of the &#8220;Summary Compensation Table&#8221; in each applicable
year.</ix:footnote></span></td></tr>

<tr style="display: none; vertical-align: top">
  <td style="text-align: left; width: 0.25in"><span id="xdx_F0B_zwgHOSLnDgv6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
  <td style="text-align: justify"><span id="xdx_F13_zA8Gm6TIYqB" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000042" xml:lang="en-US">Represents the amounts reported for Mr. Gwin, the Company&#8217;s
former Chief Executive Officer. Mr. Gwin served as the Company&#8217;s Chief Executive Officer until his resignation from such role on
March 7, 2025. Mr. Gwin also previously served as Chief Financial Officer until his resignation from such role on October 7, 2024, and
as President of Bridgetown Spirits until the sale of that entity on July 25, 2025.</ix:footnote></span></td></tr>

<tr style="display: none; vertical-align: top">
  <td style="text-align: left; width: 0.25in"><span id="xdx_F0F_zwdeQeNHBvU3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
  <td style="text-align: justify"><span id="xdx_F1F_zcAAMxUalU6c" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000043" xml:lang="en-US">SEC rules require certain adjustments be made to the &#8220;Summary
Compensation Table&#8221; totals to determine &#8220;compensation actually paid&#8221; as reported in the &#8220;Pay Versus Performance&#8221;
table above. For purposes of the equity award adjustments shown below, no equity awards were cancelled as a result of a failure to meet
vesting conditions. The valuation assumptions used to calculate fair values for purposes of the compensation actually paid calculation
did not materially differ from those disclosed at the time of grant (as applicable). The table below details the applicable adjustments
to the amount in the &#8220;Total&#8221; column of the &#8220;Summary Compensation Table&#8221; in each applicable year that were made
to determine &#8220;compensation actually paid&#8221; (all amounts are averages for the NEOs other than the PEO).</ix:footnote></span></td></tr>

<tr style="display: none; vertical-align: top">
  <td style="text-align: left; width: 0.25in"><span id="xdx_F05_zkAtKR5xdBnf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
  <td style="text-align: justify"><span id="xdx_F1B_zZb4usbmVCw2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000044" xml:lang="en-US">Represents the average of the amounts reported for the NEOs
as a group (excluding the PEOs) in the &#8220;Total&#8221; column of the &#8220;Summary Compensation Table&#8221; in each applicable
year. The names of each of the non-PEO NEOs included for these purposes for 2025 are Mr. Moe and Ms. Milton, for 2024 include Mr. Moe
only, for 2023 include Ms. Milton only. Mr. Moe was appointed as the Company&#8217;s Chief Financial Officer on October 7, 2024, and
prior to that Mr. Moe served as the Chief Financial Officer of Beeline Financial since June 2023. Ms. Milton was appointed as the Company&#8217;s
Chief Accounting Officer on April 25, 2025.</ix:footnote></span></td></tr>

<tr style="display: none; vertical-align: top">
  <td style="text-align: left; width: 0.25in"><span id="xdx_F00_zuZF1m7OUOva" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
  <td style="text-align: justify"><span id="xdx_F1E_zDfABwcDPdCh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000045" xml:lang="en-US">Represents the cumulative total shareholder return of a fixed
investment of $100 made at the closing price of the Company&#8217;s Common Stock at December 31, 2022, for the measurement period beginning
on such date and continuing through and including the end of the applicable fiscal year reflected in the table.</ix:footnote></span></td></tr>

<tr style="display: none; vertical-align: top">
  <td style="text-align: left; width: 0.25in"><span id="xdx_F05_zinCtwTKEOTi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
  <td style="text-align: justify"><span id="xdx_F1F_zTjZd7CLCX34" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000046" xml:lang="en-US">Represents the amount of net income/(loss) reflected in the
Company&#8217;s audited consolidated financial statements for the applicable fiscal year reflected in the table.</ix:footnote></span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
Represents the amounts reported for <span id="xdx_907_eecd--PeoName_c20250101__20251231__ecd--IndividualAxis__custom--NicholasRLiuzzaJrMember_z68SWit6nasb"><span id="xdx_90A_eecd--PeoName_c20240101__20241231__ecd--IndividualAxis__custom--NicholasRLiuzzaJrMember_zBHHTtw3YNsg"><span id="xdx_904_eecd--PeoName_c20230101__20231231__ecd--IndividualAxis__custom--NicholasRLiuzzaJrMember_zFr6d27J544b"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_NicholasRLiuzzaJrMember" id="Fact000047" name="ecd:PeoName"><ix:nonNumeric contextRef="From2024-01-012024-12-31_custom_NicholasRLiuzzaJrMember" id="Fact000048" name="ecd:PeoName"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_NicholasRLiuzzaJrMember" id="Fact000049" name="ecd:PeoName">Mr. Liuzza</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></span></span></span>, the Company&#8217;s current Chief Executive Officer, in the &#8220;Total&#8221; column
of the &#8220;Summary Compensation Table&#8221; in each applicable year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Represents the amounts reported for <span id="xdx_900_eecd--PeoName_c20250101__20251231__ecd--IndividualAxis__custom--GeoffreyGwinMember_zTQcaJt30Raa"><span id="xdx_901_eecd--PeoName_c20240101__20241231__ecd--IndividualAxis__custom--GeoffreyGwinMember_zvXpNLI82Zx"><span id="xdx_905_eecd--PeoName_c20230101__20231231__ecd--IndividualAxis__custom--GeoffreyGwinMember_zeBWbUKHg0Hg"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_GeoffreyGwinMember" id="Fact000050" name="ecd:PeoName"><ix:nonNumeric contextRef="From2024-01-012024-12-31_custom_GeoffreyGwinMember" id="Fact000051" name="ecd:PeoName"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_GeoffreyGwinMember" id="Fact000052" name="ecd:PeoName">Mr. Gwin</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></span></span></span>, the Company&#8217;s former Chief Executive Officer. Mr. Gwin served as the Company&#8217;s
Chief Executive Officer until his resignation from such role on March 7, 2025. Mr. Gwin also previously served as Chief Financial Officer
until his resignation from such role on October 7, 2024, and as President of Bridgetown Spirits until the sale of that entity on July
25, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
SEC rules require certain adjustments be made to the &#8220;Summary Compensation Table&#8221; totals to determine &#8220;compensation
actually paid&#8221; as reported in the &#8220;Pay Versus Performance&#8221; table above. For purposes of the equity award adjustments
shown below, no equity awards were cancelled as a result of a failure to meet vesting conditions. The valuation assumptions used to calculate
fair values for purposes of the compensation actually paid calculation did not materially differ from those disclosed at the time of
grant (as applicable). The table below details the applicable adjustments to the amount in the &#8220;Total&#8221; column of the &#8220;Summary
Compensation Table&#8221; in each applicable year that were made to determine &#8220;compensation actually paid&#8221; (all amounts are
averages for the NEOs other than the PEO).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
Represents the average of the amounts reported for the NEOs as a group (excluding the PEOs) in the &#8220;Total&#8221; column of the
&#8220;Summary Compensation Table&#8221; in each applicable year. The names of each of the non-PEO NEOs included for these purposes for
2025 are Mr. Moe and Ms. Milton, for 2024 include Mr. Moe only, for 2023 include Ms. Milton only. Mr. Moe was appointed as the Company&#8217;s
Chief Financial Officer on October 7, 2024, and prior to that Mr. Moe served as the Chief Financial Officer of Beeline Financial since
June 2023. Ms. Milton was appointed as the Company&#8217;s Chief Accounting Officer on April 25, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 22; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact000054" name="ecd:TotalShareholderRtnVsPeerGroupTextBlock"><p id="xdx_896_eecd--TotalShareholderRtnVsPeerGroupTextBlock_dU_zcAKa5q6vwg7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)
Represents the cumulative total shareholder return of a fixed investment of $100 made at the closing price of the Company&#8217;s Common
Stock at December 31, 2022, for the measurement period beginning on such date and continuing through and including the end of the applicable
fiscal year reflected in the table.</span></p>

</ix:nonNumeric><p id="xdx_8A8_zuQii6AQNdn9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)
Represents the amount of net income/(loss) reflected in the Company&#8217;s audited consolidated financial statements for the applicable
fiscal year reflected in the table.</span></p>

<p id="xdx_8AF_zLBdjmEyVTBg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reconciliation
of Summary Compensation to Compensation Actually Paid</b></span></p>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact000056" name="ecd:EquityValuationAssumptionDifferenceFnTextBlock"><p id="xdx_894_eecd--EquityValuationAssumptionDifferenceFnTextBlock_dU_zHhJHuBNEtNi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Name</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_480_eecd--PeoTotalCompAmt_zJmsmRoLUgXh" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Table Total</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_489_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember_zD0hvX0e0jUc" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Deduct &#8220;Stock</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards&#8221; and</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8220;Option</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards&#8221;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>reported in</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Table</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_484_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember_zJnRwNyhyH0k" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Add Year-</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>End Fair</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>and</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unvested</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Granted in</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>the Year</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_48E_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember_zt9tLLsDqza3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Add (Deduct)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year over</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year Change</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>in Fair</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>and Unvested</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Granted in</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Prior Years</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_489_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember_zUnAMIEvSZC9" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Add Fair</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value as of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vesting Date</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Granted and</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vested in</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>the Year</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_485_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember_ztnCSqjfF35k" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Add</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Deduct)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year over</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year Change</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>in Fair Value</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Granted in</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Prior Years</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>which</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vested in</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>the Year</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_482_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember_zylSsBXvhLEh" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Add Value</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of any</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dividends</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>or Other</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Earnings</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Paid in</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>the Year</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_48C_eecd--PeoActuallyPaidCompAmt_zucz0S7GdHUg" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Actually Paid</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_41F_20250101__20251231__ecd--IndividualAxis__custom--NicholasRLiuzzaJrMember_zkNrpcfCjdC4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 4%; font-weight: bold; text-align: center">2025</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 29%; text-align: left">PEO-Nicholas R. Liuzza, Jr.</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2025-01-012025-12-31_custom_NicholasRLiuzzaJrMember" id="Fact000057" format="ixt:numdotdecimal" decimals="0" unitRef="USD">76,080</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2025-01-012025-12-31_custom_NicholasRLiuzzaJrMember_custom_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember" id="Fact000058" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">46,080</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2025-01-012025-12-31_custom_NicholasRLiuzzaJrMember_custom_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember" id="Fact000059" format="ixt:numdotdecimal" decimals="0" unitRef="USD">77,700</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl0060">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0061">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0062">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right">&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl0063">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2025-01-012025-12-31_custom_NicholasRLiuzzaJrMember" id="Fact000064" format="ixt:numdotdecimal" decimals="0" unitRef="USD">107,700</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_419_20250101__20251231__ecd--IndividualAxis__custom--GeoffreyGwinMember_zyafbdRzRAF7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">PEO-Geoffrey Gwin</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2025-01-012025-12-31_custom_GeoffreyGwinMember" id="Fact000065" format="ixt:numdotdecimal" decimals="0" unitRef="USD">214,300</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2025-01-012025-12-31_custom_GeoffreyGwinMember_custom_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember" id="Fact000066" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">14,300</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0067">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0068">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2025-01-012025-12-31_custom_GeoffreyGwinMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" id="Fact000069" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,300</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2025-01-012025-12-31_custom_GeoffreyGwinMember_custom_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember" id="Fact000070" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">158,400</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0071">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2025-01-012025-12-31_custom_GeoffreyGwinMember" id="Fact000072" format="ixt:numdotdecimal" decimals="0" unitRef="USD">55,900</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>Other NEOs (Average)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eecd--NonPeoNeoAvgTotalCompAmt_c20250101__20251231__ecd--IndividualAxis__ecd--NonPeoNeoMember_z4jrGDchh24" style="text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2025-01-012025-12-31_ecd_NonPeoNeoMember" id="Fact000073" format="ixt:numdotdecimal" decimals="0" unitRef="USD">296,916</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eecd--AdjToCompAmt_c20250101__20251231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember_zh9rqyWIdgN8" style="text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2025-01-012025-12-31_ecd_NonPeoNeoMember_custom_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember" id="Fact000074" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">124,416</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eecd--AdjToCompAmt_c20250101__20251231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember_zkhGmHdYLrbh" style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2025-01-012025-12-31_ecd_NonPeoNeoMember_custom_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember" id="Fact000075" format="ixt:numdotdecimal" decimals="0" unitRef="USD">209,790</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eecd--AdjToCompAmt_c20250101__20251231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember_zzHyOprLMkk4" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0076">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eecd--AdjToCompAmt_c20250101__20251231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember_zV6IuRBiDI0a" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0077">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eecd--AdjToCompAmt_c20250101__20251231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember_z85VkliPmcmh" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0078">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eecd--AdjToCompAmt_c20250101__20251231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember_zLjqhlualMq8" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0079">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20250101__20251231__ecd--IndividualAxis__ecd--NonPeoNeoMember_zc3fUW31dOag" style="text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2025-01-012025-12-31_ecd_NonPeoNeoMember" id="Fact000080" format="ixt:numdotdecimal" decimals="0" unitRef="USD">382,290</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_41D_20240101__20241231__ecd--IndividualAxis__custom--NicholasRLiuzzaJrMember_z0s5wDRssRz7" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: center">2024</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">PEO-Nicholas R. Liuzza, Jr.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2024-01-012024-12-31_custom_NicholasRLiuzzaJrMember" id="Fact000081" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0082">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0083">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0084">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0085">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0086">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0087">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2024-01-012024-12-31_custom_NicholasRLiuzzaJrMember" id="Fact000088" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_41E_20240101__20241231__ecd--IndividualAxis__custom--GeoffreyGwinMember_zkBtxuDF5xAa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">PEO-Geoffrey Gwin</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2024-01-012024-12-31_custom_GeoffreyGwinMember" id="Fact000089" format="ixt:numdotdecimal" decimals="0" unitRef="USD">772,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_custom_GeoffreyGwinMember_custom_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember" id="Fact000090" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">422,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_custom_GeoffreyGwinMember_custom_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember" id="Fact000091" format="ixt:numdotdecimal" decimals="0" unitRef="USD">385,160</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0092">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_custom_GeoffreyGwinMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" id="Fact000093" format="ixt:numdotdecimal" decimals="0" unitRef="USD">190,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0094">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0095">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2024-01-012024-12-31_custom_GeoffreyGwinMember" id="Fact000096" format="ixt:numdotdecimal" decimals="0" unitRef="USD">925,160</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>Other NEOs (Average)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eecd--NonPeoNeoAvgTotalCompAmt_c20240101__20241231__ecd--IndividualAxis__ecd--NonPeoNeoMember_zacdG22DXSY4" style="text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember" id="Fact000097" format="ixt:numdotdecimal" decimals="0" unitRef="USD">290,672</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eecd--AdjToCompAmt_c20240101__20241231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember_zv6TUsMcm7Ua" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0098">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eecd--AdjToCompAmt_c20240101__20241231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember_zwXSbPAipL4e" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0099">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eecd--AdjToCompAmt_c20240101__20241231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember_z5soDv13KEO7" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0100">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eecd--AdjToCompAmt_c20240101__20241231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember_zfDS7SCirtJl" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0101">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eecd--AdjToCompAmt_c20240101__20241231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember_zQmHgxC8Exil" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0102">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eecd--AdjToCompAmt_c20240101__20241231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember_zK0AWJD0ke0c" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0103">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20240101__20241231__ecd--IndividualAxis__ecd--NonPeoNeoMember_zlqscSwyZ8Uj" style="text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember" id="Fact000104" format="ixt:numdotdecimal" decimals="0" unitRef="USD">290,672</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_418_20230101__20231231__ecd--IndividualAxis__custom--NicholasRLiuzzaJrMember_zOxnOZsAMY2c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: center">2023</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">PEO-Nicholas R. Liuzza, Jr.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0105">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0106">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0107">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0108">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0109">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0110">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0111">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0112">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_41B_20230101__20231231__ecd--IndividualAxis__custom--GeoffreyGwinMember_z6G8KK6BkGi6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">PEO-Geoffrey Gwin</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2023-01-012023-12-31_custom_GeoffreyGwinMember" id="Fact000113" format="ixt:numdotdecimal" decimals="0" unitRef="USD">250,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0114">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0115">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0116">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_custom_GeoffreyGwinMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" id="Fact000117" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,878</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0118">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0119">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2023-01-012023-12-31_custom_GeoffreyGwinMember" id="Fact000120" format="ixt:numdotdecimal" decimals="0" unitRef="USD">256,878</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>Other NEOs (Average)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eecd--NonPeoNeoAvgTotalCompAmt_c20230101__20231231__ecd--IndividualAxis__ecd--NonPeoNeoMember_zeVcqpMBZDb4" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0121">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eecd--AdjToCompAmt_c20230101__20231231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember_z0q101lGkOXk" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0122">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eecd--AdjToCompAmt_c20230101__20231231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember_zWKUsQYw3MR4" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0123">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eecd--AdjToCompAmt_c20230101__20231231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember_zmnMOLMvQq9a" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0124">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eecd--AdjToCompAmt_c20230101__20231231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember_zXBX59QcqaJ9" style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" id="Fact000125" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,452</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eecd--AdjToCompAmt_c20230101__20231231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember_zzY5a94zZQpl" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0126">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eecd--AdjToCompAmt_c20230101__20231231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember_z8hwWV9EfFvk" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0127">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20230101__20231231__ecd--IndividualAxis__ecd--NonPeoNeoMember_zdsmx6epUwBa" style="text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember" id="Fact000128" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,452</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A2_zBnWZ3tL3BQ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact000130" name="ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock"><p id="xdx_894_eecd--CompActuallyPaidVsTotalShareholderRtnTextBlock_dU_z9bliJRWBylc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Relationship
Between Compensation Actually Paid and our Total Shareholder Return</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
stock price performance is not one of the elements used in determining Compensation Actually Paid to our Named Executive Officers. However,
the amount of Compensation Actually Paid to our Named Executive Officers aligns with the Company&#8217;s Total Shareholder Return due
to the fact that a portion of the compensation paid to our NEOs is comprised of equity awards.</span></p>

</ix:nonNumeric><p id="xdx_8AF_z2bcamhbAJFi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact000132" name="ecd:CompActuallyPaidVsNetIncomeTextBlock"><p id="xdx_893_eecd--CompActuallyPaidVsNetIncomeTextBlock_dU_z0oXkZ1QWPy6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Relationship
Between Compensation Actually Paid and our Net Income/(Loss)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GAAP
net income/(loss) is a measure of our overall profitability that we believe is a factor that can drive our stock price performance. However,
Compensation Actually Paid is less sensitive to our annual GAAP net income/(loss) because management and our Board do not believe that
our GAAP net income/(loss) is the only meaningful measure in allowing investors to evaluate management&#8217;s performance. The Board
considers multiple factors when determining executive compensation, including both financial and non-financial performance metrics, strategic
objectives, and market conditions. While the Company has experienced net losses in recent years, the Board believes that compensating
executives competitively is necessary to retain key talent with the skills to provide the leadership the Company needs to succeed and
to execute on the Company&#8217;s long-term strategic plan.</span></p>

</ix:nonNumeric><p id="xdx_8A2_z71Eb4kCImuf" style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 23; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="R_009"></span>PROPOSAL
2. AUDITOR RATIFICTAION PROPOSAL: RATIFICATION OF THE SELECTION OF SALBERG &amp; COMPANY, P.A. TO SERVE AS THE COMPANY&#8217;S INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2026</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board has appointed Salberg &amp; Company, P.A. (&#8220;Salberg&#8221;) to serve as our independent registered public accounting firm
for the fiscal year ending December 31, 2026. Salberg has served as the Company&#8217;s independent registered public accounting firm
since December 4, 2024. See &#8220;Auditor Change&#8221; below. Selection of the Company&#8217;s independent registered public accounting
firm is not required to be submitted to a vote of the stockholders of the Company for ratification. However, the Company is submitting
this matter to the stockholders as a matter of good corporate governance. Even if the appointment is ratified, the Board may, in its
discretion, appoint a different independent registered public accounting firm at any time during the year if they determine that such
a change would be in the best interests of the Company and its stockholders. If the appointment is not ratified, the Board will consider
its options.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
representative of Salberg is not expected to be present at the Special Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Audit Committee currently consists of Francis Knuettel, II (Chair), Joseph Freedman and Stephen Romano. The Audit Committee reviews the
Company&#8217;s financial reporting process on behalf of the Board and administers our engagement of the independent registered public
accounting firm. The Audit Committee meets with the independent registered public accounting firm, with and without management present,
to discuss the results of its examinations, the evaluations of our internal controls, and the overall quality of our financial reporting.
Management has the primary responsibility for the financial statements and the reporting process, including the system of internal controls.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is not the duty of the Audit Committee to determine that the Company&#8217;s financial statements and disclosures are complete and accurate
and in accordance with generally accepted accounting principles or to plan or conduct audits. Those are the responsibilities of management
and the Company&#8217;s independent registered public accounting firm. In giving its recommendation to the Board with respect to the
Company&#8217;s financial statements, the Audit Committee relies: (1) management&#8217;s representations that such financial statements
have been prepared with integrity and objectivity and in conformity with U.S. generally accepted accounting principles (GAAP); and (2)
the report of the Company&#8217;s independent registered public accounting firm with respect to such financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Audit
Committee&#8217;s Pre-Approval Policy</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee pre-approves all audit and permissible non-audit services performed by the independent accountants. These services may
include audit services, audit-related services, tax services and other services. Under our policy, pre-approval is generally provided
for particular services or categories of services, including planned services, project-based services and routine consultations. In addition,
the Board may also pre-approve particular services on a case-by-case basis. Our Board approved all services that our independent accountants
provided to us in the past two fiscal years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fees
incurred for the Services Provided by our Principal Accountants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the aggregate fees paid for or accrued by the Company for audit and other services provided by Salberg for
the years ended December 31, 2025 and 2024. The table does not include fees paid for or accrued by the Company for audit and other services
provided by M&amp;K CPAS, PLLC, the Company&#8217;s former independent registered public accounting firm prior to such firm&#8217;s replacement
with Salberg, although we voluntarily include such amounts in the footnotes to the below table. See also &#8220;Auditor Change&#8221;
below for more information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; text-align: left">Audit Fees (1)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">267,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">175,500</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Audit Related Fees (2)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">30,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">42,200</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Total</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">297,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">217,700</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit fees &#8211; these
    fees relate to the annual audits and quarterly reviews of our financial statements and registration statements as well as services
    that are normally provided by the independent registered public accounting firm in connection with statutory and regulatory filings
    or engagements.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit Related Fees &#8211;
    these fees relate to audit related fees pertained to a subsidiary standalone audit required for mortgage licensing requirements in
    various states. Does not include fees totaling $102,002 paid to M&amp;K CPAS, PLLC, the Company&#8217;s former independent registered
    public accounting firm, in 2024.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 24; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Auditor
Change</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 4, 2024, the Board dismissed M&amp;K CPAS, PLLC from its position as the Company&#8217;s principal independent accountant. The
dismissal was approved by the Audit Committee of the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
audit reports of M&amp;K CPAS, PLLC on the Company&#8217;s financial statements for the years ended December 31, 2023 and 2022 did not
contain any adverse opinion or disclaimer of opinion or qualification, except that the audit report of M&amp;K CPAS, PLLC on the Company&#8217;s
financial statements for the years ended December 31, 2023 and 2022 did contain a modification expressing substantial doubt about the
Company&#8217;s ability to continue as a going concern. M&amp;K CPAS, PLLC did not, during the applicable period, advise the Company
of any of the enumerated items described in Item 304(a)(1)(iv) of Regulation S-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the two most recent fiscal years, there was no disagreement between the Company and its independent registered public accounting firm
on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreement,
if not resolved to its satisfaction, would have caused our its independent registered public accounting firm to make reference to the
subject matter of such disagreement in connection with its report. During the same period, there was no &#8220;reportable event,&#8221;
as described in Item 304(a)(1)(v) of Regulation S-K, except that, in connection with its audit of the financial statements for the years
ended December 31, 2023 and 2022, M&amp;K CPAS, PLLC advised the Company that there was a material weakness in the internal controls
necessary for the Company to develop reliable financial statements since management lacked a formal policy of inputs in testing for impairment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company requested M&amp;K CPAS, PLLC to furnish a letter addressed to the Securities Exchange Commission stating whether or not M&amp;K
CPAS, PLLC agrees with the foregoing statements pertaining to M&amp;K CPAS, PLLC. A copy of the letter is filed as Exhibit 16.1 to the
Company&#8217;s Form 8-K filed with the SEC on December 5, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 4, 2024, the Company appointed Salberg as its independent registered public accounting firm for the year ended December 31,
2024. During the Company&#8217;s two most recent fiscal years ended December 31, 2025 and 2024, and through December 4, 2024, neither
the Company nor anyone on behalf of the Company consulted with Salberg regarding (a) the application of accounting principles to a specified
transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company&#8217;s financial statements
as to which the Company received a written report or oral advice that was an important factor in reaching a decision on any accounting,
auditing or financial reporting issue, or (b) any matter that was the subject of a disagreement or a reportable event as defined in Item
304(a)(1)(iv) and (v), respectively, of Regulation S-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vote
Required</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
affirmative vote of a majority of the votes cast at the Annual Meeting is required to approve the Auditor Ratification Proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
BOARD RECOMMENDS THAT YOU VOTE &#8220;<span style="text-decoration: underline">FOR</span>&#8221; THE AUDITOR RATIFICATION PROPOSAL (PROPOSAL 2)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 25; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="R_010"></span>Audit
Committee Report</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
principal purpose of the Audit Committee is to assist the Board in its general oversight of our accounting practices, system of internal
controls, audit processes and financial reporting processes. The Audit Committee is responsible for selecting and retaining our independent
auditor and approving the audit and non-audit services to be provided by the independent auditor. The Audit Committee&#8217;s function
is more fully described in its charter.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management is responsible for preparing our financial statements and ensuring they are complete and accurate and prepared in accordance
with generally accepted accounting principles. The independent registered public accounting firm is responsible for performing an independent
audit of our consolidated financial statements and expressing an opinion on the conformity of those financial statements with generally
accepted accounting principles.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee has:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewed and discussed
    the audited financial statements with management;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">discussed with the independent
    registered public accounting firm matters required to be discussed by Statement on Auditing Standards No. 1301;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">received the written disclosures
    and the letter from the independent registered public accounting firm, as required by the applicable requirements of the Public Company
    Accounting Oversight Board regarding the independent registered public accounting firm&#8217;s communications with the Audit Committee
    concerning independence, and has discussed its independence with the Company; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in reliance on the review
    and discussions referred to above, the Audit Committee recommended to the Board that the audited financial statements be included
    in the Annual Report on Form 10-K for the year ended December 31, 2025 for filing with the SEC.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
report is submitted by the Audit Committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Francis
Knuettel II, Chair</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joseph
Freedman</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stephen
Romano</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
above Audit Committee Report is not deemed to be &#8220;soliciting material,&#8221; is not &#8220;filed&#8221; with the SEC and is not
to be incorporated by reference in any filings that the Company files with the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is not the duty of the Audit Committee to determine that the Company&#8217;s financial statements and disclosures are complete and accurate
and in accordance with GAAP or to plan or conduct audits. Those are the responsibilities of management and the Company&#8217;s independent
registered public accounting firm. In giving its recommendation to the Board, the Audit Committee has relied on: (1) management&#8217;s
representations that such financial statements have been prepared with integrity and objectivity and in conformity with GAAP; and (2)
the report of the Company&#8217;s independent registered public accounting firm with respect to such financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 26; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="R_011"></span>PROPOSAL
3: THE EQUITY LINE OF CREDIT PROPOSAL</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Background</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the Annual Meeting, stockholders will be asked to approve potential future amendments or modifications to the Equity Line of Credit Transaction
under the Common Stock Purchase Agreement and related Registration Rights Agreement between the Company and C/M Capital Master Fund LP
(the &#8220;Purchaser&#8221;), originally entered into on December 31, 2024, and subsequently amended, (the &#8220;ELOC Agreement&#8221;),
pursuant to which the Company can issue and sell to the Purchaser from time to time, up to $20 million of Common Stock subject to the
terms and conditions of the ELOC Agreement. The ELOC Agreement and the sales and issuances of Common Stock pursuant to the Equity Line
of Credit contemplated thereby were previously approved by the Company&#8217;s stockholders at a Special Meeting of Stockholders held
on March 7, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Proposal</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company and the Purchaser may in the future determine to amend or modify the ELOC Agreement and the terms of the Equity Line of Credit
contemplated thereby as may be desirable to the parties and in the interest of meeting the Company&#8217;s financing using the Equity
Line of Credit and ELOC Agreement. Such amendments or modifications may include amendments or modifications to the pricing per share
and adjustment terms set forth in the ELOC Agreement, and thereby the number of shares issuable thereunder, other than the maximum total
dollar amount of sales thereunder which shall remain $20 million. Any such future amendments or modifications to the ELOC Agreement and
the Equity Line of Credit thereunder as described above and for which the Company is seeking stockholder approval at the Annual Meeting
are sometimes referred to herein as the &#8220;Amendments&#8221;. As of the Record Date, the Company has previously sold a total of 7,015,227
shares of Common Stock under the ELOC Agreement for gross proceeds of $9,798,332, and may in the future sell up to an additional $10,201,668
under the ELOC Agreement after giving effect to the prior sales.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is seeking stockholder approval of the Amendments under this Proposal 3 to, among other things, ensure compliance with Nasdaq
Rules with respect to any such future Amendments. See &#8220;Nasdaq Rules&#8221; below for more information on such Rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reasons
for the Proposal</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ELOC Agreement provides the Company with needed access to capital in order to enable it to fund its working capital and general corporate
expenses. The Company may also use proceeds from the ELOC Agreement to repay indebtedness, to fund its growth initiatives, or fund its
operations. The Company&#8217;s business is capital intensive given real estate lending requires constant and substantial access to capital.
The additional capital the ELOC Agreement presents may, if needed, help the Company maintain sufficient stockholders&#8217; equity to
maintain the minimum amount of $2.5 million in stockholders&#8217; equity required by Nasdaq. Approval of Proposal 3 will provide the
Company with additional flexibility with respect to the ELOC Agreement which may help enable the Company to access capital as contemplated
by the ELOC Agreement more efficiently by enabling the parties to adopt future Amendments without the time and resource constraints presented
by a subsequent stockholder&#8217;s meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Proposal 3 is approved by stockholders, the Company anticipates potentially making Amendments to the ELOC Agreement, provided that the
Company will not increase the maximum amount of sales under the ELOC Agreement above the $20 million currently provided for under the
ELOC Agreement without further stockholder approval.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will be required to register any sales under the ELOC Agreement through which we issue underlying Common Stock in order to permit us
to raise capital under the ELOC Agreement. On October 21 2025, we filed a registration statement on Form S-1 registering the sale of
up to 5,000,000 shares of Common Stock under the ELOC Agreement, of which 3,679,288 shares remain available for future sales. Our ability
to raise a material amount under the ELOC Agreement will depend upon the future liquidity of our Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Potential
Consequences if Proposal 3 is not Approved</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Equity Line of Credit Proposal (Proposal 3) is not approved by our stockholders, the Company will not have the flexibility to engage
in the transactions contemplated by the ELOC Agreement quickly and may not be able to access capital thereunder. In such event, the Company
may be required to seek alternative means of raising capital, including for the purposes and uses described in the preceding subsection
titled &#8220;Reasons for the Proposal,&#8221; which it may be unable to do within a reasonable period of time, on favorable terms, or
at all.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 27; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nasdaq
Rules</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Common Stock is listed on The Nasdaq Capital Market under the symbol &#8220;BLNE,&#8221; and we are therefore subject to Nasdaq Rules.
Nasdaq Rule 5635(d) requires stockholder approval prior to the issuance of Common Stock in a non-public offering at a price per share
that is less than the lower of: (i) the official closing price of the Common Stock immediately preceding the signing of the binding agreement
therefor; or (ii) the average official closing price of the Common Stock for the five trading days immediately preceding the signing
of the binding agreement therefor, and which equals 20% or more of the then outstanding Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
we previously obtained stockholder approval for the ELOC Agreement, we are seeking stockholder approval of Proposal 3 to enable the Company
and the Purchaser to adopt potential future Amendments to the provisions of the ELOC Agreement, including potential future amendments
or modifications to the pricing per share thereunder, other than the maximum total dollar amount of sales thereunder which shall remain
$20 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is seeking stockholder approval under this Proposal 3 for purposes of Nasdaq Rule 5635(d) which requires stockholder approval
for certain offerings of over 20% of the outstanding Common Stock at a price per share which may be less than the &#8220;Minimum Price&#8221;
as defined therein in connection with potential future Amendments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vote
Required</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approval
of the Equity Line of Credit Proposal (Proposal 3) requires the affirmative vote of a majority of votes cast on the Proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dissenters&#8217;
(Appraisal) Rights</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no &#8220;dissenters&#8221; or &#8220;appraisal&#8221; rights in connection with the Equity Line of Credit Proposal (Proposal 3).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
BOARD RECOMMENDS THAT YOU VOTE &#8220;<span style="text-decoration: underline">FOR</span>&#8221; PROPOSAL 3</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="R_012"></span>PROPOSAL
4. ADJOURNMENT PROPOSAL</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>General</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is asking its stockholders to approve, if necessary, a proposal to adjourn the Annual Meeting to a later date and time to solicit
additional proxies in favor of one or more proposals submitted to a vote by the stockholders at the Annual Meeting. Any adjournment of
the Annual Meeting for the purpose of soliciting additional proxies will allow stockholders who have already sent in their proxies to
revoke them at any time prior to the time that the proxies are used. Our Bylaws allow the Chairman of any Annual or Special Meeting of
the Stockholders to have the authority to adjourn or postpone such meeting if a quorum is not present, or as otherwise authorized or
instructed by the Board of Directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
affirmative vote of a majority of the votes cast is required to approve Proposal 4.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
BOARD RECOMMENDS A VOTE &#8220;<span style="text-decoration: underline">FOR</span>&#8221; PROPOSAL 4.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OTHER
MATTERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beeline
has no knowledge of any other matters that may come before the Annual Meeting and does not intend to present any other matters at the
Annual Meeting. However, if any other matters shall properly come before the Annual Meeting or any adjournment, the persons soliciting
proxies will have the discretion to vote as they see fit unless directed otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 28; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td rowspan="2" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>BEELINE
    HOLDINGS, INC.</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 80%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VOTE
    BY INTERNET - www. BLNE.vote</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use
    the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 p.m. Eastern Time on
    August 16, 2026. Have your proxy card in hand when you access the web site and then follow the instructions. Enter the 12 digit Control
    Number below and follow the instructions to vote your proxy.</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DURING
    THE MEETING- Dial 1-877-407-3088.</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
    may attend the meeting exclusively via audio conference call. Have the information that is printed in the box marked by the arrow
    available and follow instructions.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VOTE
    BY EMAIL</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark,
    date, sign and email the proxy card to proxy@equitystock.com ATTN: Shareholder Services.</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VOTE BY FAX</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark, date, sign and fax the enclosed proxy card to
    347-584-3644, ATTN: Shareholder Services.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VOTE
    BY MAIL</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark,
    sign and date your proxy card and mail it to 237 W. 37<sup>th</sup> Street, Suite 602, New York, New York 10018, Attention: Shareholder
    Services.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TO VOTE, MARK
    BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 49%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">KEEP
    THIS PORTION FOR YOUR RECORDS</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- - - - - - - - - - - - - - - - - - - -
    - - - - - - - - - - - - - - - - - - - - - -</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DETACH AND RETURN THIS PORTION
    ONLY</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 29 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THIS
PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BEELINE
    HOLDINGS, INC.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>All</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Withhold</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>All</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
    All</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Except</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    withhold authority to vote for any individual nominee(s), mark &#8220;For All Except&#8221; and write the number(s) of the nominee(s)
    on the line below.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The Board of Directors recommends you
    vote FOR all listed nominees:</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 16%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Elect five directors to the Board
    of Directors.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#160;&#160;]</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#160;&#160;]</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#160;&#160;]</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 43%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">____________________________</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nominees:</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="9" style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">01)
    Nicholas R. Liuzza, Jr. 02) Joseph Caltabiano 03) Joseph Freedman</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">04)
    Francis Knuettel, II 05) Stephen Romano</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The Board
    of Directors recommends you vote &#8220;FOR&#8221; Proposals 2, 3, and 4.</b></span></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For</b></span></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Against</b></span></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Abstain</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 61%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ratify the selection of
    Salberg &amp; Company, P.A. to serve as the Company&#8217;s independent registered public accounting firm for the fiscal year ending
    December 31, 2026.</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#160;&#160;]</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#160;&#160;]</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#160;&#160;]</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approve potential future
    amendments or modifications to the provisions of the Company&#8217;s Equity Line of Credit, or ELOC, which the Company and the Purchaser
    may adopt, including amendments or modifications to the pricing per share thereunder, other than the maximum total dollar amount
    of sales thereunder which shall remain $20 million.</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#160;&#160;]</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#160;&#160;]</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#160;&#160;]</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approve an adjournment
    of the Annual Meeting to a later date or time, if necessary, to permit further solicitation and vote of proxies if there are not
    sufficient votes at the time of the Annual Meeting to approve any of the proposals presented for a vote at the Annual Meeting.</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#160;&#160;]</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#160;&#160;]</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#160;&#160;]</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE:
</b>Transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary, please give full
title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full
corporate or partnership name by authorized officer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 42%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature [PLEASE SIGN WITHIN BOX]</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature (Joint Owners)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Important
Notice Regarding the Availability of Proxy Materials for the Annual Meeting:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Notice, Proxy Statement and Annual Report on Form 10-K for the year ended December 31, 2025 are available at <b>www.BLNE.vote</b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 30 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BEELINE
HOLDINGS, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Annual
Meeting of Stockholders</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>August
17, 2026 11:00 AM, ET</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>This
proxy is solicited on behalf of the Board of Directors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
stockholder(s) hereby appoint(s) <span style="background-color: white">Nicholas R. Liuzza, Jr</span>. and Christopher R. Moe, or either
of them, as proxies, each with the power to appoint his substitute, and hereby authorize(s) them to represent and to vote, as designated
on the reverse side of this ballot, all of the shares of Common Stock of BEELINE HOLDINGS, INC. that the stockholder(s) is/are entitled
to vote at the Annual Meeting of Stockholders to be held at 11:00 AM, ET on August 17, 2026, virtually via audio conference call at 1-877-407-3088,
and any adjournment or postponement thereof. No in-person meeting will be held.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>This
proxy, when properly executed, will be voted in the manner directed herein. If no such direction is made, this proxy will be voted in
accordance with the Board of Directors&#8217; recommendations.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Continued
and to be signed on reverse side</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 31; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- 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 -->
<!-- Field: Set; Name: xdx; ID: xdx_088_labels -->
<!-- eJwdzLEOgkAMgOHdxHdobjaU6Mams8MNbMShd1eVWCkpFw7fXmD//t9dU+pzrwMJ3CmwTO7k3jmPDWIppVqCSaX2wnNdX9BUGGVj7nhwHFPj57GlINzykm+i8bPmnn4wT+DZnmpfGiJDtyPYFOzssQ7+OCopiQ== -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>2
<FILENAME>blne-20251231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWa2DebP9z5Z8SekhvWB5bekqXyEtlhyRJiUwapFG8Y0P -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:BLNE="http://makeabeeline.com/20251231" elementFormDefault="qualified" targetNamespace="http://makeabeeline.com/20251231">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://makeabeeline.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="blne-20251231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="blne-20251231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="blne-20251231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/ecd/2025" schemaLocation="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
    <element id="BLNE_NicholasRLiuzzaJrMember" name="NicholasRLiuzzaJrMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BLNE_GeoffreyGwinMember" name="GeoffreyGwinMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BLNE_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember" name="StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BLNE_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember" name="YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BLNE_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember" name="YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BLNE_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" name="FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BLNE_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember" name="YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BLNE_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember" name="ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>3
<FILENAME>blne-20251231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="blne-20251231.xsd#Cover" roleURI="http://makeabeeline.com/role/Cover" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpExecutiveCategoriesOnly" roleURI="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpAdjustmentsOnly" roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#IndividualsOnly" roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#AwardTypeOnly" roleURI="http://xbrl.sec.gov/ecd/AwardTypeOnly" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#TradingArrangmentsOnly" roleURI="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://makeabeeline.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllAdjToCompMember" xlink:label="loc_ecdAllAdjToCompMember" />
      <link:loc xlink:type="locator" xlink:href="blne-20251231.xsd#BLNE_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember" xlink:label="loc_BLNEStockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_BLNEStockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="blne-20251231.xsd#BLNE_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember" xlink:label="loc_BLNEYearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_BLNEYearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="blne-20251231.xsd#BLNE_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember" xlink:label="loc_BLNEYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_BLNEYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="blne-20251231.xsd#BLNE_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" xlink:label="loc_BLNEFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_BLNEFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="blne-20251231.xsd#BLNE_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember" xlink:label="loc_BLNEYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_BLNEYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="blne-20251231.xsd#BLNE_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember" xlink:label="loc_BLNEValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_BLNEValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember" xlink:type="arc" order="50" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:loc xlink:type="locator" xlink:href="blne-20251231.xsd#BLNE_NicholasRLiuzzaJrMember" xlink:label="loc_BLNENicholasRLiuzzaJrMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllIndividualsMember" xlink:to="loc_BLNENicholasRLiuzzaJrMember" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="blne-20251231.xsd#BLNE_GeoffreyGwinMember" xlink:label="loc_BLNEGeoffreyGwinMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllIndividualsMember" xlink:to="loc_BLNEGeoffreyGwinMember" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoMember" xlink:label="loc_ecdNonPeoNeoMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllIndividualsMember" xlink:to="loc_ecdNonPeoNeoMember" xlink:type="arc" order="20" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/AwardTypeOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>blne-20251231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDateAxis" xlink:label="ecd_RestatementDateAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDateAxis" xlink:to="ecd_RestatementDateAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDateAxis_lbl" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis" xlink:label="ecd_IndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_IndividualAxis" xlink:to="ecd_IndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_IndividualAxis_lbl" xml:lang="en-US">Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="blne-20251231.xsd#BLNE_NicholasRLiuzzaJrMember" xlink:label="BLNE_NicholasRLiuzzaJrMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BLNE_NicholasRLiuzzaJrMember" xlink:to="BLNE_NicholasRLiuzzaJrMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BLNE_NicholasRLiuzzaJrMember_lbl" xml:lang="en-US">Nicholas R Liuzza Jr [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="blne-20251231.xsd#BLNE_GeoffreyGwinMember" xlink:label="BLNE_GeoffreyGwinMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BLNE_GeoffreyGwinMember" xlink:to="BLNE_GeoffreyGwinMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BLNE_GeoffreyGwinMember_lbl" xml:lang="en-US">Geoffrey Gwin [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAxis" xlink:label="ecd_AdjToCompAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToCompAxis" xlink:to="ecd_AdjToCompAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToCompAxis_lbl" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="blne-20251231.xsd#BLNE_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember" xlink:label="BLNE_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BLNE_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember" xlink:to="BLNE_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BLNE_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember_lbl" xml:lang="en-US">Stock Awards and Option Awards Reported in Summary Compensation Table [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="blne-20251231.xsd#BLNE_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember" xlink:label="BLNE_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BLNE_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember" xlink:to="BLNE_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BLNE_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember_lbl" xml:lang="en-US">Year End Fair Value of Outstanding and Unvested Equity Awards Granted in Year [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="blne-20251231.xsd#BLNE_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember" xlink:label="BLNE_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BLNE_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember" xlink:to="BLNE_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BLNE_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember_lbl" xml:lang="en-US">Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards Granted in Prior Years [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="blne-20251231.xsd#BLNE_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" xlink:label="BLNE_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BLNE_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" xlink:to="BLNE_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BLNE_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember_lbl" xml:lang="en-US">Fair Value as of Vesting Date of Equity Awards Granted and Vested in Year [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="blne-20251231.xsd#BLNE_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember" xlink:label="BLNE_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BLNE_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember" xlink:to="BLNE_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BLNE_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember_lbl" xml:lang="en-US">Year Over Year Change in Fair Value of Equity Awards Granted in Prior Years which Vested in Year [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="blne-20251231.xsd#BLNE_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember" xlink:label="BLNE_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BLNE_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember" xlink:to="BLNE_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BLNE_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember_lbl" xml:lang="en-US">Value of Any Dividends or Other Earnings Paid in Year [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoMember" xlink:label="ecd_NonPeoNeoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoMember" xlink:to="ecd_NonPeoNeoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoMember_lbl" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTable" xlink:label="ecd_PvpTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PvpTable" xlink:to="ecd_PvpTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PvpTable_lbl" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTableTextBlock" xlink:label="ecd_PvpTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PvpTableTextBlock" xlink:to="ecd_PvpTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PvpTableTextBlock_lbl" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureName" xlink:label="ecd_CoSelectedMeasureName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CoSelectedMeasureName" xlink:to="ecd_CoSelectedMeasureName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CoSelectedMeasureName_lbl" xml:lang="en-US">Company Selected Measure Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NamedExecutiveOfficersFnTextBlock" xlink:label="ecd_NamedExecutiveOfficersFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="ecd_NamedExecutiveOfficersFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NamedExecutiveOfficersFnTextBlock_lbl" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupIssuersFnTextBlock" xlink:label="ecd_PeerGroupIssuersFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeerGroupIssuersFnTextBlock" xlink:to="ecd_PeerGroupIssuersFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeerGroupIssuersFnTextBlock_lbl" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChangedPeerGroupFnTextBlock" xlink:label="ecd_ChangedPeerGroupFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ChangedPeerGroupFnTextBlock" xlink:to="ecd_ChangedPeerGroupFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ChangedPeerGroupFnTextBlock_lbl" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoTotalCompAmt" xlink:label="ecd_PeoTotalCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoTotalCompAmt" xlink:to="ecd_PeoTotalCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoTotalCompAmt_lbl" xml:lang="en-US">PEO Total Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoActuallyPaidCompAmt" xlink:label="ecd_PeoActuallyPaidCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoActuallyPaidCompAmt" xlink:to="ecd_PeoActuallyPaidCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoActuallyPaidCompAmt_lbl" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToPeoCompFnTextBlock" xlink:label="ecd_AdjToPeoCompFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToPeoCompFnTextBlock" xlink:to="ecd_AdjToPeoCompFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToPeoCompFnTextBlock_lbl" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgTotalCompAmt" xlink:label="ecd_NonPeoNeoAvgTotalCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="ecd_NonPeoNeoAvgTotalCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoAvgTotalCompAmt_lbl" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:label="ecd_NonPeoNeoAvgCompActuallyPaidAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="ecd_NonPeoNeoAvgCompActuallyPaidAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoAvgCompActuallyPaidAmt_lbl" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:label="ecd_AdjToNonPeoNeoCompFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="ecd_AdjToNonPeoNeoCompFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToNonPeoNeoCompFnTextBlock_lbl" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:label="ecd_EquityValuationAssumptionDifferenceFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="ecd_EquityValuationAssumptionDifferenceFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_EquityValuationAssumptionDifferenceFnTextBlock_lbl" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:label="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_lbl" xml:lang="en-US">Relationship Between Compensation Actually Paid and our Total Shareholder Return</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:label="ecd_CompActuallyPaidVsNetIncomeTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="ecd_CompActuallyPaidVsNetIncomeTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsNetIncomeTextBlock_lbl" xml:lang="en-US">Relationship Between Compensation Actually Paid and our Net Income/(Loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:label="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:label="ecd_TotalShareholderRtnVsPeerGroupTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="ecd_TotalShareholderRtnVsPeerGroupTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TotalShareholderRtnVsPeerGroupTextBlock_lbl" xml:lang="en-US">Total Shareholder Return Vs Peer Group [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:label="ecd_CompActuallyPaidVsOtherMeasureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="ecd_CompActuallyPaidVsOtherMeasureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsOtherMeasureTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TabularListTableTextBlock" xlink:label="ecd_TabularListTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TabularListTableTextBlock" xlink:to="ecd_TabularListTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TabularListTableTextBlock_lbl" xml:lang="en-US">Tabular List, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnAmt" xlink:label="ecd_TotalShareholderRtnAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TotalShareholderRtnAmt" xlink:to="ecd_TotalShareholderRtnAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TotalShareholderRtnAmt_lbl" xml:lang="en-US">Total Shareholder Return Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupTotalShareholderRtnAmt" xlink:label="ecd_PeerGroupTotalShareholderRtnAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="ecd_PeerGroupTotalShareholderRtnAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeerGroupTotalShareholderRtnAmt_lbl" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureAmt" xlink:label="ecd_CoSelectedMeasureAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CoSelectedMeasureAmt" xlink:to="ecd_CoSelectedMeasureAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CoSelectedMeasureAmt_lbl" xml:lang="en-US">Company Selected Measure Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OtherPerfMeasureAmt" xlink:label="ecd_OtherPerfMeasureAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OtherPerfMeasureAmt" xlink:to="ecd_OtherPerfMeasureAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OtherPerfMeasureAmt_lbl" xml:lang="en-US">Other Performance Measure, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAmt" xlink:label="ecd_AdjToCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToCompAmt" xlink:to="ecd_AdjToCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToCompAmt_lbl" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoName" xlink:label="ecd_PeoName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoName" xlink:to="ecd_PeoName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoName_lbl" xml:lang="en-US">PEO Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureName" xlink:label="ecd_MeasureName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MeasureName" xlink:to="ecd_MeasureName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MeasureName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonGaapMeasureDescriptionTextBlock" xlink:label="ecd_NonGaapMeasureDescriptionTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="ecd_NonGaapMeasureDescriptionTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonGaapMeasureDescriptionTextBlock_lbl" xml:lang="en-US">Non-GAAP Measure Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Additional402vDisclosureTextBlock" xlink:label="ecd_Additional402vDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Additional402vDisclosureTextBlock" xlink:to="ecd_Additional402vDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Additional402vDisclosureTextBlock_lbl" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnBnftsAdjFnTextBlock" xlink:label="ecd_PnsnBnftsAdjFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PnsnBnftsAdjFnTextBlock" xlink:to="ecd_PnsnBnftsAdjFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PnsnBnftsAdjFnTextBlock_lbl" xml:lang="en-US">Pension Benefits Adjustments, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjFnTextBlock" xlink:label="ecd_EqtyAwrdsAdjFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_EqtyAwrdsAdjFnTextBlock" xlink:to="ecd_EqtyAwrdsAdjFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_EqtyAwrdsAdjFnTextBlock_lbl" xml:lang="en-US">Equity Awards Adjustments, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompRecoveryTable" xlink:label="ecd_ErrCompRecoveryTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ErrCompRecoveryTable" xlink:to="ecd_ErrCompRecoveryTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ErrCompRecoveryTable_lbl" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDeterminationDate" xlink:label="ecd_RestatementDeterminationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDeterminationDate" xlink:to="ecd_RestatementDeterminationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDeterminationDate_lbl" xml:lang="en-US">Restatement Determination Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompAmt" xlink:label="ecd_AggtErrCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AggtErrCompAmt" xlink:to="ecd_AggtErrCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AggtErrCompAmt_lbl" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompAnalysisTextBlock" xlink:label="ecd_ErrCompAnalysisTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ErrCompAnalysisTextBlock" xlink:to="ecd_ErrCompAnalysisTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ErrCompAnalysisTextBlock_lbl" xml:lang="en-US">Erroneous Compensation Analysis [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:label="ecd_StkPrcOrTsrEstimationMethodTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="ecd_StkPrcOrTsrEstimationMethodTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_StkPrcOrTsrEstimationMethodTextBlock_lbl" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingAggtErrCompAmt" xlink:label="ecd_OutstandingAggtErrCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingAggtErrCompAmt" xlink:to="ecd_OutstandingAggtErrCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingAggtErrCompAmt_lbl" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:label="ecd_AggtErrCompNotYetDeterminedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="ecd_AggtErrCompNotYetDeterminedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AggtErrCompNotYetDeterminedTextBlock_lbl" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryIndName" xlink:label="ecd_ForgoneRecoveryIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryIndName" xlink:to="ecd_ForgoneRecoveryIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_ForgoneRecoveryIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:label="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_lbl" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:label="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_lbl" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:label="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_lbl" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:label="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_lbl" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryIndName" xlink:label="ecd_OutstandingRecoveryIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryIndName" xlink:to="ecd_OutstandingRecoveryIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_OutstandingRecoveryIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryCompAmt" xlink:label="ecd_OutstandingRecoveryCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryCompAmt" xlink:to="ecd_OutstandingRecoveryCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingRecoveryCompAmt_lbl" xml:lang="en-US">Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:label="ecd_RestatementDoesNotRequireRecoveryTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="ecd_RestatementDoesNotRequireRecoveryTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDoesNotRequireRecoveryTextBlock_lbl" xml:lang="en-US">Restatement does not require Recovery</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTable" xlink:label="ecd_AwardsCloseToMnpiDiscTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscTable" xlink:to="ecd_AwardsCloseToMnpiDiscTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscTable_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiDiscTextBlock" xlink:label="ecd_AwardTmgMnpiDiscTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMnpiDiscTextBlock" xlink:to="ecd_AwardTmgMnpiDiscTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMnpiDiscTextBlock_lbl" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMethodTextBlock" xlink:label="ecd_AwardTmgMethodTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMethodTextBlock" xlink:to="ecd_AwardTmgMethodTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMethodTextBlock_lbl" xml:lang="en-US">Award Timing Method</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgPredtrmndFlag" xlink:label="ecd_AwardTmgPredtrmndFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgPredtrmndFlag" xlink:to="ecd_AwardTmgPredtrmndFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgPredtrmndFlag_lbl" xml:lang="en-US">Award Timing Predetermined</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiCnsdrdFlag" xlink:label="ecd_AwardTmgMnpiCnsdrdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="ecd_AwardTmgMnpiCnsdrdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMnpiCnsdrdFlag_lbl" xml:lang="en-US">Award Timing MNPI Considered</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:label="ecd_AwardTmgHowMnpiCnsdrdTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="ecd_AwardTmgHowMnpiCnsdrdTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgHowMnpiCnsdrdTextBlock_lbl" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MnpiDiscTimedForCompValFlag" xlink:label="ecd_MnpiDiscTimedForCompValFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MnpiDiscTimedForCompValFlag" xlink:to="ecd_MnpiDiscTimedForCompValFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MnpiDiscTimedForCompValFlag_lbl" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:label="ecd_AwardsCloseToMnpiDiscTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="ecd_AwardsCloseToMnpiDiscTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscTableTextBlock_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscIndName" xlink:label="ecd_AwardsCloseToMnpiDiscIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscIndName" xlink:to="ecd_AwardsCloseToMnpiDiscIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_AwardsCloseToMnpiDiscIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardUndrlygSecuritiesAmt" xlink:label="ecd_AwardUndrlygSecuritiesAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardUndrlygSecuritiesAmt" xlink:to="ecd_AwardUndrlygSecuritiesAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardUndrlygSecuritiesAmt_lbl" xml:lang="en-US">Underlying Securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardExrcPrice" xlink:label="ecd_AwardExrcPrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardExrcPrice" xlink:to="ecd_AwardExrcPrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardExrcPrice_lbl" xml:lang="en-US">Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardGrantDateFairValue" xlink:label="ecd_AwardGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardGrantDateFairValue" xlink:to="ecd_AwardGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardGrantDateFairValue_lbl" xml:lang="en-US">Fair Value as of Grant Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_UndrlygSecurityMktPriceChngPct" xlink:label="ecd_UndrlygSecurityMktPriceChngPct" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_UndrlygSecurityMktPriceChngPct" xlink:to="ecd_UndrlygSecurityMktPriceChngPct_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_UndrlygSecurityMktPriceChngPct_lbl" xml:lang="en-US">Underlying Security Market Price Change</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrByIndTable" xlink:label="ecd_TradingArrByIndTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TradingArrByIndTable" xlink:to="ecd_TradingArrByIndTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TradingArrByIndTable_lbl" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrAxis" xlink:label="ecd_TradingArrAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TradingArrAxis" xlink:to="ecd_TradingArrAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TradingArrAxis_lbl" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="ecd_MtrlTermsOfTrdArrTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock_lbl" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndName" xlink:label="ecd_TrdArrIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndName" xlink:to="ecd_TrdArrIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_TrdArrIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndTitle" xlink:label="ecd_TrdArrIndTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndTitle" xlink:to="ecd_TrdArrIndTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrIndTitle_lbl" xml:lang="en-US">Title</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="ecd_Rule10b51ArrAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrAdoptedFlag" xlink:to="ecd_Rule10b51ArrAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="ecd_NonRule10b51ArrAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrAdoptedFlag" xlink:to="ecd_NonRule10b51ArrAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrAdoptionDate" xlink:label="ecd_TrdArrAdoptionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrAdoptionDate" xlink:to="ecd_TrdArrAdoptionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrAdoptionDate_lbl" xml:lang="en-US">Adoption Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="ecd_Rule10b51ArrTrmntdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrTrmntdFlag" xlink:to="ecd_Rule10b51ArrTrmntdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="ecd_NonRule10b51ArrTrmntdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrTrmntdFlag" xlink:to="ecd_NonRule10b51ArrTrmntdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrTerminationDate" xlink:label="ecd_TrdArrTerminationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrTerminationDate" xlink:to="ecd_TrdArrTerminationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrTerminationDate_lbl" xml:lang="en-US">Termination Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrExpirationDate" xlink:label="ecd_TrdArrExpirationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrExpirationDate" xlink:to="ecd_TrdArrExpirationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrExpirationDate_lbl" xml:lang="en-US">Expiration Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrDuration" xlink:label="ecd_TrdArrDuration" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrDuration" xlink:to="ecd_TrdArrDuration_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrDuration_lbl" xml:lang="en-US">Arrangement Duration</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrSecuritiesAggAvailAmt" xlink:label="ecd_TrdArrSecuritiesAggAvailAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="ecd_TrdArrSecuritiesAggAvailAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrSecuritiesAggAvailAmt_lbl" xml:lang="en-US">Aggregate Available</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingPoliciesProcLineItems" xlink:label="ecd_InsiderTradingPoliciesProcLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTradingPoliciesProcLineItems" xlink:to="ecd_InsiderTradingPoliciesProcLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTradingPoliciesProcLineItems_lbl" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:label="ecd_InsiderTrdPoliciesProcAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="ecd_InsiderTrdPoliciesProcAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTrdPoliciesProcAdoptedFlag_lbl" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:label="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_lbl" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BLNE_NicholasRLiuzzaJrMember" xlink:to="BLNE_NicholasRLiuzzaJrMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BLNE_NicholasRLiuzzaJrMember_doc" xml:lang="en-US">Nicholas R Liuzza Jr [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BLNE_GeoffreyGwinMember" xlink:to="BLNE_GeoffreyGwinMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BLNE_GeoffreyGwinMember_doc" xml:lang="en-US">Geoffrey Gwin [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BLNE_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember" xlink:to="BLNE_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BLNE_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember_doc" xml:lang="en-US">Stock Awards and Option Awards Reported in Summary Compensation Table [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BLNE_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember" xlink:to="BLNE_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BLNE_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember_doc" xml:lang="en-US">Year End Fair Value of Outstanding and Unvested Equity Awards Granted in Year [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BLNE_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember" xlink:to="BLNE_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BLNE_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember_doc" xml:lang="en-US">Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards Granted in Prior Years [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BLNE_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" xlink:to="BLNE_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BLNE_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember_doc" xml:lang="en-US">Fair Value as of Vesting Date of Equity Awards Granted and Vested in Year [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BLNE_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember" xlink:to="BLNE_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BLNE_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember_doc" xml:lang="en-US">Year Over Year Change In Fair Value Of Equity Awards Granted In Prior Years Which Vested In The Year [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BLNE_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember" xlink:to="BLNE_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="BLNE_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember_doc" xml:lang="en-US">Value of Any Dividends or Other Earnings Paid in Year [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryIndName" xlink:to="ecd_ForgoneRecoveryIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryIndName_2_lbl" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryIndName" xlink:to="ecd_OutstandingRecoveryIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingRecoveryIndName_2_lbl" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscIndName" xlink:to="ecd_AwardsCloseToMnpiDiscIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscIndName_2_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndName" xlink:to="ecd_TrdArrIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrIndName_2_lbl" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>blne-20251231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="blne-20251231.xsd#Cover" roleURI="http://makeabeeline.com/role/Cover" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpDisclosure" roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpDisclosureWithAdditionalMeasures" roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosureWithAdditionalMeasures" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpTable" roleURI="http://xbrl.sec.gov/ecd/role/PvpTable" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpAdjustmentsToCompensation" roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsToCompensation" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#TabularListsByExecutiveCategory" roleURI="http://xbrl.sec.gov/ecd/role/TabularListsByExecutiveCategory" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#TabularListMeasures" roleURI="http://xbrl.sec.gov/ecd/role/TabularListMeasures" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpMeasures" roleURI="http://xbrl.sec.gov/ecd/role/PvpMeasures" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpPensionBenefitsAdjustments" roleURI="http://xbrl.sec.gov/ecd/role/PvpPensionBenefitsAdjustments" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ErrCompDisclosure" roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ForgoneRecoveries" roleURI="http://xbrl.sec.gov/ecd/role/ForgoneRecoveries" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#OutstandingRecoveries" roleURI="http://xbrl.sec.gov/ecd/role/OutstandingRecoveries" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#AwardTimingDisclosure" roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#AwardsCloseToMnpiDisc" roleURI="http://xbrl.sec.gov/ecd/role/AwardsCloseToMnpiDisc" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#InsiderTradingArrangements" roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#InsiderTradingArrangemenstByInd" roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangementsByInd" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#InsiderTradingPoliciesProc" roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#Defaults" roleURI="http://xbrl.sec.gov/ecd/role/Defaults" />
    <link:presentationLink xlink:type="extended" xlink:role="http://makeabeeline.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:title="995410 - Disclosure - Pay vs Performance Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PayVsPerformanceDisclosureLineItems" xlink:label="loc_ecdPayVsPerformanceDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTable" xlink:label="loc_ecdPvpTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPvpTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="blne-20251231.xsd#BLNE_NicholasRLiuzzaJrMember" xlink:label="loc_BLNENicholasRLiuzzaJrMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllIndividualsMember" xlink:to="loc_BLNENicholasRLiuzzaJrMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="blne-20251231.xsd#BLNE_GeoffreyGwinMember" xlink:label="loc_BLNEGeoffreyGwinMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllIndividualsMember" xlink:to="loc_BLNEGeoffreyGwinMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoMember" xlink:label="loc_ecdNonPeoNeoMember" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllIndividualsMember" xlink:to="loc_ecdNonPeoNeoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAxis" xlink:label="loc_ecdAdjToCompAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdAdjToCompAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllAdjToCompMember" xlink:label="loc_ecdAllAdjToCompMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAdjToCompAxis" xlink:to="loc_ecdAllAdjToCompMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="blne-20251231.xsd#BLNE_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember" xlink:label="loc_BLNEStockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_BLNEStockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="blne-20251231.xsd#BLNE_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember" xlink:label="loc_BLNEYearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_BLNEYearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="blne-20251231.xsd#BLNE_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember" xlink:label="loc_BLNEYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_BLNEYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="blne-20251231.xsd#BLNE_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" xlink:label="loc_BLNEFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_BLNEFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="blne-20251231.xsd#BLNE_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember" xlink:label="loc_BLNEYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_BLNEYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="blne-20251231.xsd#BLNE_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember" xlink:label="loc_BLNEValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_BLNEValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTableTextBlock" xlink:label="loc_ecdPvpTableTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPvpTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureName" xlink:label="loc_ecdCoSelectedMeasureName" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdCoSelectedMeasureName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NamedExecutiveOfficersFnTextBlock" xlink:label="loc_ecdNamedExecutiveOfficersFnTextBlock" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdNamedExecutiveOfficersFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupIssuersFnTextBlock" xlink:label="loc_ecdPeerGroupIssuersFnTextBlock" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeerGroupIssuersFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChangedPeerGroupFnTextBlock" xlink:label="loc_ecdChangedPeerGroupFnTextBlock" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdChangedPeerGroupFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoTotalCompAmt" xlink:label="loc_ecdPeoTotalCompAmt" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoTotalCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoActuallyPaidCompAmt" xlink:label="loc_ecdPeoActuallyPaidCompAmt" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoActuallyPaidCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToPeoCompFnTextBlock" xlink:label="loc_ecdAdjToPeoCompFnTextBlock" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdAdjToPeoCompFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgTotalCompAmt" xlink:label="loc_ecdNonPeoNeoAvgTotalCompAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdNonPeoNeoAvgTotalCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:label="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:label="loc_ecdAdjToNonPeoNeoCompFnTextBlock" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdAdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:label="loc_ecdEquityValuationAssumptionDifferenceFnTextBlock" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdEquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:label="loc_ecdCompActuallyPaidVsTotalShareholderRtnTextBlock" />
      <link:presentationArc order="2120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdCompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:label="loc_ecdCompActuallyPaidVsNetIncomeTextBlock" />
      <link:presentationArc order="2130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdCompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:label="loc_ecdCompActuallyPaidVsCoSelectedMeasureTextBlock" />
      <link:presentationArc order="2140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdCompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:label="loc_ecdTotalShareholderRtnVsPeerGroupTextBlock" />
      <link:presentationArc order="2150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdTotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:label="loc_ecdCompActuallyPaidVsOtherMeasureTextBlock" />
      <link:presentationArc order="2160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdCompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TabularListTableTextBlock" xlink:label="loc_ecdTabularListTableTextBlock" />
      <link:presentationArc order="2170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdTabularListTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnAmt" xlink:label="loc_ecdTotalShareholderRtnAmt" />
      <link:presentationArc order="2180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdTotalShareholderRtnAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupTotalShareholderRtnAmt" xlink:label="loc_ecdPeerGroupTotalShareholderRtnAmt" />
      <link:presentationArc order="2190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeerGroupTotalShareholderRtnAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="2200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureAmt" xlink:label="loc_ecdCoSelectedMeasureAmt" />
      <link:presentationArc order="2210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdCoSelectedMeasureAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OtherPerfMeasureAmt" xlink:label="loc_ecdOtherPerfMeasureAmt" />
      <link:presentationArc order="2220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdOtherPerfMeasureAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAmt" xlink:label="loc_ecdAdjToCompAmt" />
      <link:presentationArc order="2230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdAdjToCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoName" xlink:label="loc_ecdPeoName" />
      <link:presentationArc order="2240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureName" xlink:label="loc_ecdMeasureName" />
      <link:presentationArc order="2250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdMeasureName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonGaapMeasureDescriptionTextBlock" xlink:label="loc_ecdNonGaapMeasureDescriptionTextBlock" />
      <link:presentationArc order="2260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdMeasureName" xlink:to="loc_ecdNonGaapMeasureDescriptionTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Additional402vDisclosureTextBlock" xlink:label="loc_ecdAdditional402vDisclosureTextBlock" />
      <link:presentationArc order="2270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdAdditional402vDisclosureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnBnftsAdjFnTextBlock" xlink:label="loc_ecdPnsnBnftsAdjFnTextBlock" />
      <link:presentationArc order="2280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPnsnBnftsAdjFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjFnTextBlock" xlink:label="loc_ecdEqtyAwrdsAdjFnTextBlock" />
      <link:presentationArc order="2290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdEqtyAwrdsAdjFnTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:title="995440 - Disclosure - Recovery of Erroneously Awarded Compensation">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RecoveryOfErrCompDisclosureLineItems" xlink:label="loc_ecdRecoveryOfErrCompDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompRecoveryTable" xlink:label="loc_ecdErrCompRecoveryTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecdErrCompRecoveryTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDateAxis" xlink:label="loc_ecdRestatementDateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdErrCompRecoveryTable" xlink:to="loc_ecdRestatementDateAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDeterminationDate" xlink:label="loc_ecdRestatementDeterminationDate" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecdRestatementDeterminationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompAmt" xlink:label="loc_ecdAggtErrCompAmt" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdAggtErrCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompAnalysisTextBlock" xlink:label="loc_ecdErrCompAnalysisTextBlock" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdErrCompAnalysisTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:label="loc_ecdStkPrcOrTsrEstimationMethodTextBlock" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdStkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingAggtErrCompAmt" xlink:label="loc_ecdOutstandingAggtErrCompAmt" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdOutstandingAggtErrCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:label="loc_ecdAggtErrCompNotYetDeterminedTextBlock" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdAggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryIndName" xlink:label="loc_ecdForgoneRecoveryIndName" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:label="loc_ecdForgoneRecoveryDueToExpenseOfEnforcementAmt" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:label="loc_ecdForgoneRecoveryDueToViolationOfHomeCountryLawAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:label="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:label="loc_ecdForgoneRecoveryExplanationOfImpracticabilityTextBlock" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryIndName" xlink:label="loc_ecdOutstandingRecoveryIndName" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdOutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryCompAmt" xlink:label="loc_ecdOutstandingRecoveryCompAmt" />
      <link:presentationArc order="2120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdOutstandingRecoveryCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:label="loc_ecdRestatementDoesNotRequireRecoveryTextBlock" />
      <link:presentationArc order="2130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdRestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:title="995443 - Disclosure - Award Timing Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgDiscLineItems" xlink:label="loc_ecdAwardTmgDiscLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTable" xlink:label="loc_ecdAwardsCloseToMnpiDiscTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardsCloseToMnpiDiscTable" xlink:to="loc_ecdIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiDiscTextBlock" xlink:label="loc_ecdAwardTmgMnpiDiscTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMnpiDiscTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMethodTextBlock" xlink:label="loc_ecdAwardTmgMethodTextBlock" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMethodTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgPredtrmndFlag" xlink:label="loc_ecdAwardTmgPredtrmndFlag" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgPredtrmndFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiCnsdrdFlag" xlink:label="loc_ecdAwardTmgMnpiCnsdrdFlag" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMnpiCnsdrdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:label="loc_ecdAwardTmgHowMnpiCnsdrdTextBlock" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MnpiDiscTimedForCompValFlag" xlink:label="loc_ecdMnpiDiscTimedForCompValFlag" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdMnpiDiscTimedForCompValFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:label="loc_ecdAwardsCloseToMnpiDiscTableTextBlock" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscIndName" xlink:label="loc_ecdAwardsCloseToMnpiDiscIndName" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardUndrlygSecuritiesAmt" xlink:label="loc_ecdAwardUndrlygSecuritiesAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardUndrlygSecuritiesAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardExrcPrice" xlink:label="loc_ecdAwardExrcPrice" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardExrcPrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardGrantDateFairValue" xlink:label="loc_ecdAwardGrantDateFairValue" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_UndrlygSecurityMktPriceChngPct" xlink:label="loc_ecdUndrlygSecurityMktPriceChngPct" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdUndrlygSecurityMktPriceChngPct" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:title="995445 - Disclosure - Insider Trading Arrangements">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingArrLineItems" xlink:label="loc_ecdInsiderTradingArrLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrByIndTable" xlink:label="loc_ecdTradingArrByIndTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTradingArrByIndTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrAxis" xlink:label="loc_ecdTradingArrAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrByIndTable" xlink:to="loc_ecdTradingArrAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllTradingArrangementsMember" xlink:label="loc_ecdAllTradingArrangementsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrAxis" xlink:to="loc_ecdAllTradingArrangementsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrByIndTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="loc_ecdMtrlTermsOfTrdArrTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdMtrlTermsOfTrdArrTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndName" xlink:label="loc_ecdTrdArrIndName" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndTitle" xlink:label="loc_ecdTrdArrIndTitle" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrIndTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="loc_ecdRule10b51ArrAdoptedFlag" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdRule10b51ArrAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="loc_ecdNonRule10b51ArrAdoptedFlag" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdNonRule10b51ArrAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrAdoptionDate" xlink:label="loc_ecdTrdArrAdoptionDate" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrAdoptionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="loc_ecdRule10b51ArrTrmntdFlag" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdRule10b51ArrTrmntdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="loc_ecdNonRule10b51ArrTrmntdFlag" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdNonRule10b51ArrTrmntdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrTerminationDate" xlink:label="loc_ecdTrdArrTerminationDate" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrTerminationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrExpirationDate" xlink:label="loc_ecdTrdArrExpirationDate" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrExpirationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrDuration" xlink:label="loc_ecdTrdArrDuration" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrDuration" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrSecuritiesAggAvailAmt" xlink:label="loc_ecdTrdArrSecuritiesAggAvailAmt" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrSecuritiesAggAvailAmt" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:title="995447 - Disclosure - Insider Trading Policies and Procedures">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingPoliciesProcLineItems" xlink:label="loc_ecdInsiderTradingPoliciesProcLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:label="loc_ecdInsiderTrdPoliciesProcAdoptedFlag" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingPoliciesProcLineItems" xlink:to="loc_ecdInsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:label="loc_ecdInsiderTrdPoliciesProcNotAdoptedTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingPoliciesProcLineItems" xlink:to="loc_ecdInsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">DEF 14A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BEELINE
HOLDINGS, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001534708<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTableTextBlock', window );">Pay vs Performance [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_880_eecd--PvpTableTextBlock_zBvx4atBvnR1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Pay vs Performance Disclosure">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: center">Year <br/> (a)</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_481_eecd--PeoTotalCompAmt_hecd--IndividualAxis__custom--NicholasRLiuzzaJrMember_zCHKJsOPM1Fg" style="border-bottom: Black 1pt solid; text-align: center">Summary
    Compensation Table Total for PEO (Nicholas R. Liuzza, Jr.)<br/> (b)<span id="xdx_F5C_zhf3gNDGe9X9">(1)</span>($)</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_48E_eecd--PeoActuallyPaidCompAmt_hecd--IndividualAxis__custom--NicholasRLiuzzaJrMember_z0yEM0AQE258" style="border-bottom: Black 1pt solid; text-align: center">Compensation
    Actually Paid to PEO (Nicholas R. Liuzza, Jr.)<br/> (c)<span id="xdx_F5B_zorajZrQbL68">(3)</span>($)</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_481_eecd--PeoTotalCompAmt_hecd--IndividualAxis__custom--GeoffreyGwinMember_zbwmuCs8nAN" style="border-bottom: Black 1pt solid; text-align: center">Summary
    Compensation Table Total for PEO (Geoffrey Gwin) <br/> (b)<span id="xdx_F5E_zpegBq8nz6l9">(2)</span>($)</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_480_eecd--PeoActuallyPaidCompAmt_hecd--IndividualAxis__custom--GeoffreyGwinMember_zZCrIUs84tzk" style="border-bottom: Black 1pt solid; text-align: center">Compensation
    Actually Paid to PEO (Geoffrey Gwin)<br/> (c)<span id="xdx_F5E_z7srRy3clvDh">(3)</span>($)</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_483_eecd--NonPeoNeoAvgTotalCompAmt_zcJWEJlMHFBh" style="border-bottom: Black 1pt solid; text-align: center">Average
    Summary Compensation Table Total for non-PEO Named Executive Officers<br/> (d)<span id="xdx_F5A_ztJ7RKaQUkmb">(4)</span>($)</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_48A_eecd--NonPeoNeoAvgCompActuallyPaidAmt_zWTTYBUuKkH" style="border-bottom: Black 1pt solid; text-align: center">Average
    Compensation Actually Paid to non-PEO Named Executive Officers<br/> (e)<span id="xdx_F50_zFbOUeqwaxr5">(3)</span>($)</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_480_eecd--TotalShareholderRtnAmt_pp2d_z01T7iiuPHL1" style="border-bottom: Black 1pt solid; text-align: center">Value
    of Initial Fixed $100 Investment Based On Total Shareholder Return<br/> (f)<span id="xdx_F5A_z5Zmcbgw8VRg">(5)</span>($)</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_48B_eus-gaap--NetIncomeLoss_zUsHkNlheIK" style="border-bottom: Black 1pt solid; text-align: center">Net Income/
    (Loss)<br/> (g)<span id="xdx_F55_zox12ceEF5r3">(6)</span>($)</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_416_20250101__20251231_zUUH9HU1GC38" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 9%; text-align: center">2025</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%; text-align: right">76,080</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%; text-align: right">107,700</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">214,300</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">55,900</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">296,916</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">382,290</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">28.18</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">(23,381,000</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_413_20240101__20241231_z0Wn5UiTQEZ7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">772,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">925,160</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">290,672</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">290,672</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">21.03</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(13,076,000</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_41C_20230101__20231231_z3zkBHj7DGL" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0033">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0034">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">250,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">256,878</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0037">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20,452</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.76</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(7,535,000</td><td style="text-align: left">)</td></tr>
  </table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgTotalCompAmt', window );">Non-PEO NEO Average Total Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 296,916<span></span>
</td>
<td class="nump">$ 290,672<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt', window );">Non-PEO NEO Average Compensation Actually Paid Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 382,290<span></span>
</td>
<td class="nump">290,672<span></span>
</td>
<td class="nump">20,452<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_EquityValuationAssumptionDifferenceFnTextBlock', window );">Equity Valuation Assumption Difference, Footnote [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_894_eecd--EquityValuationAssumptionDifferenceFnTextBlock_dU_zHhJHuBNEtNi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Name</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_480_eecd--PeoTotalCompAmt_zJmsmRoLUgXh" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Table Total</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_489_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember_zD0hvX0e0jUc" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Deduct &#8220;Stock</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards&#8221; and</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8220;Option</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards&#8221;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>reported in</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Table</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_484_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember_zJnRwNyhyH0k" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Add Year-</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>End Fair</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>and</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unvested</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Granted in</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>the Year</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_48E_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember_zt9tLLsDqza3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Add (Deduct)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year over</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year Change</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>in Fair</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>and Unvested</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Granted in</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Prior Years</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_489_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember_zUnAMIEvSZC9" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Add Fair</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value as of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vesting Date</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Granted and</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vested in</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>the Year</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_485_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember_ztnCSqjfF35k" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Add</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Deduct)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year over</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year Change</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>in Fair Value</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Granted in</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Prior Years</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>which</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vested in</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>the Year</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_482_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember_zylSsBXvhLEh" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Add Value</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of any</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dividends</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>or Other</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Earnings</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Paid in</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>the Year</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_48C_eecd--PeoActuallyPaidCompAmt_zucz0S7GdHUg" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Actually Paid</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_41F_20250101__20251231__ecd--IndividualAxis__custom--NicholasRLiuzzaJrMember_zkNrpcfCjdC4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 4%; font-weight: bold; text-align: center">2025</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 29%; text-align: left">PEO-Nicholas R. Liuzza, Jr.</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right">76,080</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right">(46,080</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right">77,700</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl0060">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0061">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0062">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right">&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl0063">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right">107,700</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_419_20250101__20251231__ecd--IndividualAxis__custom--GeoffreyGwinMember_zyafbdRzRAF7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">PEO-Geoffrey Gwin</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">214,300</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(14,300</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0067">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0068">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,300</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(158,400</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0071">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">55,900</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>Other NEOs (Average)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eecd--NonPeoNeoAvgTotalCompAmt_c20250101__20251231__ecd--IndividualAxis__ecd--NonPeoNeoMember_z4jrGDchh24" style="text-align: right">296,916</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eecd--AdjToCompAmt_c20250101__20251231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember_zh9rqyWIdgN8" style="text-align: right">(124,416</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eecd--AdjToCompAmt_c20250101__20251231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember_zkhGmHdYLrbh" style="text-align: right">209,790</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eecd--AdjToCompAmt_c20250101__20251231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember_zzHyOprLMkk4" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0076">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eecd--AdjToCompAmt_c20250101__20251231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember_zV6IuRBiDI0a" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0077">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eecd--AdjToCompAmt_c20250101__20251231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember_z85VkliPmcmh" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0078">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eecd--AdjToCompAmt_c20250101__20251231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember_zLjqhlualMq8" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0079">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20250101__20251231__ecd--IndividualAxis__ecd--NonPeoNeoMember_zc3fUW31dOag" style="text-align: right">382,290</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_41D_20240101__20241231__ecd--IndividualAxis__custom--NicholasRLiuzzaJrMember_z0s5wDRssRz7" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: center">2024</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">PEO-Nicholas R. Liuzza, Jr.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0082">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0083">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0084">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0085">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0086">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0087">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30,000</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_41E_20240101__20241231__ecd--IndividualAxis__custom--GeoffreyGwinMember_zkBtxuDF5xAa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">PEO-Geoffrey Gwin</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">772,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(422,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">385,160</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0092">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">190,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0094">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0095">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">925,160</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>Other NEOs (Average)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eecd--NonPeoNeoAvgTotalCompAmt_c20240101__20241231__ecd--IndividualAxis__ecd--NonPeoNeoMember_zacdG22DXSY4" style="text-align: right">290,672</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eecd--AdjToCompAmt_c20240101__20241231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember_zv6TUsMcm7Ua" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0098">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eecd--AdjToCompAmt_c20240101__20241231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember_zwXSbPAipL4e" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0099">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eecd--AdjToCompAmt_c20240101__20241231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember_z5soDv13KEO7" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0100">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eecd--AdjToCompAmt_c20240101__20241231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember_zfDS7SCirtJl" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0101">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eecd--AdjToCompAmt_c20240101__20241231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember_zQmHgxC8Exil" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0102">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eecd--AdjToCompAmt_c20240101__20241231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember_zK0AWJD0ke0c" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0103">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20240101__20241231__ecd--IndividualAxis__ecd--NonPeoNeoMember_zlqscSwyZ8Uj" style="text-align: right">290,672</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_418_20230101__20231231__ecd--IndividualAxis__custom--NicholasRLiuzzaJrMember_zOxnOZsAMY2c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: center">2023</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">PEO-Nicholas R. Liuzza, Jr.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0105">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0106">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0107">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0108">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0109">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0110">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0111">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0112">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_41B_20230101__20231231__ecd--IndividualAxis__custom--GeoffreyGwinMember_z6G8KK6BkGi6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">PEO-Geoffrey Gwin</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">250,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0114">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0115">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0116">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,878</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0118">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0119">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">256,878</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>Other NEOs (Average)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eecd--NonPeoNeoAvgTotalCompAmt_c20230101__20231231__ecd--IndividualAxis__ecd--NonPeoNeoMember_zeVcqpMBZDb4" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0121">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eecd--AdjToCompAmt_c20230101__20231231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember_z0q101lGkOXk" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0122">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eecd--AdjToCompAmt_c20230101__20231231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember_zWKUsQYw3MR4" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0123">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eecd--AdjToCompAmt_c20230101__20231231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember_zmnMOLMvQq9a" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0124">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eecd--AdjToCompAmt_c20230101__20231231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember_zXBX59QcqaJ9" style="text-align: right">20,452</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eecd--AdjToCompAmt_c20230101__20231231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember_zzY5a94zZQpl" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0126">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eecd--AdjToCompAmt_c20230101__20231231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember_z8hwWV9EfFvk" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0127">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20230101__20231231__ecd--IndividualAxis__ecd--NonPeoNeoMember_zdsmx6epUwBa" style="text-align: right">20,452</td><td style="text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock', window );">Relationship Between Compensation Actually Paid and our Total Shareholder Return</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_894_eecd--CompActuallyPaidVsTotalShareholderRtnTextBlock_dU_z9bliJRWBylc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Relationship
Between Compensation Actually Paid and our Total Shareholder Return</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
stock price performance is not one of the elements used in determining Compensation Actually Paid to our Named Executive Officers. However,
the amount of Compensation Actually Paid to our Named Executive Officers aligns with the Company&#8217;s Total Shareholder Return due
to the fact that a portion of the compensation paid to our NEOs is comprised of equity awards.</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsNetIncomeTextBlock', window );">Relationship Between Compensation Actually Paid and our Net Income/(Loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_893_eecd--CompActuallyPaidVsNetIncomeTextBlock_dU_z0oXkZ1QWPy6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Relationship
Between Compensation Actually Paid and our Net Income/(Loss)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GAAP
net income/(loss) is a measure of our overall profitability that we believe is a factor that can drive our stock price performance. However,
Compensation Actually Paid is less sensitive to our annual GAAP net income/(loss) because management and our Board do not believe that
our GAAP net income/(loss) is the only meaningful measure in allowing investors to evaluate management&#8217;s performance. The Board
considers multiple factors when determining executive compensation, including both financial and non-financial performance metrics, strategic
objectives, and market conditions. While the Company has experienced net losses in recent years, the Board believes that compensating
executives competitively is necessary to retain key talent with the skills to provide the leadership the Company needs to succeed and
to execute on the Company&#8217;s long-term strategic plan.</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnVsPeerGroupTextBlock', window );">Total Shareholder Return Vs Peer Group [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_896_eecd--TotalShareholderRtnVsPeerGroupTextBlock_dU_zcAKa5q6vwg7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)
Represents the cumulative total shareholder return of a fixed investment of $100 made at the closing price of the Company&#8217;s Common
Stock at December 31, 2022, for the measurement period beginning on such date and continuing through and including the end of the applicable
fiscal year reflected in the table.</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnAmt', window );">Total Shareholder Return Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">$ 28.18<span></span>
</td>
<td class="nump">21.03<span></span>
</td>
<td class="nump">3.76<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="num">(23,381,000)<span></span>
</td>
<td class="num">(13,076,000)<span></span>
</td>
<td class="num">(7,535,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=BLNE_NicholasRLiuzzaJrMember', window );">Nicholas R Liuzza Jr [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">76,080<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 107,700<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoName', window );">PEO Name</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Mr. Liuzza<span></span>
</td>
<td class="text">Mr. Liuzza<span></span>
</td>
<td class="text">Mr. Liuzza<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=BLNE_NicholasRLiuzzaJrMember', window );">Nicholas R Liuzza Jr [Member] | Stock Awards and Option Awards Reported in Summary Compensation Table [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (46,080)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=BLNE_NicholasRLiuzzaJrMember', window );">Nicholas R Liuzza Jr [Member] | Year End Fair Value of Outstanding and Unvested Equity Awards Granted in Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">77,700<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=BLNE_NicholasRLiuzzaJrMember', window );">Nicholas R Liuzza Jr [Member] | Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards Granted in Prior Years [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=BLNE_NicholasRLiuzzaJrMember', window );">Nicholas R Liuzza Jr [Member] | Fair Value as of Vesting Date of Equity Awards Granted and Vested in Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=BLNE_NicholasRLiuzzaJrMember', window );">Nicholas R Liuzza Jr [Member] | Year Over Year Change in Fair Value of Equity Awards Granted in Prior Years which Vested in Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=BLNE_NicholasRLiuzzaJrMember', window );">Nicholas R Liuzza Jr [Member] | Value of Any Dividends or Other Earnings Paid in Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=BLNE_GeoffreyGwinMember', window );">Geoffrey Gwin [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="nump">214,300<span></span>
</td>
<td class="nump">772,000<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 55,900<span></span>
</td>
<td class="nump">$ 925,160<span></span>
</td>
<td class="nump">$ 256,878<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoName', window );">PEO Name</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Mr. Gwin<span></span>
</td>
<td class="text">Mr. Gwin<span></span>
</td>
<td class="text">Mr. Gwin<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=BLNE_GeoffreyGwinMember', window );">Geoffrey Gwin [Member] | Stock Awards and Option Awards Reported in Summary Compensation Table [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (14,300)<span></span>
</td>
<td class="num">$ (422,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=BLNE_GeoffreyGwinMember', window );">Geoffrey Gwin [Member] | Year End Fair Value of Outstanding and Unvested Equity Awards Granted in Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">385,160<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=BLNE_GeoffreyGwinMember', window );">Geoffrey Gwin [Member] | Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards Granted in Prior Years [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=BLNE_GeoffreyGwinMember', window );">Geoffrey Gwin [Member] | Fair Value as of Vesting Date of Equity Awards Granted and Vested in Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">14,300<span></span>
</td>
<td class="nump">190,000<span></span>
</td>
<td class="nump">6,878<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=BLNE_GeoffreyGwinMember', window );">Geoffrey Gwin [Member] | Year Over Year Change in Fair Value of Equity Awards Granted in Prior Years which Vested in Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(158,400)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=BLNE_GeoffreyGwinMember', window );">Geoffrey Gwin [Member] | Value of Any Dividends or Other Earnings Paid in Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgTotalCompAmt', window );">Non-PEO NEO Average Total Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">296,916<span></span>
</td>
<td class="nump">290,672<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt', window );">Non-PEO NEO Average Compensation Actually Paid Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">382,290<span></span>
</td>
<td class="nump">290,672<span></span>
</td>
<td class="nump">20,452<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Stock Awards and Option Awards Reported in Summary Compensation Table [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(124,416)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Year End Fair Value of Outstanding and Unvested Equity Awards Granted in Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">209,790<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards Granted in Prior Years [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Fair Value as of Vesting Date of Equity Awards Granted and Vested in Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">20,452<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Year Over Year Change in Fair Value of Equity Awards Granted in Prior Years which Vested in Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Value of Any Dividends or Other Earnings Paid in Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Represents the average of the amounts reported for the NEOs
as a group (excluding the PEOs) in the &#8220;Total&#8221; column of the &#8220;Summary Compensation Table&#8221; in each applicable
year. The names of each of the non-PEO NEOs included for these purposes for 2025 are Mr. Moe and Ms. Milton, for 2024 include Mr. Moe
only, for 2023 include Ms. Milton only. Mr. Moe was appointed as the Company&#8217;s Chief Financial Officer on October 7, 2024, and
prior to that Mr. Moe served as the Chief Financial Officer of Beeline Financial since June 2023. Ms. Milton was appointed as the Company&#8217;s
Chief Accounting Officer on April 25, 2025.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">SEC rules require certain adjustments be made to the &#8220;Summary
Compensation Table&#8221; totals to determine &#8220;compensation actually paid&#8221; as reported in the &#8220;Pay Versus Performance&#8221;
table above. For purposes of the equity award adjustments shown below, no equity awards were cancelled as a result of a failure to meet
vesting conditions. The valuation assumptions used to calculate fair values for purposes of the compensation actually paid calculation
did not materially differ from those disclosed at the time of grant (as applicable). The table below details the applicable adjustments
to the amount in the &#8220;Total&#8221; column of the &#8220;Summary Compensation Table&#8221; in each applicable year that were made
to determine &#8220;compensation actually paid&#8221; (all amounts are averages for the NEOs other than the PEO).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Represents the cumulative total shareholder return of a fixed
investment of $100 made at the closing price of the Company&#8217;s Common Stock at December 31, 2022, for the measurement period beginning
on such date and continuing through and including the end of the applicable fiscal year reflected in the table.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">Represents the amount of net income/(loss) reflected in the
Company&#8217;s audited consolidated financial statements for the applicable fiscal year reflected in the table.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">Represents the amounts reported for Mr. Liuzza, the Company&#8217;s
current Chief Executive Officer, in the &#8220;Total&#8221; column of the &#8220;Summary Compensation Table&#8221; in each applicable
year.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[6]</td>
<td style="vertical-align: top;" valign="top">Represents the amounts reported for Mr. Gwin, the Company&#8217;s
former Chief Executive Officer. Mr. Gwin served as the Company&#8217;s Chief Executive Officer until his resignation from such role on
March 7, 2025. Mr. Gwin also previously served as Chief Financial Officer until his resignation from such role on October 7, 2024, and
as President of Bridgetown Spirits until the sale of that entity on July 25, 2025.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsNetIncomeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsNetIncomeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_EquityValuationAssumptionDifferenceFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_EquityValuationAssumptionDifferenceFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgCompActuallyPaidAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoActuallyPaidCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoActuallyPaidCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnVsPeerGroupTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnVsPeerGroupTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=BLNE_NicholasRLiuzzaJrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=BLNE_NicholasRLiuzzaJrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=BLNE_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=BLNE_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=BLNE_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=BLNE_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=BLNE_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=BLNE_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=BLNE_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=BLNE_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=BLNE_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=BLNE_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=BLNE_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=BLNE_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=BLNE_GeoffreyGwinMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=BLNE_GeoffreyGwinMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=ecd_NonPeoNeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=ecd_NonPeoNeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Recovery of Erroneously Awarded Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_RestatementDateAxis=2025-12-31', window );">Restatement Determination Date [Axis]: 2025-12-31</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ErrCompRecoveryTable', window );"><strong>Erroneously Awarded Compensation Recovery [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ErrCompAnalysisTextBlock', window );">Erroneous Compensation Analysis [Text Block]</a></td>
<td class="text"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has implemented <span style="background-color: white">a Clawback Policy in accordance with the Nasdaq Rules, to recoup &#8220;excess&#8221;
incentive compensation, if any, earned by current and former executive officers during a three year look back period in the event of
a financial restatement due to material noncompliance with any financial reporting requirement under the securities laws (with no fault
required)</span>. The Company also uses forms of agreements relating to equity grants which also include other drawbacks relating to
improper conduct.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ErrCompAnalysisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br> -Paragraph 1<br> -Subparagraph i<br> -Sentence B<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 6<br> -Subsection F<br> -Paragraph 1<br> -Subparagraph i<br> -Sentence B<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Section 19<br> -Paragraph a<br> -Subparagraph 1<br> -Sentence ii<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-CSR<br> -Section 18<br> -Paragraph a<br> -Subparagraph 1<br> -Sentence ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ErrCompAnalysisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ErrCompRecoveryTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 6<br> -Subsection F<br> -Paragraph 1<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Section 19<br> -Paragraph a<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-CSR<br> -Section 18<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ErrCompRecoveryTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_RestatementDateAxis=2025-12-31">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_RestatementDateAxis=2025-12-31</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>67</ContextCount>
  <ElementCount>19</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>10</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>1</UnitCount>
  <MyReports>
    <Report instance="formdef14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://makeabeeline.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="formdef14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="formdef14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995440 - Disclosure - Recovery of Erroneously Awarded Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/ErrCompDisclosure</Role>
      <ShortName>Recovery of Erroneously Awarded Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="formdef14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>blne-20251231.xsd</File>
    <File>blne-20251231_def.xml</File>
    <File>blne-20251231_lab.xml</File>
    <File>blne-20251231_pre.xml</File>
    <File doctype="DEF 14A" isProxy="true" isUsgaap="true" original="formdef14a.htm">formdef14a.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="3">http://fasb.org/us-gaap/2025</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="106">http://xbrl.sec.gov/ecd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "formdef14a.htm": {
   "nsprefix": "BLNE",
   "nsuri": "http://makeabeeline.com/20251231",
   "dts": {
    "schema": {
     "local": [
      "blne-20251231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "blne-20251231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "blne-20251231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "blne-20251231_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "formdef14a.htm"
     ]
    }
   },
   "keyStandard": 19,
   "keyCustom": 0,
   "axisStandard": 3,
   "axisCustom": 0,
   "memberStandard": 2,
   "memberCustom": 8,
   "hidden": {
    "total": 51,
    "http://xbrl.sec.gov/ecd/2025": 48,
    "http://xbrl.sec.gov/dei/2025": 3
   },
   "contextCount": 67,
   "entityCount": 1,
   "segmentCount": 10,
   "elementCount": 104,
   "unitCount": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ecd/2025": 106,
    "http://xbrl.sec.gov/dei/2025": 4,
    "http://fasb.org/us-gaap/2025": 3
   },
   "report": {
    "R1": {
     "role": "http://makeabeeline.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "formdef14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "formdef14a.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "2",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "formdef14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "formdef14a.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
     "longName": "995440 - Disclosure - Recovery of Erroneously Awarded Compensation",
     "shortName": "Recovery of Erroneously Awarded Compensation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "3",
     "firstAnchor": {
      "contextRef": "From2025-01-012025-12-31_2025-12-31",
      "name": "ecd:ErrCompAnalysisTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "formdef14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-012025-12-31_2025-12-31",
      "name": "ecd:ErrCompAnalysisTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "formdef14a.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "4",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "formdef14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "formdef14a.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r79",
      "r89",
      "r99",
      "r124"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r82",
      "r92",
      "r102",
      "r127"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r113"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r83",
      "r93",
      "r103",
      "r120",
      "r128",
      "r132",
      "r140"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "auth_ref": [
      "r138"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://makeabeeline.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://makeabeeline.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgDiscLineItems",
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52",
      "r53",
      "r54",
      "r55",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r112"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r112"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Relationship Between Compensation Actually Paid and our Net Income/(Loss)"
       }
      }
     },
     "auth_ref": [
      "r116"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Relationship Between Compensation Actually Paid and our Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r115"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://makeabeeline.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://makeabeeline.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://makeabeeline.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r74"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://makeabeeline.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r74"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r79",
      "r89",
      "r99",
      "r124"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r76",
      "r86",
      "r96",
      "r121"
     ]
    },
    "BLNE_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://makeabeeline.com/20251231",
     "localname": "FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value as of Vesting Date of Equity Awards Granted and Vested in Year [Member]",
        "documentation": "Fair Value as of Vesting Date of Equity Awards Granted and Vested in Year [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r83",
      "r93",
      "r103",
      "r128"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r83",
      "r93",
      "r103",
      "r128"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r83",
      "r93",
      "r103",
      "r128"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r83",
      "r93",
      "r103",
      "r128"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r83",
      "r93",
      "r103",
      "r128"
     ]
    },
    "BLNE_GeoffreyGwinMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://makeabeeline.com/20251231",
     "localname": "GeoffreyGwinMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geoffrey Gwin [Member]",
        "documentation": "Geoffrey Gwin [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r83",
      "r93",
      "r103",
      "r120",
      "r128",
      "r132",
      "r140"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingArrLineItems",
     "auth_ref": [
      "r138"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r75",
      "r144"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r75",
      "r144"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r75",
      "r144"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name"
       }
      }
     },
     "auth_ref": [
      "r112"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Attributable to Parent",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r61",
      "r62",
      "r63",
      "r64",
      "r65",
      "r66",
      "r67",
      "r68",
      "r69",
      "r70",
      "r71",
      "r72",
      "r73",
      "r145"
     ]
    },
    "BLNE_NicholasRLiuzzaJrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://makeabeeline.com/20251231",
     "localname": "NicholasRLiuzzaJrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nicholas R Liuzza Jr [Member]",
        "documentation": "Nicholas R Liuzza Jr [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r112"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r109"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r112"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r81",
      "r91",
      "r101",
      "r126"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r84",
      "r94",
      "r104",
      "r129"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r84",
      "r94",
      "r104",
      "r129"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "auth_ref": [
      "r107"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r109"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r109"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r107"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r107"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "auth_ref": [
      "r76",
      "r86",
      "r96",
      "r121"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r77",
      "r87",
      "r97",
      "r122"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r78",
      "r88",
      "r98",
      "r123"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r85",
      "r95",
      "r105",
      "r130"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52",
      "r53",
      "r54",
      "r55",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r80",
      "r90",
      "r100",
      "r125"
     ]
    },
    "BLNE_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://makeabeeline.com/20251231",
     "localname": "StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Awards and Option Awards Reported in Summary Compensation Table [Member]",
        "documentation": "Stock Awards and Option Awards Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r138"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r140"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r141"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r140"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title"
       }
      }
     },
     "auth_ref": [
      "r140"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r143"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r141"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "BLNE_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://makeabeeline.com/20251231",
     "localname": "ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Any Dividends or Other Earnings Paid in Year [Member]",
        "documentation": "Value of Any Dividends or Other Earnings Paid in Year [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "BLNE_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://makeabeeline.com/20251231",
     "localname": "YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year End Fair Value of Outstanding and Unvested Equity Awards Granted in Year [Member]",
        "documentation": "Year End Fair Value of Outstanding and Unvested Equity Awards Granted in Year [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "BLNE_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://makeabeeline.com/20251231",
     "localname": "YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year Over Year Change in Fair Value of Equity Awards Granted in Prior Years which Vested in Year [Member]",
        "documentation": "Year Over Year Change In Fair Value Of Equity Awards Granted In Prior Years Which Vested In The Year [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "BLNE_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://makeabeeline.com/20251231",
     "localname": "YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards Granted in Prior Years [Member]",
        "documentation": "Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards Granted in Prior Years [Member]"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-3"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-3"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "(24)(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "17",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-14"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-21"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-4"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r145": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001493152-26-031067-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-26-031067-xbrl.zip
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M-_W^0D2MB*P2J%L7UB*M[9\U4RTVRZIA7LC S*VQ#9:C@8#W+BK#A<S2_CW
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MBH??M.*^OO8XPN-'C:@Y=3CXUZ6TRS_=\C_QG_.?^'^F 8/\E_\!4$L#!!0
M   ( *B@W5Q?!"7T&@X  +>U   5    8FQN92TR,#(U,3(S,5]P<F4N>&UL
M[5W;<MLX$GW?JOT'KO=9ENTD,QM/LE/R)1[O.K;*5CP[3RF8A"2,24(!*%N:
MKU^ HB2*PHVTB':JD@?'EAK@Z=.-9@,-D!]^G25Q\(09)S3]N'>X?[ 7X#2D
M$4E''_>^W'5Z=Z>7EWL!SU :H9BF^.->2O=^_???_Q:(?Q_^T>D$GPB.H^/@
MC(:=RW1(?PFN48*/@PN<8H8RRGX)[E$\E9_03R3&+#BER23&&19?+"Y\'/RT
M_PX%G8Y#M_<XC2C[<GNYZG:<91-^W.T^/S_OI_0)/5/VR/=#FKAU>)>A;,I7
MO1W,#HI_B^8?8I(^'LL?#XCC0-"5\N,9)Q_WY'6+RSZ_V:=LU#TZ.#CL_N_S
MU5TXQ@GJD%32%N*]92O9BZK=X?OW[[OYMTO1+<G9 XN7UWC37<)9]2R^)0;Y
M$A).CGD.[XJ&*,NM;KU,H)60?W668AWY4>?PJ//F<'_&H[TE^3F#C,;X%@^#
M7,WC;#X1GL2)=(2]XK,QP\./>P]Q*CLZ>G=XM.CFGZ=4^.=>(#L09E_!3= C
M1@\8B[986KLK!;J%<+?1M9>>E.O(<;@_HD]='$9=B4?^D@/+0?6?)F>$AS'E
M4X:WP6WUD(.K-/(+\G>2C7M11*3-4?P9(_DA;P1=UY4/A0;H(:Y#>"'O UHO
M^G/*LP2G&1]0&>1PRO,A5@.NH8_651!436/$K@C/^,G\?(;#:4:>\"G*\(BR
MN:L6UFY\*E+7SY5-?3A/@P'I%V!?>*+PPQ-Q6Q^2C)<<M09D4R>M*W'.F!Q1
M]>.VHF'K8#^)>ZQ(MVYQ*.]HQ-TQ% U;!WLSS?(,462-]0%K&K<.NO>,6#0@
MB;AN?9?0-/8#FI^*Z^$!_9Q.B+QZ+=#;C5L'?2D&?839@"%IY!YC*!WA6J'#
MU ,8?)Z=S"_3Z.4Z%-UX5J1/8Q**H=9GU-F#3#VT#O\,#]$T=G>:M?PFM(FX
M9PK:\[3J2GRP@1'/,C'#Q-$2I>S);<Y1]$(RV:"80QX&'3GAG$HSBU\7D@68
M)9R8AAL(8CDQH\R!I@B3!4WBES5-XH^O^85Z#SQC*,R6/<4">ISW_U7(5$2Z
M'E MF1B('M6@-B6JF,J&Z[$PH$SXHN!ZV1=BX8:YMN>KA41W@ICHJ!..2;RR
M])#11,=.P035 "T3)2[AA\WS5/C:_!:/B$299G(Y0\VJ6M*1W4,(>DVZ@=!\
M*O1A*!9Q&L_^B^<FGK=$'8D^@B-:HYUGII=CJB\R0!J=I]&9F#*:XT1%U)'I
M-Y 10ZF=9Z9[ D@DP7R*T4C-<$7$D=FW$,PJM8%B] SSD)')8LG&2.R&I"._
M[T#Y5>BFH/E#5YEE[2@%<UI9W4C%WK]_]_;P0"9B*PGQ1Q_-@R<>B-$XI"R1
MB^.E[W>7HJDS6?''5P'@GI<NO[ZZ( 1?9CCA"@<2+9T:[L[G#1JL5E>5,+?6
M7G6^O>5)N_5P5\HV_7Y#@U4J=."'67$C)D\DFJ*X-R,:-ZC*O *6*_Y0HK(*
MMI1;^N"S%\=K!/PS3A[6$[9-5M62\-RJ/:+$L!KX>H;4B.;M8MS)U?7YUVL2
MCFF,^.T5F?[U%_H/TS(JQ;728'FQEJY-5HW@=Y-E: B^P'0X9'A^\4Q2([<J
M0; DN :M>@5;R=OTD>&:IGU,KS$U!84M(5?/!7-=%6@0?GO1GXLZIOY&5A&!
MC[6&^U@%:RE">;J-K0!8;F);<O"T*EUA\PZVA;J=^]==1L/'13&DET8W^81F
M\><MGE"687&[O9LF"6+S<@D^=PIC.-Y%Q\[+<BW%%HV'E:/W[OAKZ?[Y!T;L
M/(T^(<+R;5UT6"HR"LA?TB?,!<SS;U.2S1?0+^0ZHT0^&&/9WFCH75[ U>"[
M7XAU-OCN^6S1\#=/F,G_3\>RP':9KE#?U$'=9X3FW>BG"TMFVKJ@JV.TE64X
M.D:[?+?D*"N0/7XSO!>P9"$?90*S IW ?I\C=PL..^K;U?QM)?(.YM\IBS A
MP>*,OX_%!+".\=N[G*L_['X-?E?AX,5<M^0B!;Q>.C^3TRJ<1OR&W61CS,X1
M2X5/\SXBCO9OV)>K<7=? ' V[HM8\CSM7$[A!GB6G8@.'\UKU"4QYT6I5O+O
MERU4;VGKF?53>H=C'(KQ6VQ-U6Q)$+(:46?V6TF&F[%OU-KW<I:X=+3:<GTS
M')(0,_XIM8P#AV;.EFDE&S5S3.LH A./,&87C$XGEYQ/72QB;.!LBU920U=;
M..CL.S[E*<D:F-4*Q@;.5F@E(7.U@H/.WL<"'= ,Q?E28*+:G9@[3T7(F>U6
M,B1WGU?JYI_A7IA-41S/94IF(UHIZ\SW3\!\&S2%J'4(1!*%-;1HA9V)_QF2
M>(NN4%6\WM/('EOTTL[<_PLTR;%H"TA^CJ0T()ULH&SD;(KWK\44!MTA M$*
MFGLXTC=QM48[5:E:0<FFMV=;+-:\Y-K)@BR1"R=YP>R,#(=8*!YBJW'J]N%L
MK59FT:[6:L:,]R6-S4%]S_.(>S<6+(QI+'B\S:RSB)I].)L/=*K=C!EP\UWC
M[#(-:6);&G1KZ6PJT)EX'1; #;2E5&U#F7IP-ACLI+T!*YX-IQCL<NVT6&6P
MV,RYL;.Y0&?]-;D 'V)YT:;IZ-(T=K84Z'I!32Y\CZGUPT=<JE<&<6=K@"XB
M6/6%CVG:":Q.UIEYT"4$LZ90Q9$Z_%L;.1L"= '!4?>=6F2(^$.NTI1W1@A-
M"K/$&5]^LK9/\<'75<)X1;EJ'W<A5Q%SWR</9@,U<* ;=06OUOG5DLYL@T[[
M35IZ)CR_]\MZOXUOI: SW:#3=(..8$=!=#1O2CCS"SJW5FGEO]RGWVBS^M*9
M3M"9;T47STQ:MRTUVJQTU,KDM-EFI5>P18FF%^*&6P I/5+ MD?)H9VS15J9
MA%I+18YZ>X_+RR>YOCTX>EJ[D;5B9&WF;(Y69J'-!H@S&[Z#?,K3DW28/S/3
MOGM,)^QLD59FIPUWMYHU]U[/DSO8Y<DW!SMHA9WMT,KDM)D=+)J_DB?!*)[5
M6O2X?AK,VZVGP10/'IT'=!B('FB*Z93'\R _JX"C8.-)S!Z\;(GG9KBESY:)
M-EW.K:67D;*X_A*0X5$Q:DGX$\MUK% >*$IU?#]#YA9SP57^@%%Y)$M__EXI
M"$^^R7U*9"O1>WZ\3!D#SC!+2)H3I7E^707U=@O8,R@-O=Z%!-^9[6B4%3KH
MUQPJ,K G4)Q(I%KP,!E1 4"DS'-.N"TETDK#GC#14+D5U;5J>F;]+GOLL_"&
M#3@[YQE)<IH^XVQ,(XL%W%K"GC&Q6J..^KY7E4N'WAT"D$$<]H2)U0961>'"
M_37-_L"K$(IM0\*M)>P1%*LYZJCOV3*;[Z203[O7+['J9&$/I%C9-ZM8XEO@
M'F+&<'2U4%N++0<F^GJ@'.>R(+8ZF^(!/9_)V:\\P9\.*0OS_$0;T&IU 'O:
MI:Y57<B '5HYPGM"XYS!F^%O-,&G=)IF;'Z%GFO9S-P+[%&9FGER4Y)>@2W%
MY.O;%,5D2,("[0#-5N]/JF-/>T^P9VYV8%-7LF#M*@)(C-("X&4RD8_=%H ?
M2$RRN253:=@5[/F=%YE*:_%Z-,)- IRR'I,\['&>'1G/3LAWE",IE'&=XVW)
MPY[V:<^ZL'/!\LV$8BXF1+?XVY2PE::6.%NG/>PAH!U9L#YAKZ3@IWD3WW;1
M[TVUZ)>W#!9-/;_\80$ZR1%?F0MZ&E$O"RJJ]P4:ZG@F>?B"DI'S\CJ*08L?
M+X)P9MKH-S]>#?&]OQKBQ2<*%L-17$#CV85<10R>;G?G5FNPTV?&-R$^/V1R
M@CB.RKM:-M]'NI;IHWF^P"656&N21GTQ]Y+9^QE-$%&]ZJJX7#M7 W8#M665
MUF]'_UT.7O=L9>7MEFJ*7AQV9T.M#,"DK^_"UA*/2WE7*PR[LZ$V]Z^BEKM$
MTV<XREB21IH7)I: 5T2!=S749%VI)Y2WB]%WFO*(.9!>E07>O= @SFQK"D3[
M;_1YC<<QUNC: &]@J&D&L^:^CR(M[STDP7*-1V8/]RC6#P5C ^"M"XZ&<- 9
M8E HDWV7D6%K"+REX<7K(=!C1(G,6&8QMP#>C/ 2>WR_M91<G2]IQ.+YZ Z'
M4T8R@O65;8,X[):$6N8SZ0LQB,YG+.PS$IJ&34D&=J- +::W-(.@-W_9B=S'
ML'H9BH%GE3!L_;X6X7I=/3._.<;FGQ^SW ].Q^FH'VJBBZT-;"G>U0YNFK^2
M^MUERHD@;<!0OI&XM#"F*N*]JQ;QBN9!T3[8Z,!+A:8"?\LPU6J-7M[+,ZY6
M%SZ1&S ,U3RU)/P"O)WQ\H.NE$KX+N.M4>C+>%49>*)-KJ*D&*J IX@=ED*>
MH<5KXEU?T#,HX+<V\'U6J!U=6U.;]OB^YQ^U:0]+;1F+!Y@E_&8X8)'P"<O:
MCDD>ML!5Z]9H5]OWXS=S%,;UFXH(;$FK9B*B4.X[6J99X1_(;-QBG4(&MO;5
MS#P;ZOG>M#J-\>'!P[M#>>N/Z"3#AM*75ABV]E6+=8O"_I],5LL")GG8RE<M
M(]C5!KD/Y#B,#]%0R<$6NAJ$')6:@&%GP)(T<XPZ95G84E;CH+.M+FS,L=%O
M$(<M7KTDXH ;89G^.CRX1R,*6WIJ$'8TRH(0?SZ;$.;$>U42M@[5@':UJB"L
MGTT70$Q\KV5@"U -F*ZJ!\)QJ;X[&O6>$(GU[Y,P-8 M.S5@WZCXJRP\]6E,
M0H&WS^AJ(:Q<>/K95GA:=A"@- ID+S@2@@ UJ+(F6Y8R%:,T#?VL(A= HC((
MZPS,H9GCT&E_W!C-LK'F[$B%YXBFQG5-LP*:9=&T1G-'DWF(=2^SF8&;6B&P
M^$;^>$ <BT_^#U!+ P04    " "HH-U<WK>J,M_1  "!? @ #@   &9O<FUD
M968Q-&$N:'1M[+UK=]LVUBC\G;\"QS.=)UE+5B3Y[J1YCF(KJ3N)[;'=IIUW
MG94%B9#%"45J>+&M_OIW[PV !"G*=F+)N@1=;6U+)+ ![#OVY<W_W@U]=B.B
MV N#G_^G66_\#Q-!+W2]X/KG_VE?'IV<_,__OG7>#!)X#!X-XI\W!DDR.GSU
MZO;VMGZ[50^CZU?-@X.#5W?XS(9\Z/"N\KE6H]%\]<>GCY>]@1CR32^($Q[T
M1/:2[P5?IX^/WV:/=B/?*SR*G^A)MEY-# W?NOD+YL.[K^27A4>3RD=WY*.)
M?M2+P^U6<^\^..03V0MWTYYM(LRP0O''NXN/^>-)]?/YHZ^2B =Q/XR&/($C
MQ)%V-ANMS=:N,<AF+'J%@>#O^G5X\^ X^YM;33W.Q.$45XI?=WF<[;@K2MNM
MYX0OX(W6CGXPC3>O.1]E#_=YW*5AU1?EAZ/0%W'ET_1-X7$WB3:3\4C$U8##
MUZ_P:WQG>[/1-%8K>FXU^/!%88I>F 9)-*Y^6'U9>"&.DDGHX</"0^\^GG:R
MIX;\J^!=(?"LZKUP2$\V6P L4J;@[EN'X3]O$B_QQ=LWK^1/Y\U0))SA()OB
MOZEW\_/&41@D(D@VKV#1&ZPG__IY(Q%WR2LBWU?PUBLYY)O_L[G)WGO"=P_9
MI4A>LU,^%(?LSKU[S4Z.Z9<OC=:[+YVCXY]:QP@2V]Q\Y&M;VU]PA5_**_NB
M5_;XH;8[]%*CV6A^Q]L[!U\$("0L /YM#T7@PG_)>Y]??^ES/Q;?,-*Q,5(G
M@",8'\%0$?=/ E?<_5.,OS2 _>UL;>\U]A\_[.Z[+[]='G]I?E&<1(X/'WW#
M$*TOEP,>B?A+ZPOQ33E&3)]]PS#'",FY&FIK J GC;WSY0+YSI=M<Y11&JD#
MZ(;NF,7)V!<_;_0!:P]9LS%*V)4WA%E.Q2V["(<\J,D/:C!/Y/61.%SO1K_F
M>O'(Y^-#%H2!P.^\NT-$=!$!]= ?GNN* $D)_X*G3M,AC-.39'*77(C^SQOO
MHW"(6(;,HM%,0OJ]V2+&X0''>,][20/_V=I@ 2P4YA7>80&Q-MX29KUY59AE
M5O-NF_-6HN'&VQP/9PL$'&7+P_.#\9LF',=A+\7E$]MY>]QYSYK;[>ESOX]@
M-2"$U C <0_/17@5)MP_"H>C]C#9J()K2\)%OQ%47WIIG !3.?5Z@]#G\<5'
M+_WK+_YK]$D,NR*: 'H+#BT-/#DH8#0PX_@P\'Q@D%$*@&N(-7P/@MSN)2GW
M_?$Y]]SY0KX]2\A/PP" /P7X;ZZ_?=<G@=N;)7!M]S]7X7T [60 [3QJ,_77
M?PH>G8$FC#^/!CRX%B?!>^Y%OW,_%6?]LS1!E1(5XW;@_A;<B#@1;@?D:C)N
MW_+(C3^ !@4?G03GD1?2,/&4X]IMK,2.9*MOQV?]WV&]L/9CGL!F5"P;-N5W
MVI*3X&H@</73%M]<B<4_@ X/'/SG 8S^R/UHK<1^J'6W@_&Q=^.!I'3CL^@L
M&8BHPZ, ,"-&+O?@8F?*8K]_L1]$V.]'8OSAU@LFS[T3N-E1A]]"^0\L?DD8
MX?V+?RX>N+_LFS$;C-];-+N#U[YD$GUAQ[VWN[S;,!\YM[=H:O_^@Y^=<-M;
M-)7?LPDSHN^#9UWA=K;"[6\2WY=)V/LJ3Q0P^&R$\\H_+\0HC.@H+]/AD$=C
MG%X$,?D!KWC7%U-6OO^\BLOWKGR. GW_>;69I^S ,['Y_9D:HG/;D?EP_/V=
ME5C\LS'__>>5^=^['[.1 _O/*^ZG+G8IE/N#)1$-W[T9LR."@R7AB/.V<PX6
MS?SNT?3FH/P</*]B^TW+G:/&<[!H;7<IK-EFXWD=N-^T#7/1;9J-YW5CS/+@
M9\;+FXU%B[5Y6[/-QJROP.9^:]=L/*_@^59XYR>#FHWGU:^_=^7S$T?-QO,J
MW4_9@>>23,^KEWSOCLQ)2#VO=C(G=)B=O&H^KYKRO?LQ&]'5G*F&\HS1&\WF
M\ZH54^&=;B+.07@UG]<N_HY%SU%N-9=$9UD&9U&SN21JS.*=1<WFDDCO.3N+
MFLV9"NJGQ:M5&543 +>>U_Q]%)!S9,ZM14NDA7BWFJWGO<_[YF4_$T-N+5HT
M+X.OI[5HJ31W7T_K>XSG5V:D/*XW$GT1B: G8OH>TX .8\KO@G$9)6T=#B*<
MHNL'8E.G:-3O8G=#?8TI.#]OQ-YPY O,0%'3%$:64\5A&JF9X"%*%3A4FRG#
MX*='J*L<&?V6H-!X_6'V,6YFXO4]$3%:A*A,FSHZ^6<QBK[\<C;9JZK9U%PC
M 7CI3H  9!PE: N_S5>BQ\F_*[\%.)"_0RO.YW;--_3'YNSZ,[65C]Q>(\IF
MT?N<;YZXQD2#_'/UC>L1EKF2%)CKP5.4\DC4>0$< ;8(W\2M:M]Y\88Y! PR
MY;&Z&PZY%Q2V_8%'3=!>3<)F+.E5Y9I^%)QZP(A>6CP3=R/?ZWE)-:J=@(@&
MEIUR7V(9IL$=3EECAA[%(2V&/&2LK!5R3"[/XH6)%]\:]K-6R+%LG&/[.S!D
M>V$88CF'Q0L3+U;42%C*S?WF6Y%UHKQE8\M;WX$A6PO#$,N6+5X4,LI7DRTO
MY>9^;_KO#"X9UHF&OY?!/W;2W%^<S_GT(["&XRQ(88874)8DGD82LSL*2QJS
M(HTY75):4GDZJ<SG:"SIS()T9A,1:ZGD:50RDU.P!/$,LN3[(STLC3R-1N9U
M,)9L9D$VWQ<;9&GB:33Q7;MN$?X[[_>M4VI6CF7KCUII K"NJ&4@!.N%6BJ"
ML ZH9200ZWM:2H*Q;J<%TX;U."T#&5AGT_)1AO4S+2FQ6!?3,U."]2[- <VK
MTK[7!$<+2?$6&[X3&ZR7<19X93V,*XKVUK>X:/2W?L4E(0/K45PVLK#>Q"4C
M$^M'7"!%6!_B4LN(']Y[N&02PGH.GY]$?FB?X7/CO_47/AFY%]AG;4V0WN9)
M?CLI+&4EAR5HO&=)XFDDL0:>I+4C#>M46EI263/OTEJ1CG4T+0.5K+;'::T(
MPCJ?EI1&ULX+M59D\T,[I&R>Y!HBO,V37,[H3>N/6C@!6%?4,A""]4(M%4%8
M!]0R$HCU/2TEP5BWD\V3M&1@G4U+2!G6S[2DQ&)=3#9/<O71W.9)6FRX%QNL
MEW'1\9[6P[A M+>^Q46CO_4K+@D96(_BLI&%]28N&9E8/Z+-D_QAD=]Z#Y>+
M'JSG<.E(Y(?V&=H\R95#[F]M\VN=14L3B[G"7J.E;*WZO:1@'4A+0Q)KX$E:
M.]*P3J6E)94U\RZM%>E81],R4,EJ>YS6BB"L\VE):63MO%!K138_M$/*YDFN
M(<+;/,GEC-ZT_JB%$X!U12T#(5@OU%(1A'5 +2.!6-_34A*,=3O9/$E+!M;9
MM(248?U,2THLUL5D\R17'\UMGJ3%AGNQP7H9%QWO:3V,"T1[ZUM<-/I;O^*2
MD('U*"X;65AOXI*1B?4CVCS)'Q;YK?=PN>C!>@Z7CD1^:)^AS9-<;N1. T]B
M]F^7QV6<&PH>IY%XZ\7A=JNY=PB/Z*'T5X7Q<:SJP2\'/!+QM/'5XNF9[YP
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MZI?V52&6D;7/SR_.?N^P3OOH%PQTA"$8?')^=MG^>,D^GEQ>=8Y9^QT\,LL
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M8$ >&$9=X0.->VC<QND0H!EK-X@9$H&</A#*CY*CF(Z-*^+)X?([!6RWQ@?
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M[O\^X)_I%I(N_KOY_0/&^I-7J\9&ON"Q8,=G[/3L2MI>=."Y++=W^\MSF%3
M4N9&X+F&M\'T' DZ1IGN4:,,CQI+(H"TEF=Z!.$0N! \6\Q;SV^J"W4:O1@>
M )L[DLF_DZGANA*/2KV("B4PZF!A/Q8@<RJJ$H1A3KA@F2RH0J$<,^^BD+Q(
M-V,**DK^<$.JD*93WB<+?\19_#9L(<?Z0K E.K^%0(8!@DV9W:RS5=[1%T[V
M!9U%5CQ$A6$!E^VE/M?E1O$CR33Q+_F:*\10Y&&3I11[O-@;I=$(UD?IW*X
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MXCXQ3IO&S*'/5AO+#E$Z*3L+. 6Y3BFG<E!=I:0F<Y!]RD7&<#A,,HY"GV'
MH+F;C@Z!P\>&^>TLM2'0BUFGZ].5 1YH6'I.'-/M"=2+977X:!1Z%0'( 3N#
M \/08$FHV]/JZPQ%=%T@3V;2!&::&E0%CSDF-S!#FS_10)I2"_27PYUA<8]'
M0K;-SJ,*^F&/>H4#> +!P@B#H7"]'D+E!2YL+34^8^W8R6A9><0[9[B$7P2G
MMG,7\#,9LRO959)CWPV?B3B1I3YNX#<J:*$K^6BN0#R@M55C ^)IKI#Y.UBU
M0]P(/QQ1I7J8 ?4;#*:(N.Q0GD;"@9T5,=5$HO)O(TK8D74\L!\S/,AU[.X
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M/@H#-^W)9J.=9.#UGKN$DCW/[U[59^%0WAMWPU%"? V/E]U_O#*AD6)B9?P
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M=PR576;O,GZ+E]"X1=EZUTC96!W@J2XR.1F<JXB3>X"8WMBRL<6R,61$1'9
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MHX]BL/_6<H-<F&@#(NKE3V/D5=T6K:3%;-VV'"1 BF!P+J[>XR+?@5[@N5T
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M^(ZTDR;]8Q8![7QZAW!?-4'=F2CRS'*(#L?;E,:L([$4O#L716R,I;\D4'_
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M3SD< +N(VQ)P^,<(Y\$H+S= G1!Y/2KKZ"9<=)OW+=O%>ZT&7;#; +$.%F[
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MG^H1]81,"7MCQRW6\>#EVYIN>'X<L*4Z.NSI5M4-NE%H$XN!MS$-=\?W$_A
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M=&>2Y54VE5?Y ]_NN*;H85D6SCW'2BU2M*04GG^@.CPX/D8@GPDX58^KV-&
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M5*])Q@1TN&L!TV2:1;+(WP*"K>!?IZP'8""7MDR "W"$\JGC&0&Z0'(!R-8
MQ99.GC0+1 9 RF_!S%/=*""!Q!C!!9AY C(%6)D#]B \W_,,5^\;7.(6A$^7
MCXI('LBIJ/S((/"&AYX]C-UT64<WX2TZH N1 &QS._PD*J![W(53 M)Q7!N
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MQKYA#*<>)Q7%P3\H&RD8WQ8#_0*)1PMB%W7!G@7!3^/(L>(Q$E]K\3$9*36
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MU^T9__[_4$L! A0#%     @ J*#=7%TI8B>6!   ]A4  !$
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M4$L! A0#%     @ J*#=7-ZWJC+?T0  @7P(  X              ( !SRL
E &9O<FUD968Q-&$N:'1M4$L%!@     %  4 1 $  -K]      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>formdef14a_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:BLNE="http://makeabeeline.com/20251231"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="blne-20251231.xsd" xlink:type="simple"/>
    <context id="From2025-01-01to2025-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_2025-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:RestatementDateAxis">
                    <ecd:RestatementDateAxis.domain>2025-12-31</ecd:RestatementDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_NicholasRLiuzzaJrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:NicholasRLiuzzaJrMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_GeoffreyGwinMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:GeoffreyGwinMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_NicholasRLiuzzaJrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:NicholasRLiuzzaJrMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_GeoffreyGwinMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:GeoffreyGwinMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_NicholasRLiuzzaJrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:NicholasRLiuzzaJrMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_GeoffreyGwinMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:GeoffreyGwinMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_NicholasRLiuzzaJrMember_custom_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:NicholasRLiuzzaJrMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_NicholasRLiuzzaJrMember_custom_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:NicholasRLiuzzaJrMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_NicholasRLiuzzaJrMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:NicholasRLiuzzaJrMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_NicholasRLiuzzaJrMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:NicholasRLiuzzaJrMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_NicholasRLiuzzaJrMember_custom_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:NicholasRLiuzzaJrMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_NicholasRLiuzzaJrMember_custom_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:NicholasRLiuzzaJrMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_GeoffreyGwinMember_custom_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:GeoffreyGwinMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_GeoffreyGwinMember_custom_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:GeoffreyGwinMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_GeoffreyGwinMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:GeoffreyGwinMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_GeoffreyGwinMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:GeoffreyGwinMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_GeoffreyGwinMember_custom_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:GeoffreyGwinMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_GeoffreyGwinMember_custom_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:GeoffreyGwinMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ecd_NonPeoNeoMember_custom_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ecd_NonPeoNeoMember_custom_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ecd_NonPeoNeoMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ecd_NonPeoNeoMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ecd_NonPeoNeoMember_custom_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ecd_NonPeoNeoMember_custom_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_NicholasRLiuzzaJrMember_custom_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:NicholasRLiuzzaJrMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_NicholasRLiuzzaJrMember_custom_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:NicholasRLiuzzaJrMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_NicholasRLiuzzaJrMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:NicholasRLiuzzaJrMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_NicholasRLiuzzaJrMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:NicholasRLiuzzaJrMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_NicholasRLiuzzaJrMember_custom_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:NicholasRLiuzzaJrMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_NicholasRLiuzzaJrMember_custom_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:NicholasRLiuzzaJrMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_GeoffreyGwinMember_custom_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:GeoffreyGwinMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_GeoffreyGwinMember_custom_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:GeoffreyGwinMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_GeoffreyGwinMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:GeoffreyGwinMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_GeoffreyGwinMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:GeoffreyGwinMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_GeoffreyGwinMember_custom_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:GeoffreyGwinMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_GeoffreyGwinMember_custom_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:GeoffreyGwinMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_NicholasRLiuzzaJrMember_custom_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:NicholasRLiuzzaJrMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_NicholasRLiuzzaJrMember_custom_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:NicholasRLiuzzaJrMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_NicholasRLiuzzaJrMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:NicholasRLiuzzaJrMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_NicholasRLiuzzaJrMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:NicholasRLiuzzaJrMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_NicholasRLiuzzaJrMember_custom_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:NicholasRLiuzzaJrMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_NicholasRLiuzzaJrMember_custom_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:NicholasRLiuzzaJrMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_GeoffreyGwinMember_custom_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:GeoffreyGwinMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_GeoffreyGwinMember_custom_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:GeoffreyGwinMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_GeoffreyGwinMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:GeoffreyGwinMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_GeoffreyGwinMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:GeoffreyGwinMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_GeoffreyGwinMember_custom_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:GeoffreyGwinMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_GeoffreyGwinMember_custom_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">BLNE:GeoffreyGwinMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534708</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">BLNE:ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <dei:AmendmentFlag contextRef="From2025-01-01to2025-12-31" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="From2025-01-01to2025-12-31" id="Fact000004">0001534708</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="From2025-01-01to2025-12-31" id="xdx2ixbrl0011">DEF 14A</dei:DocumentType>
    <ecd:PeoTotalCompAmt
      contextRef="From2023-01-012023-12-31_custom_NicholasRLiuzzaJrMember"
      id="xdx2ixbrl0033"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2023-01-012023-12-31_custom_NicholasRLiuzzaJrMember"
      id="xdx2ixbrl0034"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0037"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_custom_NicholasRLiuzzaJrMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember"
      id="xdx2ixbrl0060"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_custom_NicholasRLiuzzaJrMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember"
      id="xdx2ixbrl0061"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_custom_NicholasRLiuzzaJrMember_custom_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember"
      id="xdx2ixbrl0062"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_custom_NicholasRLiuzzaJrMember_custom_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember"
      id="xdx2ixbrl0063"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_custom_GeoffreyGwinMember_custom_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember"
      id="xdx2ixbrl0067"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_custom_GeoffreyGwinMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember"
      id="xdx2ixbrl0068"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_custom_GeoffreyGwinMember_custom_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember"
      id="xdx2ixbrl0071"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_ecd_NonPeoNeoMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember"
      id="xdx2ixbrl0076"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_ecd_NonPeoNeoMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember"
      id="xdx2ixbrl0077"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_ecd_NonPeoNeoMember_custom_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember"
      id="xdx2ixbrl0078"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_ecd_NonPeoNeoMember_custom_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember"
      id="xdx2ixbrl0079"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_custom_NicholasRLiuzzaJrMember_custom_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember"
      id="xdx2ixbrl0082"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_custom_NicholasRLiuzzaJrMember_custom_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember"
      id="xdx2ixbrl0083"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_custom_NicholasRLiuzzaJrMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember"
      id="xdx2ixbrl0084"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_custom_NicholasRLiuzzaJrMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember"
      id="xdx2ixbrl0085"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_custom_NicholasRLiuzzaJrMember_custom_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember"
      id="xdx2ixbrl0086"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_custom_NicholasRLiuzzaJrMember_custom_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember"
      id="xdx2ixbrl0087"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_custom_GeoffreyGwinMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember"
      id="xdx2ixbrl0092"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_custom_GeoffreyGwinMember_custom_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember"
      id="xdx2ixbrl0094"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_custom_GeoffreyGwinMember_custom_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember"
      id="xdx2ixbrl0095"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember"
      id="xdx2ixbrl0098"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember"
      id="xdx2ixbrl0099"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember"
      id="xdx2ixbrl0100"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember"
      id="xdx2ixbrl0101"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember"
      id="xdx2ixbrl0102"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember"
      id="xdx2ixbrl0103"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:PeoTotalCompAmt
      contextRef="From2023-01-012023-12-31_custom_NicholasRLiuzzaJrMember"
      id="xdx2ixbrl0105"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_NicholasRLiuzzaJrMember_custom_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember"
      id="xdx2ixbrl0106"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_NicholasRLiuzzaJrMember_custom_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember"
      id="xdx2ixbrl0107"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_NicholasRLiuzzaJrMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember"
      id="xdx2ixbrl0108"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_NicholasRLiuzzaJrMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember"
      id="xdx2ixbrl0109"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_NicholasRLiuzzaJrMember_custom_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember"
      id="xdx2ixbrl0110"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_NicholasRLiuzzaJrMember_custom_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember"
      id="xdx2ixbrl0111"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2023-01-012023-12-31_custom_NicholasRLiuzzaJrMember"
      id="xdx2ixbrl0112"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_GeoffreyGwinMember_custom_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember"
      id="xdx2ixbrl0114"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_GeoffreyGwinMember_custom_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember"
      id="xdx2ixbrl0115"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_GeoffreyGwinMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember"
      id="xdx2ixbrl0116"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_GeoffreyGwinMember_custom_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember"
      id="xdx2ixbrl0118"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_GeoffreyGwinMember_custom_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember"
      id="xdx2ixbrl0119"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember"
      id="xdx2ixbrl0121"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember"
      id="xdx2ixbrl0122"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember"
      id="xdx2ixbrl0123"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember"
      id="xdx2ixbrl0124"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember"
      id="xdx2ixbrl0126"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember"
      id="xdx2ixbrl0127"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:EntityRegistrantName contextRef="From2025-01-01to2025-12-31" id="Fact000012">BEELINE HOLDINGS, INC.</dei:EntityRegistrantName>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="From2025-01-01to2025-12-31" id="Fact000013">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <ecd:ErrCompAnalysisTextBlock
      contextRef="From2025-01-012025-12-31_2025-12-31"
      id="Fact000014">&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has implemented &lt;span style="background-color: white"&gt;a Clawback Policy in accordance with the Nasdaq Rules, to recoup &#x201c;excess&#x201d;
incentive compensation, if any, earned by current and former executive officers during a three year look back period in the event of
a financial restatement due to material noncompliance with any financial reporting requirement under the securities laws (with no fault
required)&lt;/span&gt;. The Company also uses forms of agreements relating to equity grants which also include other drawbacks relating to
improper conduct.&lt;/span&gt;</ecd:ErrCompAnalysisTextBlock>
    <ecd:PvpTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000016">&lt;table cellpadding="0" cellspacing="0" id="xdx_880_eecd--PvpTableTextBlock_zBvx4atBvnR1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Pay vs Performance Disclosure"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;Year &lt;br/&gt; (a)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_481_eecd--PeoTotalCompAmt_hecd--IndividualAxis__custom--NicholasRLiuzzaJrMember_zCHKJsOPM1Fg" style="border-bottom: Black 1pt solid; text-align: center"&gt;Summary
    Compensation Table Total for PEO (Nicholas R. Liuzza, Jr.)&lt;br/&gt; (b)&lt;span id="xdx_F5C_zhf3gNDGe9X9"&gt;(1)&lt;/span&gt;($)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_48E_eecd--PeoActuallyPaidCompAmt_hecd--IndividualAxis__custom--NicholasRLiuzzaJrMember_z0yEM0AQE258" style="border-bottom: Black 1pt solid; text-align: center"&gt;Compensation
    Actually Paid to PEO (Nicholas R. Liuzza, Jr.)&lt;br/&gt; (c)&lt;span id="xdx_F5B_zorajZrQbL68"&gt;(3)&lt;/span&gt;($)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_481_eecd--PeoTotalCompAmt_hecd--IndividualAxis__custom--GeoffreyGwinMember_zbwmuCs8nAN" style="border-bottom: Black 1pt solid; text-align: center"&gt;Summary
    Compensation Table Total for PEO (Geoffrey Gwin) &lt;br/&gt; (b)&lt;span id="xdx_F5E_zpegBq8nz6l9"&gt;(2)&lt;/span&gt;($)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_480_eecd--PeoActuallyPaidCompAmt_hecd--IndividualAxis__custom--GeoffreyGwinMember_zZCrIUs84tzk" style="border-bottom: Black 1pt solid; text-align: center"&gt;Compensation
    Actually Paid to PEO (Geoffrey Gwin)&lt;br/&gt; (c)&lt;span id="xdx_F5E_z7srRy3clvDh"&gt;(3)&lt;/span&gt;($)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_483_eecd--NonPeoNeoAvgTotalCompAmt_zcJWEJlMHFBh" style="border-bottom: Black 1pt solid; text-align: center"&gt;Average
    Summary Compensation Table Total for non-PEO Named Executive Officers&lt;br/&gt; (d)&lt;span id="xdx_F5A_ztJ7RKaQUkmb"&gt;(4)&lt;/span&gt;($)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_48A_eecd--NonPeoNeoAvgCompActuallyPaidAmt_zWTTYBUuKkH" style="border-bottom: Black 1pt solid; text-align: center"&gt;Average
    Compensation Actually Paid to non-PEO Named Executive Officers&lt;br/&gt; (e)&lt;span id="xdx_F50_zFbOUeqwaxr5"&gt;(3)&lt;/span&gt;($)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_480_eecd--TotalShareholderRtnAmt_pp2d_z01T7iiuPHL1" style="border-bottom: Black 1pt solid; text-align: center"&gt;Value
    of Initial Fixed $100 Investment Based On Total Shareholder Return&lt;br/&gt; (f)&lt;span id="xdx_F5A_z5Zmcbgw8VRg"&gt;(5)&lt;/span&gt;($)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_48B_eus-gaap--NetIncomeLoss_zUsHkNlheIK" style="border-bottom: Black 1pt solid; text-align: center"&gt;Net Income/
    (Loss)&lt;br/&gt; (g)&lt;span id="xdx_F55_zox12ceEF5r3"&gt;(6)&lt;/span&gt;($)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_416_20250101__20251231_zUUH9HU1GC38" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 9%; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;76,080&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;107,700&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;214,300&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;55,900&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;296,916&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;382,290&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;28.18&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;(23,381,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_413_20240101__20241231_z0Wn5UiTQEZ7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;2024&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;30,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;30,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;772,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;925,160&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;290,672&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;290,672&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;21.03&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(13,076,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_41C_20230101__20231231_z3zkBHj7DGL" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;2023&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0033"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0034"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;250,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;256,878&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0037"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;20,452&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3.76&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(7,535,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ecd:PvpTableTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="From2025-01-012025-12-31_custom_NicholasRLiuzzaJrMember"
      decimals="0"
      id="Fact000017"
      unitRef="USD">76080</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2025-01-012025-12-31_custom_NicholasRLiuzzaJrMember"
      decimals="0"
      id="Fact000018"
      unitRef="USD">107700</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="From2025-01-012025-12-31_custom_GeoffreyGwinMember"
      decimals="0"
      id="Fact000019"
      unitRef="USD">214300</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2025-01-012025-12-31_custom_GeoffreyGwinMember"
      decimals="0"
      id="Fact000020"
      unitRef="USD">55900</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000021"
      unitRef="USD">296916</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000022"
      unitRef="USD">382290</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="From2025-01-01to2025-12-31"
      decimals="2"
      id="Fact000023"
      unitRef="USD">28.18</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000024"
      unitRef="USD">-23381000</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt
      contextRef="From2024-01-012024-12-31_custom_NicholasRLiuzzaJrMember"
      decimals="0"
      id="Fact000025"
      unitRef="USD">30000</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2024-01-012024-12-31_custom_NicholasRLiuzzaJrMember"
      decimals="0"
      id="Fact000026"
      unitRef="USD">30000</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="From2024-01-012024-12-31_custom_GeoffreyGwinMember"
      decimals="0"
      id="Fact000027"
      unitRef="USD">772000</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2024-01-012024-12-31_custom_GeoffreyGwinMember"
      decimals="0"
      id="Fact000028"
      unitRef="USD">925160</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000029"
      unitRef="USD">290672</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000030"
      unitRef="USD">290672</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="From2024-01-012024-12-31"
      decimals="2"
      id="Fact000031"
      unitRef="USD">21.03</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000032"
      unitRef="USD">-13076000</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt
      contextRef="From2023-01-012023-12-31_custom_GeoffreyGwinMember"
      decimals="0"
      id="Fact000035"
      unitRef="USD">250000</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2023-01-012023-12-31_custom_GeoffreyGwinMember"
      decimals="0"
      id="Fact000036"
      unitRef="USD">256878</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000038"
      unitRef="USD">20452</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="From2023-01-012023-12-31"
      decimals="2"
      id="Fact000039"
      unitRef="USD">3.76</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000040"
      unitRef="USD">-7535000</us-gaap:NetIncomeLoss>
    <ecd:PeoName
      contextRef="From2025-01-012025-12-31_custom_NicholasRLiuzzaJrMember"
      id="Fact000047">Mr. Liuzza</ecd:PeoName>
    <ecd:PeoName
      contextRef="From2024-01-012024-12-31_custom_NicholasRLiuzzaJrMember"
      id="Fact000048">Mr. Liuzza</ecd:PeoName>
    <ecd:PeoName
      contextRef="From2023-01-012023-12-31_custom_NicholasRLiuzzaJrMember"
      id="Fact000049">Mr. Liuzza</ecd:PeoName>
    <ecd:PeoName
      contextRef="From2025-01-012025-12-31_custom_GeoffreyGwinMember"
      id="Fact000050">Mr. Gwin</ecd:PeoName>
    <ecd:PeoName
      contextRef="From2024-01-012024-12-31_custom_GeoffreyGwinMember"
      id="Fact000051">Mr. Gwin</ecd:PeoName>
    <ecd:PeoName
      contextRef="From2023-01-012023-12-31_custom_GeoffreyGwinMember"
      id="Fact000052">Mr. Gwin</ecd:PeoName>
    <ecd:TotalShareholderRtnVsPeerGroupTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000054">&lt;p id="xdx_896_eecd--TotalShareholderRtnVsPeerGroupTextBlock_dU_zcAKa5q6vwg7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(5)
Represents the cumulative total shareholder return of a fixed investment of $100 made at the closing price of the Company&#x2019;s Common
Stock at December 31, 2022, for the measurement period beginning on such date and continuing through and including the end of the applicable
fiscal year reflected in the table.&lt;/span&gt;&lt;/p&gt;

</ecd:TotalShareholderRtnVsPeerGroupTextBlock>
    <ecd:EquityValuationAssumptionDifferenceFnTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000056">&lt;p id="xdx_894_eecd--EquityValuationAssumptionDifferenceFnTextBlock_dU_zHhJHuBNEtNi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Name&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_480_eecd--PeoTotalCompAmt_zJmsmRoLUgXh" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Summary&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Compensation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Table Total&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_489_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember_zD0hvX0e0jUc" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Deduct &#x201c;Stock&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Awards&#x201d; and&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#x201c;Option&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Awards&#x201d;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;reported in&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Summary&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Compensation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Table&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_484_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember_zJnRwNyhyH0k" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Add Year-&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;End Fair&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Value of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Outstanding&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;and&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Unvested&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Equity&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Awards&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Granted in&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;the Year&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_48E_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember_zt9tLLsDqza3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Add (Deduct)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year over&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year Change&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;in Fair&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Value of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Outstanding&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;and Unvested&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Equity&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Awards&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Granted in&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Prior Years&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_489_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember_zUnAMIEvSZC9" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Add Fair&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Value as of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Vesting Date&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;of Equity&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Awards&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Granted and&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Vested in&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;the Year&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_485_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember_ztnCSqjfF35k" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Add&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Deduct)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year over&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year Change&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;in Fair Value&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;of Equity&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Awards&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Granted in&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Prior Years&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;which&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Vested in&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;the Year&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_482_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember_zylSsBXvhLEh" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Add Value&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;of any&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Dividends&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;or Other&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Earnings&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Paid in&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;the Year&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_48C_eecd--PeoActuallyPaidCompAmt_zucz0S7GdHUg" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Compensation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Actually Paid&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_41F_20250101__20251231__ecd--IndividualAxis__custom--NicholasRLiuzzaJrMember_zkNrpcfCjdC4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 4%; font-weight: bold; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 29%; text-align: left"&gt;PEO-Nicholas R. Liuzza, Jr.&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 4%; text-align: right"&gt;76,080&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 4%; text-align: right"&gt;(46,080&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 4%; text-align: right"&gt;77,700&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 4%; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl0060"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 4%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0061"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 4%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0062"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 4%; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl0063"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 4%; text-align: right"&gt;107,700&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_419_20250101__20251231__ecd--IndividualAxis__custom--GeoffreyGwinMember_zyafbdRzRAF7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;PEO-Geoffrey Gwin&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;214,300&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(14,300&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0067"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0068"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,300&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(158,400&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0071"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;55,900&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;Other NEOs (Average)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eecd--NonPeoNeoAvgTotalCompAmt_c20250101__20251231__ecd--IndividualAxis__ecd--NonPeoNeoMember_z4jrGDchh24" style="text-align: right"&gt;296,916&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eecd--AdjToCompAmt_c20250101__20251231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember_zh9rqyWIdgN8" style="text-align: right"&gt;(124,416&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eecd--AdjToCompAmt_c20250101__20251231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember_zkhGmHdYLrbh" style="text-align: right"&gt;209,790&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eecd--AdjToCompAmt_c20250101__20251231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember_zzHyOprLMkk4" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0076"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eecd--AdjToCompAmt_c20250101__20251231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember_zV6IuRBiDI0a" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0077"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eecd--AdjToCompAmt_c20250101__20251231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember_z85VkliPmcmh" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0078"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eecd--AdjToCompAmt_c20250101__20251231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember_zLjqhlualMq8" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0079"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20250101__20251231__ecd--IndividualAxis__ecd--NonPeoNeoMember_zc3fUW31dOag" style="text-align: right"&gt;382,290&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_41D_20240101__20241231__ecd--IndividualAxis__custom--NicholasRLiuzzaJrMember_z0s5wDRssRz7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;PEO-Nicholas R. Liuzza, Jr.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;30,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0082"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0083"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0084"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0085"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0086"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0087"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;30,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_41E_20240101__20241231__ecd--IndividualAxis__custom--GeoffreyGwinMember_zkBtxuDF5xAa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;PEO-Geoffrey Gwin&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;772,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(422,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;385,160&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0092"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;190,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0094"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0095"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;925,160&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;Other NEOs (Average)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eecd--NonPeoNeoAvgTotalCompAmt_c20240101__20241231__ecd--IndividualAxis__ecd--NonPeoNeoMember_zacdG22DXSY4" style="text-align: right"&gt;290,672&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eecd--AdjToCompAmt_c20240101__20241231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember_zv6TUsMcm7Ua" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0098"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eecd--AdjToCompAmt_c20240101__20241231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember_zwXSbPAipL4e" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0099"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eecd--AdjToCompAmt_c20240101__20241231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember_z5soDv13KEO7" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0100"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eecd--AdjToCompAmt_c20240101__20241231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember_zfDS7SCirtJl" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0101"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eecd--AdjToCompAmt_c20240101__20241231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember_zQmHgxC8Exil" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0102"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eecd--AdjToCompAmt_c20240101__20241231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember_zK0AWJD0ke0c" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0103"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20240101__20241231__ecd--IndividualAxis__ecd--NonPeoNeoMember_zlqscSwyZ8Uj" style="text-align: right"&gt;290,672&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_418_20230101__20231231__ecd--IndividualAxis__custom--NicholasRLiuzzaJrMember_zOxnOZsAMY2c" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;PEO-Nicholas R. Liuzza, Jr.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0105"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0106"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0107"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0108"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0109"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0110"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0111"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0112"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_41B_20230101__20231231__ecd--IndividualAxis__custom--GeoffreyGwinMember_z6G8KK6BkGi6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;PEO-Geoffrey Gwin&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;250,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0114"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0115"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0116"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,878&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0118"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0119"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;256,878&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;Other NEOs (Average)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eecd--NonPeoNeoAvgTotalCompAmt_c20230101__20231231__ecd--IndividualAxis__ecd--NonPeoNeoMember_zeVcqpMBZDb4" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0121"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eecd--AdjToCompAmt_c20230101__20231231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember_z0q101lGkOXk" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0122"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eecd--AdjToCompAmt_c20230101__20231231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember_zWKUsQYw3MR4" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0123"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eecd--AdjToCompAmt_c20230101__20231231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember_zmnMOLMvQq9a" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0124"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eecd--AdjToCompAmt_c20230101__20231231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember_zXBX59QcqaJ9" style="text-align: right"&gt;20,452&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eecd--AdjToCompAmt_c20230101__20231231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember_zzY5a94zZQpl" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0126"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eecd--AdjToCompAmt_c20230101__20231231__ecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--ValueOfAnyDividendsOrOtherEarningsPaidInTheYearMember_z8hwWV9EfFvk" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0127"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20230101__20231231__ecd--IndividualAxis__ecd--NonPeoNeoMember_zdsmx6epUwBa" style="text-align: right"&gt;20,452&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</ecd:EquityValuationAssumptionDifferenceFnTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="From2025-01-012025-12-31_custom_NicholasRLiuzzaJrMember"
      decimals="0"
      id="Fact000057"
      unitRef="USD">76080</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_custom_NicholasRLiuzzaJrMember_custom_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember"
      decimals="0"
      id="Fact000058"
      unitRef="USD">-46080</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_custom_NicholasRLiuzzaJrMember_custom_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember"
      decimals="0"
      id="Fact000059"
      unitRef="USD">77700</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2025-01-012025-12-31_custom_NicholasRLiuzzaJrMember"
      decimals="0"
      id="Fact000064"
      unitRef="USD">107700</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="From2025-01-012025-12-31_custom_GeoffreyGwinMember"
      decimals="0"
      id="Fact000065"
      unitRef="USD">214300</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_custom_GeoffreyGwinMember_custom_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember"
      decimals="0"
      id="Fact000066"
      unitRef="USD">-14300</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_custom_GeoffreyGwinMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember"
      decimals="0"
      id="Fact000069"
      unitRef="USD">14300</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_custom_GeoffreyGwinMember_custom_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsWhichVestedInTheYearMember"
      decimals="0"
      id="Fact000070"
      unitRef="USD">-158400</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2025-01-012025-12-31_custom_GeoffreyGwinMember"
      decimals="0"
      id="Fact000072"
      unitRef="USD">55900</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2025-01-012025-12-31_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000073"
      unitRef="USD">296916</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_ecd_NonPeoNeoMember_custom_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember"
      decimals="0"
      id="Fact000074"
      unitRef="USD">-124416</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_ecd_NonPeoNeoMember_custom_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember"
      decimals="0"
      id="Fact000075"
      unitRef="USD">209790</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2025-01-012025-12-31_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000080"
      unitRef="USD">382290</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:PeoTotalCompAmt
      contextRef="From2024-01-012024-12-31_custom_NicholasRLiuzzaJrMember"
      decimals="0"
      id="Fact000081"
      unitRef="USD">30000</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2024-01-012024-12-31_custom_NicholasRLiuzzaJrMember"
      decimals="0"
      id="Fact000088"
      unitRef="USD">30000</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="From2024-01-012024-12-31_custom_GeoffreyGwinMember"
      decimals="0"
      id="Fact000089"
      unitRef="USD">772000</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_custom_GeoffreyGwinMember_custom_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember"
      decimals="0"
      id="Fact000090"
      unitRef="USD">-422000</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_custom_GeoffreyGwinMember_custom_YearEndFairValueofOutstandingAndUnvestedEquityAwardsGrantedInTheYearMember"
      decimals="0"
      id="Fact000091"
      unitRef="USD">385160</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_custom_GeoffreyGwinMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember"
      decimals="0"
      id="Fact000093"
      unitRef="USD">190000</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2024-01-012024-12-31_custom_GeoffreyGwinMember"
      decimals="0"
      id="Fact000096"
      unitRef="USD">925160</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000097"
      unitRef="USD">290672</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000104"
      unitRef="USD">290672</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:PeoTotalCompAmt
      contextRef="From2023-01-012023-12-31_custom_GeoffreyGwinMember"
      decimals="0"
      id="Fact000113"
      unitRef="USD">250000</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_GeoffreyGwinMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember"
      decimals="0"
      id="Fact000117"
      unitRef="USD">6878</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2023-01-012023-12-31_custom_GeoffreyGwinMember"
      decimals="0"
      id="Fact000120"
      unitRef="USD">256878</ecd:PeoActuallyPaidCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember"
      decimals="0"
      id="Fact000125"
      unitRef="USD">20452</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000128"
      unitRef="USD">20452</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000130">&lt;p id="xdx_894_eecd--CompActuallyPaidVsTotalShareholderRtnTextBlock_dU_z9bliJRWBylc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Relationship
Between Compensation Actually Paid and our Total Shareholder Return&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Our
stock price performance is not one of the elements used in determining Compensation Actually Paid to our Named Executive Officers. However,
the amount of Compensation Actually Paid to our Named Executive Officers aligns with the Company&#x2019;s Total Shareholder Return due
to the fact that a portion of the compensation paid to our NEOs is comprised of equity awards.&lt;/span&gt;&lt;/p&gt;

</ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock>
    <ecd:CompActuallyPaidVsNetIncomeTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000132">&lt;p id="xdx_893_eecd--CompActuallyPaidVsNetIncomeTextBlock_dU_z0oXkZ1QWPy6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Relationship
Between Compensation Actually Paid and our Net Income/(Loss)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;GAAP
net income/(loss) is a measure of our overall profitability that we believe is a factor that can drive our stock price performance. However,
Compensation Actually Paid is less sensitive to our annual GAAP net income/(loss) because management and our Board do not believe that
our GAAP net income/(loss) is the only meaningful measure in allowing investors to evaluate management&#x2019;s performance. The Board
considers multiple factors when determining executive compensation, including both financial and non-financial performance metrics, strategic
objectives, and market conditions. While the Company has experienced net losses in recent years, the Board believes that compensating
executives competitively is necessary to retain key talent with the skills to provide the leadership the Company needs to succeed and
to execute on the Company&#x2019;s long-term strategic plan.&lt;/span&gt;&lt;/p&gt;

</ecd:CompActuallyPaidVsNetIncomeTextBlock>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact000017"
          xlink:label="Fact000017"
          xlink:type="locator"/>
        <link:footnote id="Footnote000041" xlink:label="Footnote000041" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents the amounts reported for Mr. Liuzza, the Company&#x2019;s
current Chief Executive Officer, in the &#x201c;Total&#x201d; column of the &#x201c;Summary Compensation Table&#x201d; in each applicable
year.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000017"
          xlink:to="Footnote000041"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000025"
          xlink:label="Fact000025"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000025"
          xlink:to="Footnote000041"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0033"
          xlink:label="xdx2ixbrl0033"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0033"
          xlink:to="Footnote000041"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000019"
          xlink:label="Fact000019"
          xlink:type="locator"/>
        <link:footnote id="Footnote000042" xlink:label="Footnote000042" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents the amounts reported for Mr. Gwin, the Company&#x2019;s
former Chief Executive Officer. Mr. Gwin served as the Company&#x2019;s Chief Executive Officer until his resignation from such role on
March 7, 2025. Mr. Gwin also previously served as Chief Financial Officer until his resignation from such role on October 7, 2024, and
as President of Bridgetown Spirits until the sale of that entity on July 25, 2025.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000019"
          xlink:to="Footnote000042"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000027"
          xlink:label="Fact000027"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000027"
          xlink:to="Footnote000042"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000035"
          xlink:label="Fact000035"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000035"
          xlink:to="Footnote000042"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000018"
          xlink:label="Fact000018"
          xlink:type="locator"/>
        <link:footnote id="Footnote000043" xlink:label="Footnote000043" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">SEC rules require certain adjustments be made to the &#x201c;Summary
Compensation Table&#x201d; totals to determine &#x201c;compensation actually paid&#x201d; as reported in the &#x201c;Pay Versus Performance&#x201d;
table above. For purposes of the equity award adjustments shown below, no equity awards were cancelled as a result of a failure to meet
vesting conditions. The valuation assumptions used to calculate fair values for purposes of the compensation actually paid calculation
did not materially differ from those disclosed at the time of grant (as applicable). The table below details the applicable adjustments
to the amount in the &#x201c;Total&#x201d; column of the &#x201c;Summary Compensation Table&#x201d; in each applicable year that were made
to determine &#x201c;compensation actually paid&#x201d; (all amounts are averages for the NEOs other than the PEO).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000018"
          xlink:to="Footnote000043"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000020"
          xlink:label="Fact000020"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000020"
          xlink:to="Footnote000043"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000022"
          xlink:label="Fact000022"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000022"
          xlink:to="Footnote000043"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000026"
          xlink:label="Fact000026"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000026"
          xlink:to="Footnote000043"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000028"
          xlink:label="Fact000028"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000028"
          xlink:to="Footnote000043"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000030"
          xlink:label="Fact000030"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000030"
          xlink:to="Footnote000043"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0034"
          xlink:label="xdx2ixbrl0034"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0034"
          xlink:to="Footnote000043"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000036"
          xlink:label="Fact000036"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000036"
          xlink:to="Footnote000043"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000038"
          xlink:label="Fact000038"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000038"
          xlink:to="Footnote000043"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000021"
          xlink:label="Fact000021"
          xlink:type="locator"/>
        <link:footnote id="Footnote000044" xlink:label="Footnote000044" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents the average of the amounts reported for the NEOs
as a group (excluding the PEOs) in the &#x201c;Total&#x201d; column of the &#x201c;Summary Compensation Table&#x201d; in each applicable
year. The names of each of the non-PEO NEOs included for these purposes for 2025 are Mr. Moe and Ms. Milton, for 2024 include Mr. Moe
only, for 2023 include Ms. Milton only. Mr. Moe was appointed as the Company&#x2019;s Chief Financial Officer on October 7, 2024, and
prior to that Mr. Moe served as the Chief Financial Officer of Beeline Financial since June 2023. Ms. Milton was appointed as the Company&#x2019;s
Chief Accounting Officer on April 25, 2025.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000021"
          xlink:to="Footnote000044"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000029"
          xlink:label="Fact000029"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000029"
          xlink:to="Footnote000044"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0037"
          xlink:label="xdx2ixbrl0037"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0037"
          xlink:to="Footnote000044"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000023"
          xlink:label="Fact000023"
          xlink:type="locator"/>
        <link:footnote id="Footnote000045" xlink:label="Footnote000045" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents the cumulative total shareholder return of a fixed
investment of $100 made at the closing price of the Company&#x2019;s Common Stock at December 31, 2022, for the measurement period beginning
on such date and continuing through and including the end of the applicable fiscal year reflected in the table.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000023"
          xlink:to="Footnote000045"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000031"
          xlink:label="Fact000031"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000031"
          xlink:to="Footnote000045"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000039"
          xlink:label="Fact000039"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000039"
          xlink:to="Footnote000045"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000024"
          xlink:label="Fact000024"
          xlink:type="locator"/>
        <link:footnote id="Footnote000046" xlink:label="Footnote000046" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents the amount of net income/(loss) reflected in the
Company&#x2019;s audited consolidated financial statements for the applicable fiscal year reflected in the table.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000024"
          xlink:to="Footnote000046"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000032"
          xlink:label="Fact000032"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000032"
          xlink:to="Footnote000046"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000040"
          xlink:label="Fact000040"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000040"
          xlink:to="Footnote000046"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
